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The deterioration of lipids by oxygen, termed peroxidation, is a constitutive process in 
living systems. Enzymatic peroxidation is required for some forms of cell signalling, 
but the non-enzymatic peroxidation of polyunsaturated fatty acids (PUFA) produces 
numerous toxic and mutagenic products associated with pathology and aging. 
Phospholipids containing PUFA are common in mammalian membranes, but an inverse 
relationship has been found between membrane susceptibility to peroxidation and 
maximal lifespan (MLS). Past studies of peroxidation have focused on the PUFA 
content of phospholipids, but other elements of phospholipid composition including 
class and saturated fatty acid (SFA) or monounsaturated fatty acid (MUFA) content 
may also influence peroxidation. This thesis presents three studies investigating the 
relationship between phospholipid composition and peroxidation. 
In the first study, published data was analysed to examine the relationship 
between dietary fatty acids and the PUFA composition of cardiolipin and other classes 
of mitochondrial phospholipids. The composition of heart cardiolipin is commonly 
viewed as being strongly regulated due to its high levels of linoleic acid (18:2n-6), but 
the analysis showed that the percentage of 18:2n-6 in cardiolipin of heart conformed to 
dietary availability from 2–20% of total dietary fatty acids and was thereafter regulated. 
The percentage of 18:2n-6 in liver cardiolipin was lower than in heart, and was 
regulated across the dietary range examined. When both 18:2n-6 and docosahexaenoic 
acid (22:6n-3) were present in the diet, 22:6n-3 was incorporated into cardiolipin of 
heart and liver at the expense of 18:2n-6. The content of 22:6n-3 present in 
phosphatidylcholine and phosphatidylethanolamine also conformed to dietary levels, 
but not at the expense of 18:2n-6. This study suggests that dietary 22:6n-3 may increase 
the susceptibility of cardiolipin and other mitochondrial classes to peroxidation, and 
may therefore alter mitochondrial function. 
In the second study, in vitro assays of iron-mediated peroxidation were used to 
investigate the effect of phospholipid composition on iron-mediated, non-enzymatic 
peroxidation. The influence of phospholipid class was examined for phospholipids of 
the cardiolipin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol 
and phosphatidic acid classes that were matched for 18:2n-6 content. Iron-initiated 




Cardiolipin and phosphatidic acid were found to peroxidise more readily than other 
classes in diffuse solution, but not in liposomes. Differences in peroxidation between 
classes were found to be related to head group charges in diffuse solution but head 
group sizes in liposomes. Following this work, in vitro assays of peroxidation were used 
to investigate whether phospholipids composed of SFA and MUFA influence the rates 
and phases of peroxidation. Phospholipids containing no PUFA, termed non-
peroxidisable phospholipids (non-PPLs), were found to have an antioxidant-like effect 
that extended the duration of the lag phase of peroxidation several-fold through a weak 
inhibitory effect on rate of peroxidation during the lag phase. Non-PPLs are common in 
cellular membranes, suggesting that this antioxidant-like activity may be a widespread 
mechanism that augments traditional antioxidant defences to delay peroxidation. 
In the third study, shotgun lipidomics was used to examine the phospholipid 
composition and peroxidation index of skeletal muscle, liver, and brain from mice (Mus 
musculus, MLS of 4 years), pigs (Sus scrofa, MLS of 27 years), and humans (Homo 
sapiens, MLS of 122 years). A comparison of mitochondrial membranes found a higher 
percentage of 22:6n-3 and a higher peroxidation index for each tissue in mice than 
humans. In comparison to mice, the mitochondrial membranes of humans contained a 
lower percentage of PUFA and a higher percentage of non-PPLs. The mitochondrial 
membranes of pigs shared characteristics of both mice and humans, supporting earlier 
findings that membrane composition is associated with lifespan. A second investigation 
of the importance of membrane composition to lifespan examined whether humans 
prevent peroxidation by excluding highly peroxidisable PUFA from their mitochondrial 
membranes. This exclusion has been suggested to be an evolutionary adaptation to 
extend longevity that is unique in humans. An intra-species comparison found few 
significant differences in the distributions of phospholipid classes, molecular 
phospholipids within classes, fatty acid composition, and the peroxidation index 
between the mitochondrial and microsomal membranes of humans, mice or pigs. This 
study is one of the most in-depth lipidomics analysis of human tissue to date, and 
suggests that human longevity may be related to a decrease in the susceptibility of all 
cellular membrane phospholipids to peroxidation. 
 
  
Acknowledgement and thanks 
iv 
 
Acknowledgements and thanks 
I would like to acknowledge the following people for making the academic and 
technical aspects of this work possible: 
 Prof. Paul Else, my primary supervisor, for encouraging me to undertake a Ph.D and 
guiding me with patience, humour, and a keen eye for detail. 
 Assoc. Prof. Todd Mitchell, my co-supervisor, for his assistance with mass 
spectrometry techniques and his timely turnaround of whatever work I submitted to 
him. 
 Prof. Tony Hulbert for his lessons on scientific writing and scientific thought, and for 
suggesting the comparative biology aspect of this thesis. 
 Dr. Darryl McAndrew, for organizing and guiding the collection of human tissues. 
 Ms. Sarah Norris, my Ph.D. sister, for her assistance with the mass spectrometry 
methods and general support during the trying times of Ph.D. life. 
 Mr. Adam Zieba for his technical support in a wide range of areas. 
 
In addition, I was lucky enough to have the support of many family and friends. My 
heartfelt thanks to: 
 My parents for all their support, advice and kindness. 
 My older brother, David, for his support and advice. 
 My younger brother, Steve, for his unconditional sympathy while listening to my 
tedious complaints. 
 My grandparents for all their quiet encouragement. 
 Joel Mason, for always agreeing with me. 
 My in-laws for all their support (and food). 
 My scientific friends: Martin Engel, Lisa Franks, Franchesca Fernandez, Sarah 
Abbot, Megan Kelly, Peta Snikeris, Sai Ruthirakumar, Nicholas Martin, Adam Zieba 
and Sarah Norris for their friendship and support over the years. 
 My friends at ‘cage’ soccer for their weekly dose of Sunday exercise. 
 
And finally to my wife, Lill, for her endless love, support, and proof-reading during the 
good times and the bad. 
 
Table of contents 
v 
 
Table of contents 
Thesis certification .................................................................................................................. i 
Abstract .................................................................................................................................. ii 
Acknowledgements and thanks ............................................................................................. iv 
Table of contents .................................................................................................................... v 
List of figures ........................................................................................................................ ix 
List of tables .......................................................................................................................... xi 
List of abbreviations ............................................................................................................. xii 
Publications and presentation arising from this thesis……………..……………………..…v 
Chapter One – Preamble ..................................................................................................... 1 
1.1 Peroxidation and membrane composition ....................................................................... 1 
1.1.1 Peroxidation ........................................................................................................ 1 
1.1.2 Membrane phospholipid composition and peroxidation ..................................... 2 
1.1.3 Peroxidation of membrane PUFA: A possible cause of aging? .......................... 3 
1.2 Thesis outline .................................................................................................................. 3 
1.3 Aims and research questions ........................................................................................... 6 
Chapter Two – General literature review .......................................................................... 7 
2.1 Overview ......................................................................................................................... 7 
2.2 Cellular membranes ........................................................................................................ 7 
2.3 Phospholipids .................................................................................................................. 9 
2.3.1 Phospholipid structure ......................................................................................... 9 
2.3.2 Head groups....................................................................................................... 10 
2.3.3 Types of bonds between the glycerol and fatty acids........................................ 11 
2.3.4 Fatty acids ......................................................................................................... 11 
2.3.5 Nomenclature .................................................................................................... 14 
2.3.6 Phospholipid composition influences membrane structure ............................... 15 
2.3.7 Composition and regulation of phospholipids in mammalian tissues ............... 15 
2.4 Peroxidation: The oxidation of lipids ........................................................................... 18 
2.4.1 Background ....................................................................................................... 18 
2.4.2 Chemistry of peroxidation ................................................................................. 18 
2.4.3 Products of peroxidation ................................................................................... 22 
2.4.4 Phases of peroxidation ...................................................................................... 22 
2.4.5 Measuring peroxidation..................................................................................... 24 
2.4.6 Peroxidation in biological systems .................................................................... 25 
2.5 The biological context of peroxidation: Focus on aging .............................................. 26 
2.5.1 Background ....................................................................................................... 26 
2.5.2 The “Membrane Pacemaker Theory Of Aging.” .............................................. 28 
2.5.3 Comparing membrane vulnerability to peroxidation ........................................ 29 
2.5.4 Recent evidence for the “Membrane Pacemaker Theory of Aging” ................. 30 
2.5.5 Measuring and comparing membrane phospholipid composition .................... 32 
2.6 Conclusion .................................................................................................................... 33 
Table of contents 
vi 
 
Chapter Three – Dietary docosahexaenoic acid incorporates into cardiolipin at the 
expense of linoleic acid: An analysis of published datasets ............................................ 35 
3.1 Overview ....................................................................................................................... 35 
3.2 Introduction ................................................................................................................... 35 
3.3 Changes in the fatty acid composition of cardiolipin due to diet.................................. 36 
3.3.1 Dietary trials investigating cardiolipin in animal models ................................. 36 
3.3.2 Conformer-regulator model............................................................................... 39 
3.3.3 Modelling fatty acid composition of diet and cardiac cardiolipin .................... 40 
3.3.4 Modelling fatty acid composition of diet and liver cardiolipin ......................... 42 
3.3.5 The effect of dietary 22:6n-3 on the incorporation of 18:2n-6 into heart and 
liver cardiolipin ................................................................................................. 42 
3.3.6 Comparison of 22:6n-3 incorporation into other mitochondrial phospholipids 43 
3.4 Cardiolipin remodelling ................................................................................................ 45 
3.5 Consequences of the incorporation of 22:6n-3 into cardiolipin .................................... 46 
3.5.1 Limitations ........................................................................................................ 47 
3.6 Conclusions ................................................................................................................... 47 
Chapter Four – Comparison of lipid hydroperoxide production between 
phospholipid classes matched for linoleic acid: Cardiolipin is not an exception ......... 48 
4.1 Overview ....................................................................................................................... 48 
4.2 Introduction ................................................................................................................... 48 
4.3 Methods ......................................................................................................................... 49 
4.3.1 Materials ............................................................................................................ 49 
4.3.2 Matching the concentration of bis-allylic methylene groups between 
phospholipids .................................................................................................... 50 
4.3.3 Sample preparation ............................................................................................ 50 
4.3.4 Peroxidation ...................................................................................................... 51 
4.4 Results ........................................................................................................................... 51 
4.4.1 LOOH formation in diffuse solution ................................................................. 51 
4.4.2 Maximizing LOOH formation in liposomes ..................................................... 54 
4.4.3 Comparison of LOOH production of phospholipid classes in liposomes ......... 55 
4.5 Discussion ..................................................................................................................... 56 
4.5.1 Differences in diffuse solution and liposomes .................................................. 56 
4.5.2 Cardiolipin and peroxidation ............................................................................. 58 
4.5.3 Limitations ........................................................................................................ 59 
4.6 Conclusions ................................................................................................................... 60 
Chapter Five – An antioxidant-like action for non-peroxidisable phospholipids 
using ferrous iron as a peroxidation initiator .................................................................. 61 
5.1 Overview ....................................................................................................................... 61 
5.2 Introduction ................................................................................................................... 61 
5.3 Methods ......................................................................................................................... 62 
5.3.1 Materials ............................................................................................................ 62 
Table of contents 
vii 
 
5.3.2 Liposome preparation ........................................................................................ 63 
5.3.3 Measurement of lipid peroxidation and liposome size ..................................... 63 
5.4 Results ........................................................................................................................... 64 
5.4.1 Extension of the lag phase ................................................................................. 64 
5.4.2 Changes in rate .................................................................................................. 66 
5.4.3 The importance of the ration of Fe2+ to PPL ..................................................... 68 
5.5 Discussion ..................................................................................................................... 69 
5.5.1 Non-peroxidisable phospholipids have an antioxidant-like action ................... 69 
5.5.2 Methodological considerations ......................................................................... 71 
5.5.3 Limitations ........................................................................................................ 71 
5.6 Conclusion .................................................................................................................... 72 
Chapter Six – Of mice, pigs and humans: A lipidomics analysis of mitochondrial 
phospholipids from mammals with very different maximal lifespans .......................... 73 
6.1 Overview ....................................................................................................................... 73 
6.2 Introduction ................................................................................................................... 73 
6.3 Methods ......................................................................................................................... 75 
6.3.1 Materials ............................................................................................................ 75 
6.3.2 Animals and tissues ........................................................................................... 75 
6.3.3 Subcellular fractionation and lipid extraction ................................................... 76 
6.3.4 Mass spectrometry and bioinformatics analysis................................................ 76 
6.3.5 Fatty acid composition ...................................................................................... 77 
6.3.6 The peroxidation index...................................................................................... 78 
6.3.7 Statistical analysis ............................................................................................. 78 
6.4 Results ........................................................................................................................... 78 
6.4.1 Phospholipid composition of skeletal muscle mitochondria ............................. 78 
6.4.2 Phospholipid composition of liver mitochondria .............................................. 79 
6.4.3 Phospholipid composition of brain mitochondria ............................................. 80 
6.4.4 Fatty acid composition by class ........................................................................ 82 
6.4.5 The contributions of phospholipid class to peroxidation index ........................ 86 
6.5 Discussion ..................................................................................................................... 87 
6.5.1 Peroxidation, membrane composition, and maximum life span ....................... 87 
6.5.2 Contributions of phospholipids to the peroxidation index ................................ 89 
6.5.3 Importance of non-peroxidising phospholipids ................................................ 91 
6.5.4 Limitations ........................................................................................................ 92 
6.6 Conclusion .................................................................................................................... 94 
Chapter Seven – Is human longevity due to a unique ability to limit the 
peroxidation of mitochondrial membranes? ................................................................... 95 
7.1 Overview ....................................................................................................................... 95 
7.2 Introduction ................................................................................................................... 95 
7.3 Method .......................................................................................................................... 96 
7.4 Results ........................................................................................................................... 97 
Table of contents 
viii 
 
7.4.1 Phospholipid composition ................................................................................. 97 
7.4.2 Fatty acid composition .................................................................................... 101 
7.4.3 Susceptibility to peroxidation.......................................................................... 103 
7.5 Discussion ................................................................................................................... 105 
7.5.1 Composition of mitochondrial and microsomal membranes .......................... 105 
7.5.2 Phospholipid contributions to the peroxidation index..................................... 108 
7.5.3 Limitations ...................................................................................................... 110 
7.6 Conclusion .................................................................................................................. 111 
Chapter Eight – Conclusion and outlook ....................................................................... 112 
8.1 Membrane composition, peroxidation and longevity: ................................................ 112 
8.1.1 Cardiolipin composition is influenced by dietary fats .................................... 112 
8.1.2 The importance of phospholipid composition to peroxidation ....................... 113 
8.1.3 Membrane composition and lifespan .............................................................. 115 
8.2 Outlook and future directions ..................................................................................... 117 
 
Reference list..................................................................................................................... 114 
Appendix A – Scans used in shotgun lipidomics ........................................................... 135 
Appendix B – Distribution of phospholipid classes in mitochondrial and microsomal 
fractions ............................................................................................................................. 136 
 
List of figures 
ix 
 
List of figures 
Chapter One 
Figure 1.1. Thesis outline. ................................................................................................. 5 
 
Chapter Two 
Figure 2.1. Diagram of protein interactions with the phospholipid bilayer.. .................... 8 
Figure 2.2. A typical mammalian phospholipid ................................................................ 9 
Figure 2.3. Structure of glycerophospholipid head groups. ............................................ 10 
Figure 2.4. The structure of ester, alkyl ether and plasmalogen bonding motifs at the   
sn-1 position of a phospholipid’s glycerol backbone ................................................. 11 
Figure 2.5. Structure of a saturated fatty acid (SFA), an omega-9 monounsaturated      
(n-9 MUFA), an omega-3 polyunsaturated fatty acid (n-3 PUFA) and an omega-6 
polyunsaturated fatty acid (n-6 PUFA). ..................................................................... 12 
Figure 2.6. Structure of methylene, allylic methylene, and bis-allylic methylene groups
 .................................................................................................................................... 14 
Figure 2.7. Influence of phospholipid structures on membrane structural phases. ......... 16 
Figure 2.8. Initiation and propagation of peroxidation by hydrogen abstraction. ........... 19 
Figure 2.9. The progression of peroxidation during the lag, propagation and termination 
phases ......................................................................................................................... 23 
Figure 2.10. The association between mammalian longevity and body mass ................ 27 
Figure 2.11. Correlation of the peroxidation index of mammal muscle and longevity. . 31 
 
Chapter Three 
Figure 3.1. The relative content of 18:1n-9 and 18:2n-6 as percentages of the fatty acid 
content of cardiolipin of heart and liver of mice and rates with total dietary fatty 
acids. ........................................................................................................................... 41 
Figure 3.2. The relationship between the percentage of 18:2n-6 and 22:6n-3 in heart and 
liver cardiolipin and the percentage of 22:6n-3 present in dietary fat t ..................... 41 
Figure 3.3. Levels of 18:1n-9, 18:2n-6 and 22:6n-3 as a percentage of total fatty acids in 
phosphatidylcholine and phosphatidylethanolamine against total dietary fatty acids.... 
 .................................................................................................................................... 44 
 
Chapter Four 
Figure 4.1. Lipid hydroperoxide production of phospholipids matched for linoleic acid 
content in a solution of 1:9 water to methanol (v/v). ................................................. 53 
Figure 4.2 Production of lipid hydroperodixes after sixty min of reaction of bovine heart 
cardiolipin in liposomes containing increasing concentrations of PC 16:0/16:0. ...... 54 
Figure 4.3. Production of lipid hydroperodixes from bovine heart cardiolipin in 
liposomes containing PC 16:0/16:0 at a ratio of 1:3 (w/w) or bovine heart cardiolipin 
diffuse in a solution of 1:9 water to methanol (v/v). .................................................. 55 
Figure 4.4 Production of lipid hydroperoxides by phospholipid classes matched for 
linoleic acid content in liposomes. ............................................................................. 57 
 
Chapter Five 
Figure 5.1. The period of the lag phase during iron-mediated peroxidation of the 
peroxidisable phospholipids A) Soy PC and B) PC 16:0/18:2 in the presence of the 
non-peroxidisable phospholipids PC 16:0/16:0 and PC 16:0/18:1 ............................ 65 
List of figures 
x 
 
Figure 5.2. Rates of iron-initiated peroxidation during the lag phase of the peroxidisable 
phospholipids A) Soy PC and B) PC 16:0/18:2 in the presence of the non-
peroxidisable phospholipids PC 16:0/16:0 and PC 16:0/18:1. ................................... 66 
Figure 5.3. Rates of iron-initiated peroxidation during the propagation phase of the 
peroxidisable phospholipids A) Soy PC and B) PC 16:0/18:2 in the presence of the 
non-peroxidisable phospholipids PC 16:0/16:0 and PC 16:0/18:1. ........................... 67 
Figure 5.4. Amount of O2 consumed by the end of the lag phase of iron-mediated 
peroxidation of the peroxidisable phospholipids A) Soy PC and B) PC 16:0/18:2 in 
the presence of the non-peroxidisable phospholipids PC 16:0/16:0 and PC 16:0/18:1
 .................................................................................................................................... 68 
Figure 5.5. The relative maximal rates of peroxidation of Soy PC at either constant or 
variable ratios of Fe2+ to Soy PC ratio ...................................................................... 69 
 
Chapter Six 
Figure 6.1. Distribution of phospholipid classes in A) skeletal muscle mitochondria, B) 
liver mitochondria and C) brain mitochondria of mice (M. musculus), pigs (S. scrofa) 
and humans (H. sapiens). ........................................................................................... 80 
Figure 6.2. Common phospholipid compositions for A) phosphatidylcholine, B) 
phosphatidylethanolamine, and C) phosphatidylserine of mitochondria isolated from 
the tissues of mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens) ........... 81 
Figure 6.3. The A) peroxidation index of the total phospholipid fractions and B) the 
contribution of phospholipid class as a percentage of the peroxidation index in 
muscle, liver and brain mitochondria of mice (M. musculus), pigs (S. scrofa) and 
humans (H. sapiens). .................................................................................................. 87 
Figure 6.4. Molecular phospholipids with the largest contribution to the peroxidation 
index of mitochondria from mouse (M. musculus), pig (S. scrofa) and human (H. 
sapiens) tissues ........................................................................................................... 91 
 
Chapter Seven 
Figure 7.1. The peroxidation index of the in microsomal fraction and mitochondrial-
enriched fraction of the A) skeletal muscle, B) liver, and C) brain of mouse           (M. 
musculus), pigs (S. scrofa), and humans (H. sapiens) .............................................. 103 
Figure 7.2. Figure 7.2. Relative contributions of the major phospholipid classes to the 
peroxidation index of the microsomal fraction and mitochondrial fraction of A) 
skeletal muscle, B) liver, and C) brain of mouse (M. Musculus), pigs (S. scrofa), and 
humans (H. sapiens) ................................................................................................. 104 
Figure 7.3. Comparison of the peroxidation index of human (H. sapiens) liver from this 
chapter with published values for humans. .............................................................. 106 
 
Chapter Eight 
Figure 8.1. Oxygen consumption as a measure of the iron-mediated peroxidation of 
peroxidisable phospholipids (PPL) alone, with non-PPLs, with antioxidants, and with 
both non-PPL and antioxidants. Lines are typical examples of oxygen consumption 
curves measured experimentally. ............................................................................. 114 
Figure 8.2. Comparison of the peroxidation index of mitochondria from mice, pig and 
human skeletal muscle values from Chapter Six to published values for mammal 
muscle ....................................................................................................................... 116 
List of tables 
xi 
 
List of tables 
Chapter Two 
Table 2.1. Common mammalian fatty acids ................................................................... 13 
Table 2.2. Initiators and substrates of peroxidation ........................................................ 20 
 
Chapter Three 
Table 3.1 Details of species, sources of fat, measurement method used, and feeding 
period of studies examined. ........................................................................................ 38 
 
Chapter Six 
Table 6.1. Acyl composition of the combined phospholipids of mitochondrial from 
mouse, pig, and human tissues ................................................................................... 83 
Table 6.2. Polyunsaturated fatty acid composition in mitochondrial phosphatidylcholine, 
phosphatidylethanolamine, and phosphatidylserine. .................................................. 84 
Table 6.3. Acyl ether composition present in the combined phospholipids, 
phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine fractions of 
mitochondria. .............................................................................................................. 85 
 
Chapter Seven 
Table 7.1. Distribution of phospholipid classes in the mitochondrial and microsomal 
fractions of mouse, pig, and human tissues. ............................................................... 99 
Table 7.2. Significant differences in the acyl composition of phosphatidylcholine, 
phosphatidylethanolamine and phosphatidylserine between the mitochondrial and 
microsomal membranes of mouse, pig, and human tissue. ...................................... 100 
Table 7.3. Acyl composition of the combined phospholipids of mitochondrial and 
microsomal fractions of mouse, pig, and human tissue. .......................................... 102 
Table 7.4. Contributions of phospholipid classes and molecular phospholipids to the 
peroxidation index in the mitochondrial fraction relative to the microsomal fraction 
of mouse, pig, and human tissues. ............................................................................ 109 
 
List of abbreviations 
xii 
 
List of abbreviations 
AAPH 2,2'–Azobis (2–amidinopropane) dihydrochloride 
AGPAT Acylglycerophosphate acyltransferase  
ALag Amount of peroxidation product produced by the end of 
the lag phase 
ALCAT1 Lyso cardiolipin acyltransferease  
ANOVA Analysis of variance 
BHCL Cardiolipin isolated from bovine heart 





DBI Double bond index 
EDTA Ethylenediaminetetraacetic acid 
ER Endoplasmic reticulum 
ETC Electron transport chain 
Fe
2+
  Ferrous iron 
Fe
3+
 Ferric iron 
FOX Ferrous oxidation-xylenol orange assay 
FOX-2 Ferrous oxidation-xylenol orange assay, version two 
GC Gas chromatography 
HHE 4–Hydroxy–2(E)–hexenal  
HI Hexagonal phase 
HII Inverted hexagonal phase 
HNE 4–Hydroxy–2(E)–nonenal  
HPLC High performance liquid chromatography 
L
●
 Lipid radical 
LH Lipid methylene 
LOO
●
  Peroxyl radical 
LOOH Lipid hydroperoxide 
MBOAT Membrane-bound O-acyltransferases 
MDA Malondialdehyde 
MLS Maximal lifespan 
MS Mass spectrometry 
MUFA  Monounsaturated fatty acids 
NMR Nuclear magnetic resonance spectroscopy 
Non-PPL Non-peroxidisable phospholipids 
NSW New South Wales, Australia 
ONE 4–Oxy–2(E)–nonenal  








PPL Peroxidisable phospholipids 




PUFA Polyunsaturated fatty acids 
RLag Rate of peroxidation during the lag phase 
RMax Maximum rate of peroxidation 
ROS Reactive oxygen species 
SEM Standard error of the mean 
SFA Saturated fatty acids 
TBARS Thiobarbituric acid reactive substances  
TLag Period of lag phase 
TLC Thin layer chromatography 
TMax Total period of peroxidation reaction  
UFA Unsaturated fatty acid index 
UI Unsaturation index 
UoW The University of Wollongong 
 
Publications and presentations 
xv 
 
Publications and presentations arising from this thesis 
Publications: 
Cortie CH and Else PL, Dietary docosahexaenoic acid (22:6) incorporates into 
cardiolipin at the expense of linoleic acid (18:2): Analysis and potential implications. 
International Journal of Molecular Sciences, (2012). 13(11): p. 15447–15463. 
Cortie CH, and Else P.L., An antioxidant-like action for non-peroxidisable 
phospholipids using ferrous iron as a peroxidation initiator, Biochimica et Biophysica 
Acta - Biomembranes, 2015, 1846(6): p. 1303-1307. 
Cortie CH, Hulbert AJ, Norris SE, Mitchell TW, McAndrew D, and Else
 
PL, Of mice, 
pigs and humans: a lipidomics analysis of mitochondrial phospholipids from 
mammals with very different maximal lifespans, Experimental Gerontology, 2015, 
70: 135-143. 
Cortie CH, Hulbert AJ, Norris SE, Mitchell TW, McAndrew D, and Else
 
PL, Is human 
longevity related to the unique ability to decrease membrane susceptibility to 
peroxidation? In preparation. 
 
Presentations and posters: 
Cortie CH, Hulbert AJ, Norris SE, McAndrew D, Mitchell TW, Else PL, Of Mice and 
men (and pigs): membrane composition and longevity. Australian Lipid Meeting, 
Wollongong,Australia 2014 (Presentation). 
Cortie CH and Else PL, Comparison of lipid hydroperoxide production between 
phospholipid classes matched for linoleic acid: Cardiolipin is not an exceptional. 
AussieMit, Sydney,Australia 2010 (Presentation). 
Cortie CH, Hulbert AJ, Norris SE, McAndrew D, Mitchell TW, Else PL, Investigating 
membrane composition of mitochondrial and microsomal fractions: Have humans 
reduced mitochondrial susceptibility to peroxidation to extend longevity? Australian 
Society for Medical Research, Sydney,Australia 2014 (Poster). 
Cortie CH and Else PL, An antioxidant-like action for non-peroxidisable phospholipids 
using ferrous iron as a peroxidation initiator. International Conference on the 
Bioscience of Lipids, Bari, Italy, 2013, 2013, (Poster). 
Cortie CH and Else PL, Dietary docosahexaenoic acid incorporates into cardiolipin at 
the expense of linoleic acid: analysis and potential implications. Australian and New 
Publications and presentations 
xvi 
 
Zealand Society of Comparative Physiology and Biochemistry, Auckland, New 




1 Chapter One              
Preamble 
 
1.1 Peroxidation and membrane composition 
“We must answer the question, what is it that which, in natural objects, makes them 
easily destroyed?” 
Aristotle, On the Length and Shortness of Life, paragraph 2 [1]. 
 
1.1.1 Peroxidation 
Oxidative damage is a process that all aerobic organisms must accommodate in order to 
survive. Peroxidation is a form of oxidative modification that primarily affects the 
polyunsaturated fatty acids (PUFA) present in membrane and storage lipids. Many of 
the products of peroxidation are volatile, toxic and mutagenic [2-5] and while cells have 
adapted to make use of some of these products in enzymatically-controlled cell 
signalling pathways [6-9], the majority of products formed during peroxidation are due 
to non-enzymatic peroxidation [4]. Non-enzymatic peroxidation is commonly initiated 
by reactive oxygen species (ROS), reactive nitrogen species, and reactive chlorine 
species in a self-propagating reaction that produces multiple types of ROS [5, 10, 11]. 
This propagation may be problematic to cell function as it has the potential to greatly 
increase the oxidative stress placed on cells [11-14]. It is unsurprising, then, that 
peroxidation and its products are associated with numerous pathologies [3] and have 
been identified as a possible cause of aging [12]. The ROS produced by peroxidation 
may affect numerous components of cellular membranes including proteins, lipophilic 
antioxidants, and lipids. The major factor identified as determining membrane 
vulnerability to peroxidation is the PUFA content of membrane phospholipids, but 
phospholipid class and content of saturated fatty acids (SFA) and monounsaturated fatty 
acids (MUFA) have also been suggested to influence peroxidation [15, 16]. The general 
aim of this thesis was to examine the relationships between membrane phospholipid 
composition and peroxidation. 
 
1.1 Peroxidation and membrane composition  
2 
1.1.2 Membrane phospholipid composition and peroxidation 
Phospholipids are commonly composed of a class-defining head group, a glycerol 
backbone, and two fatty acids. Exceptions to this common structure include 
sphingomyelins with only one fatty acid, and cardiolipin (CL) with up to four fatty 
acids. Mammalian phospholipids are composed of SFA, MUFA and PUFA, with the 
distribution of these fatty acids differing between animal species, tissues, and classes of 
phospholipid [17-20]. The vulnerability of membrane phospholipids to peroxidation 
may be influenced by class [15] and proximity to sources of ROS production within a 
cell [12], but is primarily determined by fatty acid composition [5, 21-23]. Due to the 
abstraction energies required to initiate peroxidation, the vulnerability of membranes to 
peroxidation is principally determined by the percentage of PUFA present in membrane 
phospholipids, and the degree of unsaturation of PUFA [21]. Despite the risk posed by 
peroxidation, however, phospholipids containing PUFA are common in the majority of 
eukaryote membranes [24]. Between 40–80% of mammalian phospholipids contain a 
PUFA [18], and CL, a phospholipid class found primarily in mitochondria, appears to 
require a high PUFA content in order to interact with mitochondrial proteins of the 
electron transport chain (ETC) [25, 26]. It therefore appears that the incorporation of 
PUFA into membrane phospholipids is common, and is likely to be a trade-off between 
the associated risks and benefits. 
Membrane phospholipid composition has been the subject of numerous studies 
including the influence of diet on membrane composition (e.g. [27, 28]), differences in 
membrane composition between animal species (reviewed in [14, 29]) and cellular 
organelles [17], and mechanistic studies showing how phospholipid properties may 
influence peroxidation and biological processes such as apoptosis [15, 30, 31]. A great 
deal still remains to be discovered regarding the biological importance of membrane 
composition and peroxidation. For example, although PUFA content may be the 
primary factor determining peroxidation, phospholipid class may also affect 
peroxidation [15, 30]. In addition, while non-peroxidisable phospholipids (non-PPLs) 
containing only saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) 
are not generally considered to influence peroxidation, non-PPLs may delay the onset of 
peroxidation [16]. Despite the importance of membrane composition and peroxidation 
to cellular health, relatively little is known regarding how PUFA and non-PPLs are 
distributed across phospholipid classes and whether this distribution differs between 
animal species or tissues. This distribution may be of particular importance as the 
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susceptibility of membrane phospholipids to peroxidation is inversely related to species 
longevity. 
 
1.1.3 Peroxidation of membrane PUFA: A possible cause of aging? 
The ‘Free Radical Theory of Aging’ [32, 33] proposes that ROS cause aging by 
irreversibly damaging cellular components, and peroxidation has been identified as a 
likely source of such ROS due to its self-propagating nature [12, 14]. Much of the work 
supporting the importance of membrane fatty acid composition and longevity comes 
from comparative animal studies that have established a strong and inverse correlation 
between membrane susceptibility to peroxidation and longevity. This relationship is 
best characterised for mammal muscle and liver [14, 34-36], but similar relationships 
have also been found for birds [12], molluscs [37], bees [38], and strains of 
Caenorhabditis elegans [39]. The relationship between membrane composition and 
aging caused by non-enzymatic lipid peroxidation was first proposed by Pamploma et 
al. under the name “Homeoviscous-Longevity” theory of aging [35] and formalised 
within the “Membrane Pacemaker Theory Of Aging” by Hulbert in 2005 [13]. This 
theory proposes that membrane composition and susceptibility to peroxidation is a key 
component of aging, but work in this area has been primarily based on fatty acid 
composition rather than phospholipid class or composition of molecular phospholipids. 
In recent years, advances in mass spectrometry have opened up new avenues of 
investigation into membrane phospholipid composition and longevity, but use of such 
technology has been limited to a small number of studies [40-42]. 
 
1.2 Thesis outline 
Over 84 000 research articles have been published on the topic of peroxidation, with 
50% of these published in the last decade (Web of Science). Many of these articles have 
focused on the chemistry of peroxidation and its complex product formation (reviewed 
in [4, 10, 43]), while others have focused on the presence of these products across a 
range of pathologies (reviewed in [3]). This thesis builds on this extensive body of work 
by examining the importance of phospholipid composition to peroxidation in three 
studies. 
The first study was an analysis of all published in vivo dietary interventions that 
examined the influence of dietary PUFA on the fatty acid composition of cardiolipin 
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and other mitochondrial phospholipids. The results of these feeding trials are discussed 
in terms of recent reports of cardiolipin’s role in ATP production and apoptosis in an 
attempt to understand the physiological relevance of changes in membrane composition. 
This work is presented in Chapter Three. 
The second study examined in vitro iron-mediated peroxidation in liposomes of 
known membrane composition. This work investigated if phospholipid properties other 
than PUFA content influenced peroxidation. Chapter Four examined the influence of 
phospholipid head group on peroxidation independently of fatty acid content, and if the 
cardiolipin class of phospholipids is particularly susceptible to peroxidation compared 
to other phospholipid classes. This study used purified synthetic phospholipids to 
investigate the importance of phospholipid class to peroxidation independently of 
phospholipid associations with proteins, lipophilic antioxidants, and other membrane 
molecules that may influence peroxidation. In Chapter Five multiple measures of 
peroxidation were used to determine whether phospholipids containing only SFA and 
MUFA influence the onset of peroxidation by exerting an antioxidant-like effect. Such 
phospholipids are generally not thought to influence peroxidation, but are very common 
in membranes and have been suggested to delay the onset of peroxidation [16]. 
In the third study, a comparison of membrane composition of three mammal 
species with very different maximal lifespans (MLS) was conducted. The animal 
species examined were mice (Mus musculus, MLS of 4 years), pigs (Sus scrofa, MLs of 
27 years) and humans (Homo sapiens, MLS of 122 years). Mice and pigs have typical 
lifespans for their body masses, but humans are exceptionally long-lived in comparison 
to other mammals with similar body masses (AnAge Database [44]). The reason for this 
longevity may be related to human membrane composition, but relatively little data for 
humans is available in the literature. Shotgun lipidomics was used to determine the 
molecular phospholipid composition of membranes from skeletal muscle, liver and 
brain. In Chapter Six, the differences in the membrane composition and susceptibility to 
peroxidation of mitochondria were compared between the three species. Chapter Seven 
continued this examination by testing the suggestion by Hulbert (2010) [45] that 
humans have a unique ability to decrease the susceptibility of their mitochondrial 
membranes peroxidation when compared to other cellular membranes. It was suggested 
that such an ability may prevent oxidative stress and therefore extend longevity. A 
major strength of these chapters was the use of human tissues, which is rarely included 
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in comparative studies. In addition, the use of shotgun lipidomics allowed a more 
detailed lipidomics analysis of membranes than previously possible. 
The outline of this thesis is presented in Figure 1.1. Due to the different methods 
used in each study, separate introduction and method sections are provided for each 
chapter. A combined Bibliography is provided for all chapters. 
 
 
Figure 1.1. Thesis outline. 
  
Chapter Eight: Conclusions and outlook
Chapter Three: Dietary docosahexaenoic acid incorporates
into cardiolipin at the expense of linoleic acid: a review of
published datasets
Chapter Six: A lipidomics analysis of mitochondrial
phospholipids from mammals with very different maximal
lifespans
Chapter Seven: Is human longevity due to a unique ability
to limit the peroxidation of mitochondrial membranes?
Chapter One: Preamble
Chapter Two: General literature review
Study one: Dietary PUFA and cardiolipin composition
Study two: In vitro phospholipid peroxidation
Chapter Four: Examining the influence of phospholipid
class on phospholipid susceptibility to peroxidation
Chapter Five: An antioxidant-like action for non-
peroxidisable phospholipids using ferrous iron as a
peroxidation initiator
Study three: Peroxidation and its role in aging
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1.3 Aims and research questions 
The overall aim of this thesis was to investigate the relationship between membrane 
composition and peroxidation with relevance to the aging process. The specific research 
questions addressed in this thesis are: 
 How do dietary MUFA and PUFA influence the fatty acid composition of 
cardiolipin and other major classes of mitochondrial phospholipids in 
mammals? 
 Do cardiolipin and other phospholipid classes affect peroxidation 
independently of PUFA composition? 
 Do phospholipids composed of only SFA or MUFA influence the rates and lag 
phase of peroxidation of phospholipids containing PUFA through an 
antioxidant-like action? 
 Are mitochondrial phospholipids less susceptible to peroxidation in humans 
than in mice or pigs? 





2 Chapter Two         
General literature review 
 
2.1 Overview 
This chapter provides an overarching review of the literature relevant to this thesis. 
More specific literature reviews are provided within the introduction sections of each 
chapter. This chapter includes a discussion of cellular membranes and the role of 
phospholipids (2.2), phospholipid structure and regulation in membranes (2.3), the 
mechanisms and measurement of peroxidation of membrane lipids (2.4), the association 
between membrane composition and aging (2.5), and a brief conclusion (2.6). 
 
2.2 Cellular membranes 
Cellular membranes are ubiquitous structures in cells that are thin (6–8 nm),            
semi-permeable structures that define cell boundaries. Numerous interactions take place 
within and across cell membranes including the movement of molecules during 
signalling and transport, the formation of enzymes complexes to localise enzymatic 
reactions, and a great many anabolic and catabolic processes [46, 47]. In addition to the 
plasma membranes that define a cell’s boundary, eukaryotes also have membrane-
bound organelles that increase metabolic efficiency by compartmentalizing catabolic 
and anabolic functions [48]. Cellular membranes are complex structures composed of a 
diverse mixture of lipids, proteins, and carbohydrates, and this composition may differ 
between species, between tissues within a species, and even between organelles within a 
cell [17, 49-51]. The current model used to describe the interactions of the components 
in membranes is a modified form of the “Fluid-Mosaic Model” originally proposed by 
Singer and Nicolson in 1972 [49]. In this model, phospholipids form a 
thermodynamically stable, fluid and semi-permeable bilayer to which membrane 
proteins are associated by strong hydrophobic interactions (integral proteins), weaker 
hydrophilic bonds (peripheral proteins) [49], or through interactions that do not interfere 
with the intrinsic structure of cell membranes (membrane-associated proteins) [52] 
(Figure 2.1). The “Fluid-Mosaic Model” has been reviewed many times, and recent 
work in the area [46, 47, 53] supports the original “Fluid-Mosaic Model” with the 
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amendments that phospholipids are not organised randomly but rather as curved micro 
domains of varying fluidity including relatively viscous ‘rafts’ [54], that proteins are far 
more common within the bilayer than suggested in the original work [47, 53], and that 




Figure 2.1. Diagram of protein interactions with the phospholipid bilayer. Proteins are in red; 
phospholipids in the bilayer are blue. Based on Goni et al. 2014 [47]. 
 
 
The phospholipid bilayer is a fundamental component of the cell membrane, and 
the phospholipids that comprise this bilayer account for 15–45% of the weight of 
biological membranes, with the remaining weight primarily proteins [17, 51]. As the 
average phospholipid molecule is much lighter than the average protein molecule, it has 
been estimated that cellular membranes contain 10–100 phospholipids per protein, 
making phospholipids the most numerous component of cellular membranes [50, 55]. In 
comparison to phospholipids, other lipid components of membranes such as 
sphingolipids, glycolipids and cholesterols are far less abundant [17]. In addition to 
forming the bilayer structure, phospholipids also have important roles in membranes as 
allosteric effectors of proteins [25, 56-58], substrates for enzymes during signalling 
cascades [8, 59-63], and in influencing key membrane properties including curvature 
[20], fluidity [64], and susceptibility to peroxidation [5, 22]. The peroxidation of 
phospholipids may disrupt the bilayer structure and permeability [65, 66] and damage 
membrane proteins [4, 5, 12], and the relative susceptibility of membrane phospholipids 
            
        
                  
                                    -                    
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to peroxidation is the focus of this thesis. This susceptibility is primarily determined by 
phospholipid fatty composition. 
 
2.3 Phospholipids 
2.3.1 Phospholipid structure 
Phospholipids, which include all glycerophospholipids and some sphingosines, are 
composed of a polar head group joined by a phosphodiester linkage to a hydrophobic 
moiety. Due to this structure, phospholipids are amphipathic and self-orientate in 
aqueous media with head groups towards the aqueous plane and hydrophobic moieties 
away from the aqueous plane. This orientation forms a stable micelle or bilayer. 
Glycerophospholipids are composed of a head group joined by a phosphodiester link to 
the sn-3 position of a glycerol backbone and acyl chains at the sn-1 and sn-2 positions 
of the glycerol. An example of a common glycerol phospholipid is shown in Figure 2.2. 
In comparison, sphingomyelin phospholipids have a hydrophilic head group joined to a 
sphingosine backbone by a phosphodiester, and a single fatty acid joined to the 
backbone. As glycerophospholipids are the most common component of cell 
membranes and are the primary substrate of peroxidation, the subsequent use of 




Figure 2.2. A typical mammalian phospholipid composed of a glycerol backbone with a 







2.3.2 Head groups 
Phospholipids are classified according to the structure of the phosphate-ester head group 
present at the sn-3 position of the glycerol backbone. The structure of these phosphate-
ester head groups determine the ionization constants, net charges, and relative shape of 
phospholipids [24]. The seven classes of glycerophospholipid that have been identified 
in mammals are phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), phosphatidylglycerol (PG), phosphatidic acid (PA), 
phosphatidylinositol (PI), and di-phosphatidylglycerol which is more commonly known 









2.3.3 Types of bonds between the glycerol and fatty acids 
The sn-2 position of a phospholipid glycerol is typically occupied by an ester-linked 
fatty acid, but the sn-1 position of the glycerol may be unoccupied, making a           
lyso-phospholipid, or occupied by an ester-linked acyl chain, a vinyl ether-linked acyl 
chain (commonly termed a plasmalogen), or an alkyl ether [67]. The structures of these 
three bonding motifs are shown in Figure 2.4. The purpose of these different types of 
fatty acid bonding motifs is unclear, but plasmalogen deficiencies have been reported in 
a number of developmental disorders [68], and it has been suggested that plasmalogens 
and alkyl ethers are important in membrane fusion events and as sacrificial molecules 




Figure 2.4. The structure of ester, alkyl ether and plasmalogen bonding motifs at the sn-1 
position of a phospholipid’s glycerol backbone. Differences in structures are highlighted in red. 
 
 
2.3.4 Fatty acids 
Fatty acids are long-chain carboxylic acids. Mammalian fatty acids are grouped into 
three structural categories based on the number of carbon-carbon bonds present [70]. 
The categories are: saturated fatty acids (SFA) that contain no double bonds, 
monounsaturated fatty acids (MUFA) that contain a single double bond, and 
polyunsaturated fatty acids (PUFA) that contain two or more double bonds. These 
double bonds are predominately in the cis (Z) configuration in mammalian tissues [71]. 
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Isomers of MUFA and PUFA can be further classified by the position of the first double 
bond between carbons from the methyl end of the fatty acid chains [70]. This is termed 
the ‘n’ or omega position. Most MUFA are n-9 in structure, with the double bond 
beginning at the 9
th
 carbon in from the methyl end of the acyl chain, while some are n-7 
with the double bond beginning at the 7
th
 carbon from the methyl end of the acyl chain. 
PUFA are most commonly n-6 or n-3, with the notable exception of mead acid which is 
an n-9 PUFA. Fatty acids can be abbreviated using the omega abbreviation system 
proposed by Holman (1964) [72] as the number of carbons: number of double bonds 
and the position of the ‘n’ double bond. The structures of 18-carbon long SFA, n-9 
MUFA, n-6 PUFA and n-3 PUFA are presented in Figure 2.5. Examples of the names, 




Figure 2.5. Structure of a saturated fatty acid (SFA), an omega-9 monounsaturated (n-9 MUFA), 
an omega-3 polyunsaturated fatty acid (n-3 PUFA) and an omega-6 polyunsaturated fatty acid 





Table 2.1. Common mammalian fatty acids 
Trivial names Systematic name 
Carbons: 
Double bonds Class 
 
Saturated 
   
Myristic acid Tetradecanoic acid 14:0 – 
Palmitic acid Hexadecanoic acid 16:0 – 
Stearic acid Octadecanoic acid 18:0 – 
    
Monounsaturated    
Vaccenic acid 11–Octadecenoic acid 18:1 n-7 
Oleic acid 9–Octadecenoic acid 18:1 n-9 
    
Polyunsaturated    
Linoleic acid 9,12–Octadecadienoic acid 18:2 n-6 
α–Linolenic acid 9,12,15–Octadecatrienoic acid 18:3 n-3 
Arachidonic acid 5,8,11,14–Eicosatetraenoic acid 20:4 n-6 
Clupanodonic acid 7,10,13,16,19–Docosapentaenoic acid 22:5 n-3 
Cervonic acid 4,7,10,13,16,19–Docosahexaenoic acid 22:6 n-3 
 
 
The introduction of a double bond into a fatty acid can affect a number of 
phospholipid properties including melting point [64]. Phospholipid melting points 
increase with fatty acid length but are decreased by the presence of double bonds, with 
double bonds having the greatest effect when present in the middle of the chain [24, 64]. 
For example, lyso-PC 18:0 has a melting point of 55 ºC, lyso-PC 18:1n-6 has a melting 
temperature of 10 ºC, and lyso-PC 18:1n-9 has a melting temperature of –20 ºC [64]. 
The presence of MUFA and PUFA in membranes may therefore greatly increases 
membrane fluidity. 
The number and position of double bonds in the fatty acid chain is also the 
primary factor determining phospholipid susceptibility to hydrogen abstraction which 
may initiate peroxidation [5, 22, 73]. A SFA has no double bonds between carbons and 
can be considered to be a series of linked methylene groups with electrochemical 
reduction potentials of 1.90 V at the C–H bonds. The introduction of a single double 
bond produces a MUFA with two allylic methylene that have a C–H bond reduction 
potential of 0.96 V, and the introduction of multiple double bonds on alternative 
carbons produces a PUFA with bis-allylic methylene that have a reduction potential of 
only 0.60 V [73]. As a consequence of their lower reduction potential, the hydrogen in 
bis-allylic methylene groups are more likely to be abstracted than those in methylene or 
allylic methylene [11]. Due to their structure, SFA contain only methylene groups, 
MUFA contain two allylic methylene groups, and PUFA contain multiple allylic 
methylene groups and at least one bis-allylic methylene group depending on the degree 
2.3 Phospholipids 
14 
of polyunsaturation. For example, 18:2n-6 contains only one bis-allylic methylene while 
18:3n-3 contains two, 20:4n-6 contains four, and 22:6n-3 contains five. Examples of a 
methylene group, allylic methylene group, and bis-allylic methylene group are 




Figure 2.6. Structure of methylene, allylic methylene, and bis-allylic methylene groups. Red 




Phospholipids have complex systematic names, and a number of ways to abbreviate 
these names have been proposed. This thesis follows the nomenclature for phospholipid 
abbreviation established by Liebish et al in 2013 [74]. Using this nomenclature, 
phospholipids are identified by abbreviation of phospholipid class (e.g. PC) and the 
number of carbon: number of double bonds of fatty acids present (e.g. 16:0, 22:6). Fatty 
acids are separated by a “/” when sn-position is known (sn-1/sn-2) or a “_” when sn 
position is not known (Lyso species can be indicated with either an “L” preceding the 
class or with a 0:0 indicating the empty sn position. Bond types other than esters are 
indicated with a “P” for plasmalogen or an “O” for alkyl ether in front of the fatty acid. 
For example, lyso-phosphatidylcholine (LPC) composed of palmitic acid (16:0) 
has a systematic name of 1–hexadecanoyl–sn–glycero-3–phosphocholine and is 
abbreviated as LPC 16:0. Phosphatidylcholine (PC) containing a palmitic acid (16:0) 
and an oleic acid (18:1) has the systematic name 1–hexadecanoyl–2–(9-octadecenoyl) –
sn–glycero–3–phosphocholine, and is abbreviated to PC 16:0_18:1 when sn position is 
unknown or PC 16:0/18:1 if sn position has been confirmed. Phosphatidylethanolamine 
(PE) with a plasmalogen-linked stearic acid (P–18:0) at the sn-1 position and a 
docosahexaenoic acid (22:6n-3) at the sn-2 position has the systematic name                
1–(1–octadecenyl)–2–(4,7,10,13,16,19–docosahexaenoyl)–sn-glycero–3–phosphor-
ethanolamine and is abbreviated as PE P–18:0/22:6. 
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2.3.6 Phospholipid composition influences membrane structure 
The class and fatty acid composition of phospholipid properties may affect both their 
position within a membrane and the shape of the membrane itself. Phospholipids with 
head groups that are wider than their fatty acid moiety, such as lyso-phospholipids, have 
large positive curvatures and tend to form micelles in the hexagonal I (HI) phase [75]. 
Phospholipids with head groups that are narrow relative to their fatty acid moiety, such 
as non-lyso molecular species of PE, PS and CL , tend to form membranes in the cubic 
phase (HII) [75]. Phospholipids with head groups that are slightly wider than their fatty 
acid moiety, including non-lyso molecular species of PC, PG and PI, have small 
negative curvatures and tend to form in the lamellar phase which corresponds to the 
bilayer structure found in cell membranes. Figure 2.7 shows examples of phospholipids 
in the HI, HII and lamellar phases. Within stable membranes, mixtures of phospholipids 
are likely to be asymmetrically distributed based on class, with the anionic classes such 
as PE and CL accumulating on the cytofacial leaflet while PC tends to accumulate in the 
exofacial leaflet [24]. This distribution is greatly aided by flippase, floppase, and 
scramblase activity [76]. Lipid-protein interactions are more likely to occur at the inner, 
negatively charged membrane leaflet, and proteins associated with this leaflet contain 
high levels of arginine and lysine [55, 77]. 
 
2.3.7 Composition and regulation of phospholipids in mammalian tissues 
Although thousands of unique phospholipid structures are possible due to potential 
combinations of head groups, bonding motifs and fatty acids, mammalian membranes 
generally contain only a few hundred different molecular species of phospholipid. The 
composition of these molecular phospholipids may differ between species and tissues 
[17, 64], and even organelles within cells [17, 78]. The most common classes of 
phospholipids in mammal membranes are PC and PE, and together these two classes 
typically account for 60–90% of total phospholipids. CL is unusual amongst the 
phospholipid classes in that it accounts for approximately 15% of mitochondrial 
phospholipids but 1% or less phospholipids in other cell membranes [17]. The 




Figure 2.7. Influence of phospholipid structures on membrane structural phases. 
 
 
distribution differing between membrane types. Plasmalogens and alkyl ethers are 
distributed evenly across phospholipid classes, being most abundant in PC and PE of 
brain, but are also found in a variety of other tissues [67]. PUFA are also unevenly 
distributed across phospholipid classes, with phospholipids of CL commonly containing 
multiple PUFA [79] while phospholipids containing more than one PUFA are rare in 
other classes [18, 24, 80]. Less is known about the composition of individual 
phospholipid species in mammal tissue, but PC 16:0_22:6, PE 18:0_22:6, and PS 
18:0_22:6 have been found to be more common in smaller mammals than larger 
mammals [18], and more common in short-lived mammals compared to long-lived 
mammals [40]. In larger mammals, PC 16:0_18:1 and PE 18:0_18:2 are more common, 
possibly serving as replacements for phospholipid containing 22:6n-3. 
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The phospholipid composition of cellular membranes is regulated through 
synthesis [64], selective transfer between organelles, remodelling, and degradation [81]. 
The endoplasmic reticulum (ER) is the primary site of PC, PE, and PS synthesis within 
cells, mitochondria are the primary site of PG, PA, and CL synthesis and may also 
synthesize PE, and peroxisomes are the primary site of plasmalogen production [17, 82-
85]. These phospholipids are subsequently transported between cellular membranes 
where they may undergo remodelling of their acyl content. For example, while 
mammalian cells normally produce only four acyl combinations (16:0/18:1, 16:0/18:2, 
16:0/22:6 and 18:1/18:2) of PC and PE de novo, a variety of other molecular species of 
PC and PE are common suggesting that extensive acyl remodelling occurs [86]. This 
remodelling appears to be more common in PE, as PC 16:0_18:1 and PC 16:0_18:2 are 
dominant phospholipids in most mammal membranes and PC 16:0_22:6 is extremely 
common in small mammals like mice [18]. 
Phospholipid remodelling occurs by the Land cycle, a series of deacylation and 
reacylation reactions named after William E. Lands who conducted the seminal work in 
this area [87]. Phospholipid deacylation is initiated by the hydrolysing of a fatty acid at 
the sn-1 position for the phospholipase 1 (PLA1) family or at the sn-2 position by 
member of the phospholipase 2 (PLA2) family [85]. Acyl transferases, such as those of 
the acylglycerophosphate acyltransferase (AGPAT) and membrane-bound                    
O-acyltransferases (MBOAT) families, may then selectively reacylate the free sn 
position with a different fatty acid [85]. This selective reacylation can be influenced by 
availability of fatty acids substrates, with the types and amount of PUFA of particular 
importance in this respect. Unlike plants, mammals lack the desaturases required to 
produce n-3 and n-6 PUFA de novo and so must acquire 18:2n-6, 18:3n-3 and other 
PUFA from the diet [88]. In the absence of sufficient dietary PUFA, 18:1n-9 will be 
converted to mead acid (20:3n-9) in what may be an attempt by the organism to 
overcome this deficiency through alternate pathways [72]. This response is insufficient 
in the long term as animals that are not fed sufficient dietary PUFA die at an earlier age 
than controls [89]. In the presence of sufficient dietary n-3 and n-6 PUFA, the 
percentage of total dietary PUFA does not affect membrane composition but the ratio of 
n-3 PUFA to n-6 PUFA does as both are substrates for acyltransferases [28, 90, 91].  
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2.4 Peroxidation: The oxidation of lipids 
2.4.1 Background 
The term peroxidation refers to the oxidative modification of biological molecules to 
form peroxides, with lipids being the most common substrate for this reaction. 
Peroxidation was first observed in 1791 by the Swiss scientist Senebier who observed 
that the prolonged exposure of olive oil to air caused the oil to turn rancid [92]. This 
was followed by numerous investigations into the effect of peroxidation on food taste 
and stability (reviewed in Hammond (2011) [93]), including the finding in 1911 by the 
Swedish scientist Thunberg who reported that this process was catalysed by iron salts 
[94]. Despite this early work, the chemical mechanisms underlying peroxidation were 
finally elucidated by workers at the British Rubber Producers’ Association in the 1940s 
[11, 93]. In more recent years, interest into the roles of non-enzymatic and enzymatic 
peroxidation in biology has greatly expanded. 
 
2.4.2 Chemistry of peroxidation 
Initiation, propagation, and termination 
Peroxidation proceeds in a classical free radical chain reaction of initiation, propagation 
and termination that is most commonly initiated by reactive oxygen species (ROS) [4, 5, 
10, 11]. Initiation of peroxidation can occur through the addition of ROS to a lipid 
methylene group (LH) (Equation 1) or the abstraction of a hydrogen from a LH by ROS 
(Equation 2) [11]. The abstraction of hydrogen is more common than the addition of 
ROS, but in either case a carbon radical (L●) is formed. This carbon radicals often 
stabilises by re-arranging to form a conjugated diene radical, and this diene may react 
with available oxygen to form a peroxyl radical (LOO●) (Equation 3). The LOO● 
produced in this manner are sufficiently reactive to abstract hydrogen from another LH 
to produce a lipid hydroperoxide (LOOH) and a second L●, propagating the 
peroxidation reaction (Equations 4). The structures and progression of peroxidation are 
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LH + OH● → LHOH● (alternatively written L●) 
LH + R● → L● + RH 
L● + O2 → LOO
● 






Termination of peroxidation may occur when two conjugated diene radicals cross-link 
(Equation 5), two lipid peroxide radicals react (Equation 6), or a conjugated diene 
radical or lipid peroxide radical reacts with an antioxidant (Equation 7). 
 
L● + L● → L–L 
LOO●+ LOO● → LOO–LOO 
L● or LOO●
 








Figure 2.8. Initiation and propagation of peroxidation by hydrogen abstraction. Based on Yin et 
al. (2011) and Halliwell and Guetteridge (2007) [5, 11]. 
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Initiators and targets of peroxidation 
The energy required for hydrogen abstraction – and therefore the likelihood of 
abstraction occurring – is theoretically determined by difference in reduction potentials 
of substrates and oxidizing agents. Theoretically, a molecule can oxidise any compound 
with a lower standard reduction potential (V) [5, 11]. Table 2.2 shows standard 
reduction potentials of common targets and causes of oxidation in biological systems 
[73, 95]. As can be seen from the table, the bis-allylic methylene groups present in 
PUFA have a lower reduction potential than SFA, MUFA, proteins or DNA and are 
therefore more likely to undergo hydrogen abstraction. While numerous forms of ROS 
initiator may be present in cellular environments, in vitro studies of peroxidation 
generally use radical clocks such as 2,2'–azobis(2–amidinopropane)–dihydrochloride 
(AAPH) to generate ROS at a constant rate to allow the kinetics of peroxidation to be 
accurately determined [5, 96], or use iron and copper to initiate peroxidation through the 
generation of peroxyl and alkoxyl radicals [11, 96]. 
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DNA (Guanine) Various product species/guanine 0.96 
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/ascorbate monoanion 0.28 
   
Values are from [72]. 
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Role of iron and other transition metals 
Iron and copper greatly increase the rate of peroxidation, a process most extensively 
studied in ferrous (Fe
2+
) and ferric (Fe
3+
) iron [11, 97-100]. High concentrations of Fe
2+
 
may react with O2 to form OH
• 
via H2O2 production and decomposition
 
(Equation 4–7) 
or may react directly with H2O2 to produce OH

































Although OH● produced in this manner may initiate peroxidation, the presence of 
H2O2–scavenging proteins inhibits OH
● production but not peroxidation, suggesting that 





 decompose LOOH in a similar way as described for H2O2, with Fe
2+
 
reacting with LOOH to produce LOO● (Equation 8) and Fe
3+
 reacting with LOOH to 
produce alkoxyl radicals (LO
•




 + LOOH → Fe
2+














The LOO● and LO● radicals produced during this reaction are sufficiently reactive to 
abstract a hydrogen from a second bis-allylic methylene group, therefore initiating and 




 cannot abstract hydrogen 
directly, some LOOH must already be present in the lipid for mediation to occur 
through LOO● and LO● production. This is normally not a limitation for in vitro 
experiments as LOOH is commonly formed during purification, sonication and 





 can also scavenge radicals under some conditions, terminating 
peroxidation (Equations 10–11). 
 
 





















A similar mechanism for redox cycling during peroxide decomposition has been 
reported for copper [11]. Although the chemistry of initiating peroxidation with iron and 
copper is complex [11, 96, 99, 101-103], poorly liganded iron is likely to be a major 
cause of peroxidation within cells [104, 105]. 
 
2.4.3 Products of peroxidation 
It has been estimated that 120–150 different forms of lipid hydroperoxides may be 
produced in natural membranes during peroxidation [2], and the decomposition of these 
hydroperoxides produces a wide range of highly unstable secondary products including 
alkanes, aldehydes, ketones, alcohols and furanes [4]. This variety of products is due to 
the diversity off bis-allylic methylene groups position in PUFA, whether peroxidation 
occurs at one or multiple bis-allylic methylene groups, and whether cyclization or cross-
liking occurs. In addition, the products of peroxidation may be produced in racemic 
mixtures [5]. Many of these products are highly volatile and can form adducts with 
proteins [106] and DNA [42, 107], with aldehydes being particularly reactive in this 
regard [4, 106]. Common examples of lipid peroxidation products include 
malondialdehyde (MDA) formed from PUFA with three or more double bonds, 4–oxy–
2(E)–nonenal (ONE) produced from the decomposition of 18:2, 4–hydroxy–2(E)–
nonenal (HNE) produced from the peroxidation of n-6 fatty acids, and 4–hydroxy–
2(E)–hexenal (HHE) produced from the peroxidation of n-3 fatty acids [4]. The mixture 
of these products is therefore largely determined by the distribution of PUFA present in 
membrane phospholipids. 
 
2.4.4 Phases of peroxidation 
Peroxidation typically occurs in discrete phases of lag, propagation, and termination 
[96]. The phases and possible measures of peroxidation are presented in Figure 2.9. 
Following initiation, peroxidation enters a lag phase with a low rate of peroxidation 
(RLag). This phase is measured as a period of time (TLag) between the start of 
peroxidation and the beginning of the propagation phase. The amount of peroxidative 
product produced by the end of this phase is termed the (ALag). The TLag can be 
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lengthened and the the ALag increased by antioxidant defences that prevent the build-up 
of high levels of ROS. From a biological perspective, the TLag is important as it 
represents a window of opportunity for cells to prevent entry into the potentially more 
damaging propagation phase. The duration of TLag is therefore considered to be a 
measure of the antioxidant status of membranes [108]. 
The propagation phase begins when the lag phase ends. The peroxidation phase is 
when the maximal rate of peroxidation (RMax) occurs. Propagation is likely to be the 
most damaging phase of peroxidation, and the RMax of lipids has been studied in both 
solvents and liposomes [5, 21, 22, 109, 110]. The RMax increases with the number of 
bis-allylic methylene present in PUFA, and this relationship has been reported being 
exponential in some studies [21, 109] but linear in others [5, 22, 110]. The termination 
phase of peroxidation occurs as the RMax ebbs due to substrate exhaustion, radical 
crosslinking, or antioxidant quenching. The time at which this occurs is termed the TMax, 
and the maximal amount of peroxidation product that has been produced by this point is 




Figure 2.9. The progression of peroxidation during the lag, propagation and termination phases. 
Measures of peroxidation in each phase are highlighted in red. Based on Pinchuk and 
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2.4.5 Measuring peroxidation 
Lipid peroxidation produces conjugated dienes, consumes oxygen and PUFA, forms 
lipid hydroperoxides (LOOH), and produces numerous secondary products from LOOH 
decomposition. As a result, there are many ways of measuring peroxidation including 
substrate loss and product formation [11]. The earliest and simplest method used to 
measure peroxidation was to simply expose lipids to oxygen and measure the 
subsequent changes in lipid mass over time [94, 111]. Alternatively, the production of 
conjugated dienes, LOOH, and MDA can be used to measure peroxidation with various 
simple assays and absorbance spectrophotometry [111]. More complex techniques of 
measuring peroxidation include determining the loss of PUFA or production of 
secondary products measured with gas chromatography (GC), high performance liquid 
chromatography (HPLC), mass spectrometry, nuclear magnetic resonance spectroscopy 
(NMR), or a combination of these techniques [4, 10]. Much of the literature in this area 
has focused on the secondary products of peroxidation in in vivo samples, but in vitro 
studies also use more direct and continuous measures of peroxidation. In this thesis, 
peroxidation was measured using oxygen consumption and LOOH production. 
Oxygen consumption was used as a measure of the reaction of conjugated diene 
radicals with oxygen to form a peroxyl radical. This reaction is an early and 
fundamental component of the peroxidation reaction. The consumption of oxygen 
during the formation of peroxyl radical can be measured using Clark-type oxygen 
electrodes [112]. Clark-type electrodes have been used in a large number of 
peroxidation studies including recent studies (e.g. [23, 30]). Modern Clark-type 
electrodes are extremely sensitive and can detect changes of as little as 500 nmol of 
oxygen per 0.5 seconds and produce results that are less variable than most measures of 
conjugated diene formation [111]. The continuous nature of oxygen consumption also 
has the added advantage of accurately measuring the different phases of peroxidation 
and measures within these phases. 
The production of LOOH was also used to measure peroxidation in this thesis. 
This choice was based on LOOH being a primary product of peroxidation and a 
relatively stable molecule in comparison to other products of peroxidation [113]. LOOH 
production was measured using the ferrous oxidation-xylenol orange (FOX) method 
proposed by Wolff in 1994 [114] and recently updated to the FOX-2 assay by Bou et al. 
[113]. The FOX-2 method is considered an improvement on the earlier iodometric assay 
in terms of both sensitivity and reproducibility [111]. The FOX-2 method is based on 
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 by reaction with hydroperoxides formed during 
peroxidation under acid conditions (Equations 12–13). The subsequent reaction of Fe
3+
 














+ XO → Fe–XO Equation 13 
 
The FOX-2 assay measures LOOH regardless of molecule. This is an advantage over 
the commonly used thiobarbituric acid reactive substances (TBARS) for MDA, as 
MDA does not form from the peroxidation of 18:2n-6. This limitation of the TBARS 
method is of particular relevance to the current thesis as 18:2n-6 was the primary PUFA 
examined in the peroxidation assays in this thesis. 
 
2.4.6 Peroxidation in biological systems 
The chemistry of peroxidation is well understood under controlled conditions, but 
conditions of in vivo peroxidation are far more complex and varied [11]. For example, 
although the initiation of peroxidation is theoretically determined by thermodynamic 
parameters, radicals must also be stable enough to reach a suitable target within the 
hydrophobic region of the cell membrane, a requirement that may rule out the most 
volatile or hydrophobic radicals [11]. Biological systems also have added complexity in 
terms of phospholipid compositions, pH conditions, concentrations of reactants, 
antioxidants, and the presence of poorly liganded iron present in haemoproteins such as 
complexes II, III and IV of the ETC as well as ferritin, the iron storage protein [105]. 
These conditions may even vary between organelles within a cell, with mitochondrial 
membranes particularly likely to undergo peroxidation as complexes I and III of the 
ETC are the main sources of cellular ROS production [14, 36]. To add to this 
complexity, organisms have evolved many strategies to use, repair or prevent 
peroxidation. Examples of this include the small number of products formed by 
enzymatic peroxidation involved in cell signalling activities including modulating 
inflammation and apoptosis [6-8], and the repair of peroxidation damage by turnover of 
10% of membrane phospholipids over per hour [115]. Adaptations thought to prevent 
peroxidation include limiting the availability of iron and other catalysts within cells 
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[105], the formation of supercomplexes of potential enzymatic sources of ROS together 
in the ETC to limit electron leak, and production of antioxidants [11]. Substrate 
availability is also tightly controlled. For example, although the pO2 of air is 21.1%, the 
pO2 of human brain, liver and muscle is below 5% [116]. The percentage of PUFA in 
cell membranes can also be limited, with the membranes of longer-lived species 
generally having a lower degree of unsaturation than shorter-lived species [13]. Despite 
these adaptations, peroxidation is still considered a major cause of damage in cells and 
has been identified as a possible cause of aging. 
 
2.5 The biological context of peroxidation: Focus on aging 
2.5.1 Background 
“The reasons for some animals being long-lived and others short-lived and, in a word, 
causes of the length and brevity of life call for investigation.” 
Aristotle, On Longevity and Shortness of Life, paragraph 1 [1]. 
 
How aging occurs – and whether aging can be prevented – has long been of interest to 
the scientific community and the general public alike. Due to its universal nature, aging 
was identified as an important aspect of biology by the very earliest scientists. The 
seminal mechanism of aging was proposed by Aristotle, who wrote that aging was 
caused by the damaging “fires of respiration” (and possibly also the soul). Aristotle 
based this theory on observations that larger mammals generally have longer lifespans 
than smaller mammals, but realised that this trend has many exceptions as “a superior 
immunity from decay attaches neither to the largest animals (the horse has shorter life 
than man) nor to those that are small” [1]. Modern science has a greater wealth of data 
to draw on than was available to Aristotle, and this data supports the early observations 
that lifespan shows an association with body mass, but with many exceptions including 
humans (Figure 2.10). More recent investigations of aging have replaced Aristotle’s 
“fires of respiration” with multiple mechanistic and evolutionary theories of how aging 
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Figure 2.10. The association between mammalian longevity and body mass (n=1124). Data 
shown is from the AnAge Database. 
 
 
Aging has been characterised as a universal and progressive accumulation of 
deleterious changes that lead to a loss of homeostasis and an increased likelihood of 
death [118-120]. One of the leading mechanistic theories of aging that fits this 
definition is the “Free Radical Theory of Aging”, which was first proposed by Harman 
in 1956 [121]. This theory, which is also known as the “Oxidative Stress Theory of 
Aging”, is based on findings that ROS produced during aerobic metabolism can be 
mutagenic and toxic. This theory has been updated in recent years by Harman [32, 33] 
and other researchers [9, 12, 14, 36, 122, 123], but is also debated by some scientists on 
the basis that oxidative damage is not always detrimental to lifespan and is only one 
possible form of damage to cells [124-126]. The arguments against the “Free Radical 
Theory” often based on comparisons of wild-type and mutant animals within a species 
[124-126] while much of the support for this theory has come from comparative animal 
studies that have examined aging-related properties across a range of mammals 
(reviewed in [12, 14, 127]). This approach, which was first used by Aristotle and his 
colleagues, is based on the key finding that longevity may differ more within a class 
than within a species. For example, the maximal lifespans (MLS) of mammals varies 
100–fold between the short mammal lifespan of the shrew (Myosorex varius, MLS of 
2.2) and the long life of the bowhead whale (Balaena mysticetus, estimated MLS of 211 
years) (AnAge Database), but concerted efforts by the Methuselah Foundation 
(www.mfoundation.org) and other researchers have yet to extend the MLS of mice (Mus 
musculus) by more than 2–fold. Somewhat surprisingly, comparative studies of animal 
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sspecies have found only two cellular properties to be strongly related to aging: 1) the 
mitochondrial production of ROS and 2) the degree of membrane unsaturation [12, 14]. 
These two factors are related as ROS is both an initiator and product of the peroxidation 
of unsaturated fatty acids [5], supporting suggestions that the peroxidation of membrane 
phospholipids is a key component in the process of aging 
 
2.5.2 The “Membrane Pacemaker Theory Of Aging.” 
In 1978, Gudbjarbason et al. [128] reported a positive correlation between the 22:6n-3 
content of membranes and the heart rate of mammals ranging in size from mice to 
whales. This was one of the earliest findings linking membrane composition with body 
mass and metabolism, and suggested that membrane composition differs greatly 
between animals. Couture and Hulbert (1995) continued this work with a report that 
MUFA and PUFA contents of mammalian membranes vary with body mass [129]. The 
muscle, kidney, and liver of larger mammals were found to contain a higher percentage 
of 18:1n-9 and a lower percentage of 22:6n-3 than smaller animals. In contrast to these 
tissues, brain was found to contain high levels of 22:6n-3 in animals of all sizes which 
may reflect the importance is of 22:6n-3 to neural development and function [130].As 
larger mammals tend to live longer than shorter mammals, later work in this area found 
a similar relationship between membrane composition and longevity in liver 
mitochondria [12, 35, 131, 132]. Based on this work, it was proposed that the lower 
percent of PUFA and higher percent of MUFA seen in long-lived mammals than 
shorter-living mammals leads to a decrease in membrane susceptibility to peroxidation 
while maintaining membrane fluidity in what is termed a homeoviscous-longevity 
adaptation [35, 131]. The relationship between membrane composition and aging 
caused by lipid peroxidation was formalised by Hulbert as the “Membrane Pacemaker 
Theory Of Aging” in 2005 [13]. 
This theory includes the mechanistic aspects of the “Oxidative Stress Theory Of 
Aging” and is influenced by both the homeoviscous-longevity adaptation and the 
“Membrane Pacemaker Theory Of Metabolism” [12], and focusses on phospholipid 
composition and peroxidation as key determinants of oxidative damage. The key 
mechanistic aspects of this theory are based on the self-propagating nature of 
peroxidation (described in section 2.4.2), the damage caused by the highly volatile 
products of peroxidation (described in section 2.4.3) and the close relationship between 
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the membrane-bound enzymes that produce ROS and membrane phospholipids 
(described in sections 2.1 and 2.4.6). In order to establish a relationship between 
membrane composition and longevity, the “Membrane Pacemaker Theory Of Aging” 
and related work commonly distil the peroxidative capacity of complex membranes 
down to a simple theoretical measure of relative vulnerability to peroxidation. 
 
2.5.3 Comparing membrane vulnerability to peroxidation 
A number of ways to measure the relative susceptibility of membranes to peroxidation 
have been proposed by researchers in this area. The earliest measure used to calculate 
membrane susceptibility to peroxidation from membrane fatty acid composition was the 
number of unsaturated fatty acids (UFA) per 100 fatty acids. This calculation considers 
all MUFA and PUFA as UFA regardless of the number of double bonds present, despite 
MUFA being far less likely to undergo peroxidation than PUFA. As a result, the UFA is 
not a useful measure of membrane susceptibility to peroxidation. An alternative 
measure is the double bond index (DBI), also termed the unsaturation index (UI), which 
is calculated as the number of double bonds per 100 fatty acids [35]. Although popular 
with many researchers in this area, the DBI treats all double bonds as equally likely to 
undergo peroxidation regardless of whether they result in allylic or bis-allylic methylene 
groups [14, 45]. As a result, a membrane containing 100% 18:1n-9 with no bis-allylic 
methylene groups would be given the same DBI value as a membrane containing 50% 
18:2n-6 with many bis-allylic methylene groups and therefore a higher susceptibility to 
peroxidation. 
The “Membrane Pacemaker Theory Of Aging” combines membrane composition 
with RMax values for fatty acids reported from experiments in chlorobenzene solution by 
Holman (1954) [21] to give a peroxidation index per 100 fatty acids. These rates of 
peroxidation increase exponentially with the number of bis-allylic methylene groups so 
that 18:2n-6 has a normalised value of 1, 18:3n-3 has a value of 2, 20:4n-6 has a value 
of 5 and 22:6n-3 has a value of 8. The peroxidation index of membranes is therefore 
calculated as: (% MUFA x 0.025) + (% PUFA with 1 bis-allylic methylene group x 1) + 
(% PUFA with 2 bis-allylic methylene groups x 2) + (% PUFA with 3 bis-allylic 
methylene groups x 4) + (% PUFA with 4 bis-allylic methylene groups x 6) + (% PUFA 
with 5 bis-allylic methylene groups x 8).  
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The peroxidation index is widely used in comparative physiology, but the 
exponential relationship between RMax and bis-allylic methylene groups reported by 
Holman have been contested. Examinations of the peroxidation of fatty acids in 
chlorobenzene solution and liposomes have found a linear relationship between         
bis-allylic groups and RMax [5, 22, 110], although there is support for an exponential rate 
from experiments in in vitro cell cultures [109]. Overall, the relationship between RMax 
is widely considered to be linear in relation to bis-allylic methylene groups in 
contemporary chemistry. In order to maintain continuity with published physiology 
literature, however, the peroxidation index values determined by Holman (1954) [21] 
are used in this thesis. 
 
2.5.4 Recent evidence for the “Membrane Pacemaker Theory of Aging” 
A strong inverse relationship has been found between peroxidation index and longevity 
of mammals and other classes of animals [29, 127]. This relationship is best 
characterised for mammals, but relationships have also been found for birds [12], 
molluscs [37], bees [38], and strains of the nematode Caenorhabditis elegans [39]. The 
relationship between the peroxidation index of mammalian muscle and the maximal 
lifespan (MLS) of mammal species is shown in Figure 2.11 using data published in 
[29]. Although this is the most extensive dataset available, similar trends have been 
found for mammalian liver mitochondria [12]. Recent work in this area generally 
supports this relationship, with the membranes of skeletal muscle and liver 
mitochondria from naked mole rats (MLS of 28 years) found to have a lower 
peroxidation index than those from mice (MLS of 4 years) despite both animals having 
a similar body mass [133]. This difference was primarily due to phospholipids 
containing 22:6n-3 being less common in naked mole rat tissues than mouse tissues [40, 
133]. A lower peroxidation index than predicted by body mass has also been reported 
for the echidna (Tachyglossus aculeatu), which lives 3–4 times longer than predicted for 
its mass, and the long-lived Ames mutant strain of mice (Mus musculus homozygosis 
for Prop1 phenotype) [44, 134, 135]. However, not all recent data support the 
“Membrane Pacemaker Theory Of Aging”. The hoary bat (Lasiurus cinereus) has a 
predicted MLS of 4.5 years based on body mass and a reported MLS of 14 years, but 
contains a high percentage of 22:6n-3 in its muscle membranes and has a higher 
peroxidation index than predicted for a mammal of its lifespan [136]. Order Chiroptera 
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(bats) generally live longer than predicted for their body mass, but there is insufficient 
evidence available to determine if the entire order is an exception to the “Membrane 
Pacemaker” theory, or if this exception is limited to the hoary bat alone [29]. 
 
 
Figure 2.11. Correlation of the peroxidation index of mammal muscle and longevity (n=60). 
Data is from [29]. 
 
Relatively little is known regarding the peroxidation index of membrane phospholipids 
in humans (Homo sapiens). Humans have a predicted MLS of ~25 years based on their 
body mass (AnAge Database) but an actual MLS of 122 years [137]. This MLS is 
extremely long for a mammal, and is only exceeded by estimates for the bowhead 
whales. Although data on human membrane composition and peroxidation index is rare, 
there is some evidence to suggest human liver membranes contain a low percentage of 
PUFA [138, 139], and a recent comparison of mammalian plasma found humans had a 
lower DBI, a lower peroxidation index, and a lower level of peroxidation products than 
shorter lived mammals [42]. 
The link between membrane composition and peroxidation with longevity is best 
described in mammals, but similar relationships have also been found in other classes of 
animals. For birds, the membranes of long-lived petrels (order Procellariiformes) were 
less susceptible to peroxidation than those of the of short-lived fowl (order Galliformes) 
with comparable body masses [140]. Differences were not seen, however, in a 
comparison of long-lived parrots (order Psittaciformes) to fowl with similar body 
masses [141]. In invertebrates, membrane susceptibility to peroxidation was found to be 
lower in queen bees (MLS of 8 years) than worker bees from the same hive (MLS of 7 
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weeks) [38], lower in the Age–1 mutant strain of C. elegans, and lower in long-living 
molluscs than shorter-living molluscs with similar body masses and environments [37]. 
The majority of evidence for the “Membrane Pacemaker Theory Of Aging” comes 
from comparative animal studies, but some experimental interventions have been found 
to decrease the degree of membrane polyunsaturation and extend lifespan. Calorie 
restriction, which has been found to elongate lifespans in mice, rats and primates, has 
also been shown to decrease the peroxidation index of rats by increasing membrane 
MUFA content and decreasing membrane PUFA, particularly 22:6n-3 [29, 142-144]. In 
a recent study by Gómez et al. (2014) [145], the lifelong treatment of mice with 
atenolol, a β–blocker, was found to decrease the degree of polyunsaturation in cardiac 
and skeletal muscle primarily by decreasing 22:6n-3 and increasing 18:1n-9. This study, 
which was the first to examine the link between the peroxidation index and longevity 
experimentally in mammals, found that atenolol prevented oxidative modifications to 
proteins and decreased the loss of immune and behavioural functions related to aging, 
but did not increase lifespan. The authors of the study attributed the lack of an increase 
in lifespan to adverse side effects of atenolol itself that have been found to increase the 
likelihood of cardiovascular failure in humans. Despite not increasing of animal 
lifespan, this finding does provide support for the theory that a decrease in peroxidation 
slows the aging process. 
 
2.5.5 Measuring and comparing membrane phospholipid composition 
The majority of past investigations into membrane composition and longevity have used 
GC to compare relative percentages of fatty acids and peroxidation indexes between 
membranes (e.g. [80, 90, 129, 134]). Some studies have used additional purification 
steps with thin-layer chromatography (TLC) coupled with GC (e.g. [146-148]) or 
HPLC/GC (e.g. [80, 149, 150]) to better understand how fatty acids are distributed 
across classes, but these methods are relatively slow and labour intensive. More recent 
work has used mass spectrometry to examine the percentage of phospholipid class and 
molecular structure in membranes [18, 19, 40-42, 151], with some of the most detailed 
membrane studies using shotgun lipidomics techniques [18, 19, 151]. 
Shotgun lipidomics was first proposed by Han and Gross (1994) [152] as a 
method of direct infusion that “exploits the unique chemical and physical properties of 
each lipid class to facilitate the high-throughput analysis of a cellular lipidome on a 
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large scale directly from organic extracts of biological samples” [50]. This method uses 
electrospray ionization and other “soft” ionization methods in which each lipid gives 
rise to a single anion or cation depending on its molecular structure [153]. Using a triple 
quadrupole mass spectrometer, lipids may then be subjected to collision-induced 
dissociation to produce diagnostic fragmentation products, including for head group 
class and acyl chain content from which the molecular structure of the lipid can be 
deduced [50, 154]. Scan types used in such an analysis include product ion scans, 
precursor ion scans, and neutral loss ion scans [153]. Shotgun lipidomics has the 
advantage of requiring minimal sample preparation while having high sensitivity and 
high throughput in comparison to TLC/GC or HPLC/GC methods [50, 153, 154]. In 
addition, the data produced from shotgun lipidomics can be used to calculate total 
membrane fatty acid composition to give comparable results as those for GC [18]. The 
limitations of shotgun lipidomics include the potential for ion suppression and current 
lack of precursor scans to differentiate plasmalogens from alkenyl ethers. Despite these 
limitations, shotgun lipidomics is, an improvement on the use of GC and has the 
potential to give new insights into the association between membrane composition, 
peroxidation, and longevity. 
 
2.6 Conclusion 
The peroxidation of membrane phospholipids produces products that may cause cellular 
damage and aging. The susceptibility of membrane phospholipids to peroxidation is 
primarily determined by PUFA content, but other elements of phospholipid composition 
may also influence peroxidation. Many questions remain unanswered regarding the 
importance of phospholipid composition to peroxidation and aging. This dissertation 
addresses some of these questions through the use of three different methodologies. In 
Chapter Three, data is analysed to determine how dietary fatty acids influence the 
composition of mitochondrial CL, PC and PE, and the outcomes of this incorporation in 
terms of mitochondrial function and susceptibility to peroxidation. Chapter Four 
presents an in vitro examination of whether phospholipid class influences peroxidation, 
and Chapter Five investigates whether peroxidation is influenced by phospholipids that 
do not contain PUFA. This is followed by an examination of mice, pigs and human 
membranes using shotgun lipidomics that compares the mitochondrial membrane 
between species in Chapter Six, and intra-species differences in mitochondrial and 
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microsomal membranes from these animals in Chapter Seven. Chapter Eight provides 
an overview of the results of these studies. 
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3 Chapter Three                 
Dietary docosahexaenoic acid incorporates into cardiolipin at the 
expense of linoleic acid: An analysis of published datasets 
 
3.1 Overview 
Cardiolipin (CL), the signature phospholipid of mitochondria, is commonly viewed as 
having a highly regulated fatty acid content due to its high levels of linoleic acid  
(18:2n-6). In contrast to this view, numerous published studies have shown that dietary 
docosahexaenoic acid (22:6n-3) increases the percentage of 22:6n-3 present in CL 
suggesting that the fatty acid content of CL conforms to diet. This chapter reviews all 
previously published articles that examined the influence of dietary fatty acids on the 
fatty acid composition of CL, and examines the possible outcomes of changes in the 
fatty acid composition of CL in terms of mitochondrial function and susceptibility to 
peroxidation. The incorporation of 22:6n-3 into two other mitochondrial phospholipid 
classes, phosphatidylcholine and phosphatidylethanolamine, is also reviewed. This 
chapter is closely based on the published work ‘Dietary docosahexaenoic acid (22:6) 
incorporates into cardiolipin at the expense of linoleic acid (18:2): Analysis and 
potential implications’ by Cortie CH and Else PL, International Journal of Molecular 
Sciences, (2012). 13(11): p. 15447–15463. The structure of the present chapter differs 
slightly from the published work to avoid repetition of material presented in Chapter 
Two. CHC proposed the study, collected and analysed the data, and produced the 
primary draft of the paper. PLE supervised all aspects of the work. 
 
3.2 Introduction 
Cardiolipin (CL) is the only prevalent di-phospholipid present in mammalian 
membranes [155-158] and is found almost exclusively in the inner leaflet of the inner 
mitochondrial membrane where it is synthesised [155]. CL has been called the signature 
phospholipid of mitochondria [156] as it has important roles in binding the 
mitochondrial proteins required for oxidative phosphorylation [25, 158] and initiating 
mitochondrial-induced apoptosis by reacting with the haem present in cytochrome c 
[156, 157, 159, 160]. These roles are related to CL’s unusual di-phospholipid structure 
and fatty acid composition. CL possesses four fatty acids rather than the two fatty acids 
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present in other phospholipid classes, and while the combination of two PUFAs on the 
same phospholipid molecule is rare in other mammalian phospholipid classes [18, 161], 
CL containing four linoleic acid (18:2n-6) is highly common in mammalian muscle and 
other tissues [26]. Schlame et al. [26] reported that CL 18:2/18:2/18:2/18:2 comprises 
80% of all CL in human heart, 70–77% in dog heart, 41–77% in rat heart and 50% in 
bovine heart, while Han et al. [162] reported that this same species of CL comprises 
42% of CL in rat heart and 52% in rat liver. Other groups have reported the 18:2n-6 
content of CL in liver and brain as lower than 60%, meaning that this form of CL may 
not be as common in some of these tissues [146, 147, 151]. CL 18:2/18:2/18:2/18:2 has 
been found to have a closer association with the mitochondrial ADP/ATP carrier than 
CL 16:0/16:0/16:0/16:0 [163], and to have a higher binding affinity for cytochrome c in 
comparison to CL molecules with high levels of oleic (18:1n-9), stearic (18:0) and 
palmitic acid (16:0) respectively [164]. 
Although a high 18:2n-6 content is potentially important in CL-protein 
interactions, the exposure of CL to free reactive oxygen species (ROS) produced in the 
mitochondria put the PUFA present in CL at high risk of oxidative damage [156]. The 
peroxidation of CL may decrease its affinity for protein binding and disrupt the 
structure of the inner mitochondrial membrane, and has been suggested to be an early 
event in the apoptotic cascade [164-168] or even a trigger of apoptosis [159, 169]. 
Changes in the degree of unsaturation in CL’s PUFA content could therefore be 
expected to affect both its interaction with proteins and susceptibility to peroxidation, 
modifying its function in mitochondria. Such changes are thought to be unusual, as one 
of the widely held beliefs about mammalian CL fatty acid composition is that it is 
highly regulated, primarily due to its high levels of 18:2n-6 and the prevalence of a CL 
18:2/18:2/18:2/18:2 in cardiac mitochondria, but also due to an apparent resistance to 
dietary manipulation [26]. This review examines the evidence that, contrary to popular 
belief, CL’s PUFA composition does conform to dietary fatty acid intake in some 
circumstances, particularly when diets are rich in 22:6n-3 
 
3.3 Changes in the fatty acid composition of cardiolipin due to diet 
3.3.1 Dietary trials investigating cardiolipin in animal models 
It has been known for some time that dietary fats affect phospholipid composition 
[148], and CL seems to be no exception. The fatty acid composition of CL has been 
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reported in numerous studies examining the effects of various dietary fatty acids on the 
phospholipid composition of heart and liver mitochondria. Most (~75%) of these studies 
have used rats [56, 146-149, 170-182] or mice [150, 183-186], and these studies supply 
the raw data used in the present study. The primary focus of many of these studies has 
been on n-3 and n-6 PUFA that, unlike SFA and MUFA, mammals cannot form de novo 
from basic carbon sources [89]. The sources of dietary SFA, MUFA and PUFA used in 
these studies were generally from sources commonly eaten by humans including fish, 
linseed, corn, olive, rapeseed and soybean, although one study used crocodile oil [185] 
(Table 3.1). The majority of the studies examined predate the use of mass spectrometry, 
instead using combinations of thin layer chromatography (TLC) or high-performance 
liquid chromatography (HPLC) together with gas chromatography (GC). One limitation 
of these techniques (versus a lipidomics approach) is that they cannot readily determine 
the abundance of specific phospholipid molecular species within each phospholipid 
class. However, these studies did provide the total fatty acid composition of the CL 
present in membranes, 
The incorporation of dietary fatty acids was found to be a selective process in 
these studies, and so this analysis did not include all fatty acids. Although some 
researchers reported SFA in very low levels in CL, presumably due to the presence of 
immature CL (discussed in section 3.4), SFA content was not examined in this review 
as not all work reported SFAs shorter than 18:0. Linolenic acid (18:3n-3) was also not 
examined as, although it is consumed at moderate levels in the diet [187], little if any 
appears in most phospholipids [18] including CL [26], presumably due to its conversion 
through to the longer chained omega-3 fats. Arachidonic acid (20:4n-6) was not 
included in the present analysis due to limited data in this area but has been reported in 
CL at levels ranging from 0–12% [148, 170, 184]. As eicosapentaenoic acid (EPA,    
20:5n-3) can be converted to 22:6n-3, diets containing greater than 10% EPA or diets in 
which 20:5n-3 levels exceeded those of 22:6n-3 were excluded to prevent confounding 
effects. This review therefore focussed on the influence of dietary 18:1n-9, 18:2n-6 and 
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Table 3.1 Details of species, sources of fat, measurement method used, and feeding 
period of studies examined. 






Rats     
Yamaoka et al., 1988 [147] Corn oil, sardine oil TLC, GC 20% 4 
McGee et al., 1996 [146] Not stated TLC, GC 20% 4 
Charnock et al., 1986 [148] Sunflower oil, tuna, 
vegetable oil 
TLC, GC 4% or 16% 60 
Astorg et al., 1991 [149] Sunflower seed oil, 
linseed oil 
HPLC/GC 10% 20 
Ikeda et al., 1996 [170] Safflower oil, perilla 
oil, palm oil, methyl 
20:4 
TLC/GC 10% 3 
Innis and Clandinin, 1981 [171] Soya-bean, rapeseed TLC, GC 20% 5 
Jahouvey et al., 1990 [172] Palm oil, olive oil, 
sunflower oil, linseed 
oil, menhaden oil 
HPLC, GC 15% 4 
Kramer, 1980 [173] Corn oil, zephyr oil TLC, GC 20% 16 
Novak et al., 2006 [174] Standard chow diet TLC, GC 3.5% 9 
Power et al., 1994 [175] Coconut oil, olive oil, 
safflower oil, 
menhaden oil 
TLC, GC 2% or 20% 10 
Taniguchi et al., 1993 [177] 20:5 and 22:6 
methylesters 
TLC, GC 15% 2 
Yamaoka et al., 1990 [178] Corn oil, sardine oil TLC, 
HPLC, GC 
20% 2 
Hoy and Holmer, 1990 [179] Marine oil, olive oil, 
sunflower seed oil 
TLC, GC 20% 10 
Charnock et al., 1984 [180] Sunflower seed oil, 
sheep kidney fat 
TLC, GC 4%, 12% 20 
Charnock et al., 1991 [181] Sunflower, fish oil TLC, GC 16% 44 
Robblee and Clandinin, 1984 [182] Beef tallow, soybean 
oil 
TLC, GC 7–23% 2 
Lee et al., 2006 [188] Soybean oil and meal, 
fish meal, alfalfa meal, 
corn meal 
TLC, GC 4% 16 
     
Mice     
Croset and Kinsella, 1989 [183] Crocodile oil, soybean 
oil 
TLC, GC 7% 13 
Berger and German, 1990 [184] Coconut oil, safflower 
oil, flaxseed oil 
HPLC, MS 10% 17 
Watkins et al., 2001 [185] Crocodile oil, soybean 
oil 
TLC, GC 7% 13 
Hussein et al., 2009 [150] Coconut oil, safflower 
oil, flaxseed oil 
HPLC, MS 10% 17 
TLC: thin layer chromatography; GC: gas chromatography; HPLC: high performance liquid 
chromatography; MS: mass spectrometry. 
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A small number of exclusion criteria were applied for data selection. As 18:2n-6 
is the most readily consumed PUFA in the human diet (~42% of PUFA consumed 
[187]) and an essential fatty acid in mammals, the analysis excluded any diets 
containing less than 2% of 18:2n-6 as a proportion of total dietary fatty acid. Based on 
the work of Owen et al. [189], two weeks of dietary intervention is the minimum period 
required in order to allow adequate time for phospholipid remodelling to occur, so any 
dietary interventions shorter than two weeks were excluded. Where different feeding 
periods were used in the same study, the period closest to four months was chosen as it 
represented an average common feeding period across studies. In the entire analysis, the 
only study excluded as a gross outlier was that of Berger et al. from 1992 [186]. This 
study reported that the percentage of 22:6n-3 in mouse heart CL was increased from 12 
to 48% of total fatty acids after 18 days on a diet containing 22:6n-3 at 11% of total 
fatty acids [186]. This percentage was approximately double that reported by any other 
study, and has not been replicated since its original publication. 
 
3.3.2 Conformer-regulator model 
The conformer-regulator model was used to examine the relationship between dietary 
fatty acid composition and phospholipid fatty acid composition. In this model, the 
percent of a fatty acid in the diet (e.g. 18:1n-9, 18:2n-6 or 22:6n-3) is plotted against its 
level or that of another fatty acid present in CL. A slope of 1 represents a perfect 
conformation between dietary fatty acid composition and phospholipid fatty acid 
composition, and a slope of zero suggests that the fatty acid composition of 
phospholipids is independent to that of diet and is therefore perfectly regulated [90]. 
Slopes not significantly different from zero indicate regulation, slopes significantly 
greater than zero but below 1 indicate weak conformity, and slopes of 1 or more 
represent very strong, active dietary conformity. Previous work using this model has 
shown that total membrane SFA, MUFA and PUFA content are likely to show a 
regulator pattern with diet, but n-3 and n-6 PUFA show varying levels of dietary 
conformity, particularly at low dietary levels where presumably their essential dietary 
nature is displayed [28, 190]. 
Line fit and slopes in all figures presented in this study were determined using 
segmental linear regression with an unconstrained line intercept available in GraphPad 
Prism 5.04 (GraphPad Software, CA, USA). All statistical analyses were performed 
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using the same software package and slope values are reported as slope ±95% 
confidence interval. 
 
3.3.3 Modelling fatty acid composition of diet and cardiac cardiolipin  
The three fatty acids most commonly reported in CL were 18:1n-9, 18:2n-6 and 22:6n-3 
[146, 147, 149, 150, 170-174, 176, 177, 183-185, 188]. Figure 3.1 shows the percentage 
of 18:1n-9 and 18:2n-6 in CL against their percentage in the diet in heart and liver. No 
significant trend was apparent for 18:1n-9, with a slope of 0.036±0.094 (P= 0.886) 
across a wide dietary range (0–78%), indicating a regulated pattern with 18:1n-9 
comprising around ~10% of cardiac CL fatty acid content. The incorporation of 18:2n-6 
into cardiac CL showed a distinctive biphasic pattern with a rapid rise in CL 18:2n-6 
levels from 2–20% of dietary fat indicating a conformer pattern as indicated by a slope 
of 1.17±1.10 (P= 0.038). At these lower levels of dietary 18:2n-6 intake, the 
incorporation of 18:2n-6 into CL appeared to be an active and selective process as 
would be predicted from the high 18:2n-6 content generally reported for CL. At dietary 
levels where 18:2n-6 was above 20% (range 21–68%) of dietary fat, the incorporation 
of this fatty acid was reduced to a regulated pattern with a slope of 0.036±0.524, 
levelling off at ~70% of CL fatty acid being 18:2n-6 (or ~65% when rat and mouse 
values are combined), supporting reports that 18:2n-6 levels in CL is largely a regulated 
phenomenon 
Analysis of 22:6n-3 levels in heart CL showed that a small percentage (2–8%) of 
22:6n-3 was present in CL even when 22:6n-3 was absent from the diet (Figure 3.2). 
This was presumably due to the elongation and desaturation of shorter chained PUFA 
such as 18:3n-3 to 22:6n-3 by the liver [191] and the subsequent incorporation of   
22:6n-3 into heart CL. When 22:6n-3 was present in the diet at levels of up to 20% of 
total fatty acid, it was readily incorporated into CL in a strong active conformer pattern 
with a slope of 1.43±0.58 (P< 0.0001). Although 22:6n-3 was examined over a more 
extended range (0–37%) than 18:2n-6, dietary levels of 22:6n-3 above 20% of total 
dietary fatty acid indicated some degree of regulation with the plateauing of 22:6n-3 
levels at ~20% of fatty acid CL content. Therefore 18:2n-6 and 22:6n-3 seemed to be 
readily incorporated into heart CL when their levels in the diet were up to 20% of total 
dietary fatty acid, indicating a strong active conformer pattern, but at higher dietary 
levels a regulated pattern was suggested. 
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Figure 3.1. The relative content of 18:1n-9 and 18:2n-6 as percentages of the fatty acid content 
of cardiolipin and total dietary fat. Values for heart are for rat (●) and those for liver are for rat 
and mice (○). Data for heart is from [146-149, 170-174, 177-182, 188] and liver data is from 




Figure 3.2. The relationship between the percentage of 18:2n-6 and 22:6n-3 in heart and liver 
cardiolipin and the percentage of 22:6n-3 present in dietary fat. Data is from studies using both 
rats (●) and mice (○) and included the following experimental groups: control diet [180], 
sunflower oil and tuna oil diets [148], diet 1 and 4 [183], 4 month time point [188], high 18:3n-3 
diet, long chain n-3 diet [150], control, high 22:6 [177], soy oil and crocodile oil [185], sardine 
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3.3.4 Modelling fatty acid composition of diet and liver cardiolipin 
Fewer studies have examined CL acyl remodelling in liver compared to heart, but what 
was available [149, 175, 177, 184, 185] is presented in Figure 3.1 for 18:1n-9 and 
18:2n-6, and in Figure 3.2 for 22:6n-3. Both figures use data for mice and rats. In 
general, the percentage of 18:1n-9 was higher (at ~20%) in liver than in heart and the 
percentages of 18:2n-6 and 22:6n-3 were lower. Presumably 18:1n-9 was acting as an 
alternative for some of the 18:2n-6 and 22:6n-3 fatty acids in liver, with some studies 
reporting 18:1n-9 levels of 25% or higher in liver CL [175, 179, 184]. The incorporation 
of 18:1n-9 into liver CL was regulated at a low level with a very mild and non-
significant accrual (slope of 0.237±0.266; P= 0.076) throughout the dietary range 
examined (2–70%). Similarly, 18:2n-6 showed little indication of any strong trend to 
incorporate into liver CL at either low or high dietary 18:2n-6 intakes (Figure 3.1) with 
a slope of 0.164±0.352; (P= 0.33) across a broad dietary range, again indicating that the 
incorporation of 18:2n-6 into CL is highly regulated. Although there was little data 
available for the influence of dietary 22:6n-3 on the composition of liver CL         
(Figure 3.2), what was available suggested a conformer pattern when 22:6n-3 levels 
were below 10% of total dietary fatty acid with a slope of 1.04±0.85 (P= 0.02). 
 
3.3.5 The effect of dietary 22:6n-3 on the incorporation of 18:2n-6 into heart and 
liver cardiolipin 
All studies that incorporated both 22:6n-3 and 18:2n-6 into the same diet and measured 
the fatty acid composition of CL were analysed (Figure 3.2) for heart [147, 148, 150, 
172, 177, 180, 181, 183, 185, 188] and liver [147, 175, 177, 185, 186]. Owing to the 
more limited number of studies available that included both 22:6n-3 and 18:2n-6 in the 
same diet, the analysis includes data for both rat and mouse tissues. No statistical 
relationship was found between dietary levels of 22:6n-3 and 18:2n-6. For example, 
when 22:6n-3 was at its highest level in the diet (37%) the level of 18:2n-6 was also one 
of the highest of any of the diets (56%) indicating that changes in 18:2n-6 levels in heart 
CL were not simply due to dietary 22:6n-3 displacing dietary 18:2n-6 [183]. Figure 3.2 
clearly shows the deposing influence of 22:6n-3 on 18:2n-6 levels in cardiac CL at 
22:6n-3 levels of up to 20% of total dietary fatty acid. At dietary levels where 22:6n-3 
was less than 20% of total fatty acids, 22:6n-3 was incorporated into cardiac CL (slope 
of 1.43±0.58; P= 0.0001) while percentages of 18:2n-6 in CL decreased (slope of          
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–2.14±1.24; P= 0.002). At percentages of dietary 22:6n-3 above 20% of fatty acids, the 
percentage of 18:2n-6 appeared to plateau at just under 40% of total fatty acids in heart 
CL which was below its “normal level” of ~70% (Figure 3.1), whereas 22:6n-3 
plateaued at just above ~20% of total fatty acid making up most of the difference 
(Figure 3.2). 
Liver CL also appeared to accrue 22:6n-3 at the expense of 18:2n-6 (slope of 
1.041±0.846; P= 0.022) although less data was available for liver than heart (Figure 
3.2). A study that examined the effects of very high levels of dietary 22:6n-3 on CL 
composition reported liver CL did not incorporate 22:6n-3 even when dietary 22:6n-3 
exceeded 10% of total fatty acid in the diet [177]. At this point 18:2n-6 plateaued at 
slightly over ~20% of CL fatty acid content, down from the normal ~30–60% with 
22:6n-3 at ~13% of CL fatty acid making up a large proportion of the difference. 
Therefore CL in heart and liver maintained 18:2n-6 levels at ~70% and 50% 
respectively, and in the case of heart readily accrued 18:2n-6 from the diet when this 
fatty acid is at lower levels (<20%). However, when 22:6n-3 was available in the diet it 
was incorporated into CL at the expense of 18:2n-6 until 22:6-3 made up ~20% of CL 
fatty acid content in heart and ~13% in liver, after which both 18:2-6 and 22:6n-3 levels 
seemed to be constant and therefore regulated. 
 
3.3.6 Comparison of 22:6n-3 incorporation into other mitochondrial phospholipids 
Although functionally important, CL is not the major phospholipid class in 
mitochondria, comprising 5–20% of mitochondrial phospholipids [17, 51]. The two 
major mammalian mitochondrial phospholipids classes are phosphatidylcholine (PC) 
and phosphatidylethanolamine (PE), which make up ~45% and ~35% of total 
mitochondrial phospholipid respectively [192]. Some of the studies examined here [28, 
56, 164, 167, 168, 170, 172, 173, 175, 176, 178-185] included data for PC and PE in 
addition to CL, and a brief analysis of 18:1n-9, 18:2n-6 and 22:6n-3 incorporation into 
PC and PE of heart and liver mitochondria was conducted (Figure 3.3). There were no 
significant trends in the incorporation of 18:1n-9 and 18:2n-6 into PC and 18:1n-9 into 
PE of cardiac mitochondria across a broad range of dietary supplementation (2–78% of 
total fatty acids), indicating a regulated pattern for these fatty acids in heart. In 
comparison, the incorporation of 18:2n-6 into heart PE showed a weak but significant 
conformer trend with increasing levels across the same dietary range with a slope of 
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0.056±0.051 (P= 0.034). The incorporation of 22:6n-3 in both PC and PE in heart 
mitochondria displayed a strong conformer trend with slopes of 0.93±0.45 (P= 0.0003) 
for PC and 0.89±0.58 (P= 0.005) for PE when 22:6n-3 composed up to 38% of dietary 
fatty acids. In liver mitochondria the incorporation of 18:1n-9, 18:2n-6 into PC and 
18:1n-9 into PE also showed no significant trends in across a broad dietary range. Liver 
mitochondrial PE showed a weak conformer uptake for 18:2n-6 (slope 0.045±0.038; P= 
0.024) but both liver PC and PE showed a strong dietary conformer pattern for 22:6n-3 
uptake with slopes of 0.95±0.32 (P< 0.0001) for PC and 1.33±0.79 (P= 0.0025) for PE 
across a dietary range of 22:6n-3 of up to 20%. Unlike in CL, the incorporation of 
22:6n-3 into PC and PE was not found to be at the expense of 18:2n-6. 
 
 
Figure 3.3. Levels of 18:1n-9, 18:2n-6 and 22:6n-3 as a percentage of total fatty acids in 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) against total dietary fatty acids. 
Each figure includes both rat (●) and mouse (○) data. Data used for heart PC was from [147-
150, 171, 172, 174, 177, 178, 180-185], for heart PE was from [56, 149, 183, 184], for liver PC 
and PE were from [147, 149, 170, 175, 177, 184, 185]. Data excluded from the analysis 
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3.4 Cardiolipin remodelling 
This analysis used a comprehensive compilation of studies to show that dietary 18:2n-6 
is selectively incorporated into heart and liver CL, but that the incorporation of dietary 
22:6n-3 has an even greater selectivity. The analysis indicated a strong conformer 
pattern when dietary levels of 18:2n-6 were between 2–20% of total dietary fatty acid, 
with higher dietary availability of 18:2n-6 showing regulated levels. In liver, no trend 
was evident for 18:2n-6 incorporation into CL across a broad range of dietary 18:2n-6 
intakes, indicating a regulated level of 18:2n-6 into CL of liver mitochondria. When 
22:6n-3 and 18:2n-6 were present in the same diet and 22:6n-3 was between 0–20% of 
total dietary fatty acids, CL preferentially incorporated 22:6n-3 into its structure at the 
expense of 18:2n-6. This preference for the incorporation of 22:6n-3 over 18:2n-6 
seems to be present in both heart and liver. The replacement of 18:2n-6 by 22:6n-3 has 
previously been noted in phospholipids of heart. For example, in a dose-response study 
of dietary 22:6n-3 (0–32%) examining myocardial phospholipids, Owen et al. [189] 
found that 22:6n-3 replaced 18:2n-6, and to a lesser extent 18:1n-9. Other studies 
comparing diets low and high in 22:6n-3 have noted similar trends in cardiac 
phospholipids [183, 185] and CL specifically [147, 149, 178, 185]. The present analysis 
found that 22:6n-3 will replace 18:2n-6 in CL even when dietary levels of 18:2n-6 are 
high, but this replacement will occur at levels of dietary 22:6n-3 of up to 20% in heart 
and ~10% in liver. 
The selectivity of 22:6n-3 over 18:2n-6 in CL and the preferential incorporation of 
these two fatty acids over others is likely due to the complex nature of CL synthesis and 
remodelling. CL is synthesised from the condensation of a PG molecule with cytidine 
diphosphate diacylglycerol resulting in what is commonly referred to as immature CL 
with a mixed acyl content that is then remodelled to produce mature CL with high 
18:2n-6 content [156]. The selected incorporation of fatty acids during remodelling was 
recently investigated by Kiebish et al. [193], who reported that only 1–5% of the fatty 
acids incorporated into CL during the remodelling process come from PC and PE, with 
this process having a low acyl selectivity. The majority of fatty acids are drawn from the 
pool of acyl-CoA fatty acids and this incorporation is highly selective [193]. 
Interestingly, heart acyltransferases were reported to have 1.3 times the specificity for 
22:6n-3 in comparison to 18:2n-6, which in turn had specificity many times higher than 
that of any other fatty acid. In contrast, liver acyltransferases had a far higher specificity 
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for 18:2n-6 over 22:6n-3 or any other fatty acid [193]. The specificities of these 
acyltransferases and tissue differences are likely to explain the underlying mechanism 
by which 22:6n-3 replaces 18:2n-6 in heart CL but does not explain the response in 
liver. 
 
3.5 Consequences of the incorporation of 22:6n-3 into cardiolipin 
The accrual of 22:6n-3 into phospholipids in a conformer fashion probably reflects the 
essential dietary nature of omega-3 fats generally and the readiness of tissues to use 
preformed fatty acid if available. Based on the roles CL performs in mitochondria, the 
functional consequences of accruing 22:6n-3 into the structure of CL are likely to be 
significant. The incorporation of 22:6n-3 in CL might increase the fluidity and 
permeability of inner mitochondrial membranes and may adversely affect CL’s 
interactions with proteins [163]. These changes would be expected to decrease the 
efficiency of oxidative phosphorylation, and the three dietary studies in the analysis that 
investigated the effect of 22:6n-3 incorporation into CL on mitochondrial oxidative 
phosphorylation found no change [183] or a decrease in activity [147, 182]. More recent 
work in this area has shown a similar trend of dietary 22:6n-3 either decreasing or not 
affecting mitochondrial respiration [194, 195]. 
As 18:2n-6 contains only one bis-allylic methylene group but 22:6n-3 contains 
five, the incorporation of 22:6n-3 over 18:2n-6 into CL, PC and PE will increase 
membrane susceptibility to peroxidation, which is an important mechanism in cellular 
health and disease [3-5]. Furthermore, the products formed during peroxidation of n-3 
PUFA are proposed to be more reactive than those produced from n-6 PUFA [196]. CL 
has been shown to be more susceptible to peroxidation than other phospholipid classes 
both in vitro [30] and in vivo [166] due to its high level of 18:2n-6, proximity to ROS 
production, and close association with the haem-containing cytochrome c [25, 197, 
198]. An increase in CL’s susceptibility to peroxidation due to the incorporation of 
22:6n-3 may also increase cell sensitivity to apoptosis as the peroxidation of CL is 
thought to be an early event in mitochondrial-induced apoptosis related to cytochrome c 
release and disruption of the inner and outer mitochondrial membranes [164-166, 199]. 
Overall, the replacement of 18:2n-6 with 22:6n-3 has the potential to adversely affect 
cell function, but the finding that CL selectively accrues 22:6n-3 in place of 18:2-6 
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suggests that the incorporation of 22:6n-3 into CL is not a disadvantageous under 
normal dietary circumstances. 
 
3.5.1 Limitations 
This chapter shows both the limitations and importance of analysing data from 
published works. The incorporation of 22:6n-3 into the CL of mammalian heart and 
liver is likely to increase the peroxidation index of these tissues, but the exact changes 
in the peroxidation index could not be determined from the available data. In addition, 
physiological changes due to increased 22:6n-3 in CL composition were not examined, 
and so it could not be determined if the incorporation of 22:6n-3 into the CL of healthy 
organisms has an overall positive or negative influence on longevity and health. The 
advantage of the present study, however, is that it combines similar findings from 
multiple sources to provide the best evidence available that the fatty acid composition of 
CL can be influenced by diet, particularly dietary 22:6n-3. 
 
3.6 Conclusions 
The high level of 18:2n-6 reported in CL has led to the view that the fatty acid 
composition of CL is regulated interdependently of diet [26]. This analysis has, 
however, shown that the 18:2n-6 and 22:6n-3 content of CL is influenced by the 
percentage of these fatty acids in the diet. The accrual of 18:2n-6 into cardiac CL 
increased when 18:2n-6 was present at 2–20% of dietary fatty acids, and was regulated 
at ~70% of CL when 18:2n-6 was present at higher percentages in the diet. In 
comparison, liver showed no indication of accrual at lower 18:2n-6 dietary levels and 
overall levels of 18:2n-6 in liver CL are lower. This analysis also clearly shows that the 
incorporation of 22:6n-3 into heart CL is favoured over the incorporation of 18:2-n6 
when 22:6n-3 is present at up to 20% of dietary fatty acids, but not at higher 
percentages of dietary 22:6n-3. There is less evidence that this is occurring in liver, 
suggesting that selectivity may differ between tissues. The replacement of the single 
bis-allylic methylene group present in 18:2n-6 with the five bis-allylic methylene 
groups in 22:6n-3 may result in changes in cellular respiration, membrane peroxidation 




4 Chapter Four         
Comparison of lipid hydroperoxide production between phospholipid 
classes matched for linoleic acid: Cardiolipin is not an exception 
 
4.1 Overview 
Phospholipid peroxidation is primarily a function of polyunsaturated fatty acid (PUFA) 
content, but a number of studies have also found phospholipid class to influence 
susceptibility to peroxidation. This chapter presents an in vitro comparison of iron-
mediated peroxidation of cardiolipin and other phospholipid classes in diffuse solutions 
and in liposomes. Unlike many past works, the phospholipids compared in this chapter 
all contained linoleic acid at equivalent amounts in order to remove fatty acid 
composition as a variable in comparisons. 
 
4.2 Introduction 
The oxidative damage of phospholipids by reactive oxygen species (ROS), a process 
termed peroxidation, is intrinsic to aerobic organisms [3-5, 200, 201]. Although the 
head groups that define phospholipid class do not normally peroxidises, differences in 
head group structures have been suggested to influence phospholipid peroxidation [15, 
22, 30, 202-204]. Work in this area is limited and has resulted in contradictory findings 
due to differences in initiators, phospholipid mixtures, buffers and measurement 
technique used [15]. For example, negatively charged phosphatidylethanolamine (PE) 
has been reported to increase iron-initiated peroxidation in some conditions but inhibit it 
in others [202, 203]. Phosphatidic acid (PA) and phosphatidylglycerol (PG), both small 
head groups, have been reported to inhibit peroxidation [204] but the di-phospholipid 
cardiolipin (CL), also a small head group in respect to molecule size, has greatly 
increased peroxidation in comparison to phosphatidylcholine (PC) or PE [30]. The 
peroxidation of CL is of particular interest due to CLs close association with the early 
stages of apoptosis involving the release of cytochrome c into the cytosol [30, 197, 205, 
206]. 
CL is the only prevalent di-phospholipid class present in mammalian membranes 
and is found almost exclusively in mitochondria where it facilitates oxidative 
phosphorylation by binding cytochrome c and other mitochondrial proteins [197, 205, 
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206]. Mammalian CL often contains multiple linoleic acids (18:2n-6) and occasionally 
also 22:6n-3, as described in Chapter Three, but other phospholipid classes in 
mammalian tissue rarely contain more than one polyunsaturated fatty acid [18]. The 
presence of multiple PUFA in a single phospholipid, particularly the presence of   
22:6n-3, is likely to make CL highly susceptible to peroxidation. The peroxidation of 
CL is an early event in apoptosis, and some researchers have suggested that the 
peroxidation of CL by cytochrome c is a trigger of apoptosis [156, 157, 159, 160]. This 
idea has resonated recently in a number of studies that have reported preferential 
peroxidation of CL compared to other phospholipid classes during oxidative stress [30] 
and hyperoxia [169], with reports of CL having twice the peroxidisability of comparable 
amounts of 18:2n-6 in methyl ester form [207]. However, measurement of CL 
peroxidation via its production of lipid hydroperoxides has never been compared to 
other phospholipid classes with similar fatty acid compositions. 
This chapter examines the influence of the phospholipid head groups by 
comparing the auto and iron-mediated peroxidation of CL, of PC, PE, PG and PA 
matched for amounts of 18:2n-6. Phospholipids were examined as either diffuse in 
solution or as liposomes in mixtures with a carrier phospholipid, PC 16:0/16:0. All 
phospholipids contained comparable concentrations of 18:2n-6 to ensure comparable 
peroxidation indexes between experiments. Peroxidation was initiated using ferrous iron 
(Fe
2+
) and measured as LOOH levels due to their high level of production and relative 




The bovine heart cardiolipin (BHCL) had a purity of >97% and fatty acid composition 
of 90% 18:2, 5% 18:1 and 5% unknown. The synthetic phospholipids had a purity of 
>99% and included: PC 16:0/16:0, PC 16:0/18:2, PC 18:2/18:2, PE.16:0/18:2,.PE 
18:2/18:2, PG 16:0/18:2, PA 16:0/18:2. All phospholipids were purchased from Avanti 
Polar Lipids Inc. (Alabama, USA) without any added butylated hydroxytoluene (BHT) 
and kept as 5 mg/ml stock solutions maintained under nitrogen in sealed containers at –
20℃. Ammonium ferrous sulfate (NH4)2Fe(SO4)2.6H2O, xylenol orange and butylated 
hydroxytoluene (BHT) were purchased from Sigma-Aldrich (USA). Methanol and 
chloroform (HPLC grade) were purchased from Crown Scientific (Australia). Sulfuric 
4.3 Methods 
50 
acid (98%) was purchased from Ajax Chemicals (Australia). All chemicals used were of 
analytical grade. 
 
4.3.2 Matching the concentration of bis-allylic methylene groups between 
phospholipids 
Phospholipids were made-up from stock solutions to a final concentration of bis-allylic 
methylene of group concentration of 194 mM. This concentration of bis-allylic 
methylene groups reflected original work performed using soy PC to ensure a 
comparable peroxidative index between phospholipid classes. Based on this 
concentration, 54 mM of BHCL (containing 90% 18:2n-6) had an equivalent 
peroxidation index of 194 mM of phospholipids composed of 16:0/18:2 or 97 mM of 
phospholipids composed of 18:2/18:2. 
4.3.3 Sample preparation 
Initial methanol experiments were carried out in 250 µM ammonium ferrous sulfate in a 
solution of 90% methanol, 10% 2.5 mM sulfuric acid (v/v) [113]. As CL, PE, and PA 
do not readily form liposomes in aqueous media [24] it was necessary to stabilise them 
in liposomes of PC 16:0/16:0, a non-peroxidisable phospholipid commonly used to 
produce liposomes. During initial experiments, a ratio of 1:3 BHCL:PC 16:0/16:0 (w/w) 
was found to have low levels of auto peroxidation and high levels of iron initiated 
peroxidation. Based on these results, all phospholipids tested were mixed with 0.3 
mg/ml of PC 16:0/16:0 and enough peroxidisable phospholipid to yield 194 mM of   
bis-allylic methylene groups. To form liposomes, lipid mixtures were dried under 
nitrogen for 60 min at 37 ºC and then hydrated with 140 mM NaCl solution (pH 3.4) for 
10 min at 45 ºC. The solution was maintained at pH 3.4 to ensure that the iron used to 
initiate peroxidation remained in the ferrous form. Following hydration, mixtures were 
vortexed for 15 min and sonicated on ice using a Sanyo Soniprep 150 with an 
exponential probe. The probe sonicator output frequency was 23 kHz with an amplitude 
of 63 microns. Sonication occurred in 3 bouts of 45 seconds separated by 5 second rest 
periods. Liposomes were maintained at 45 ºC and used immediately after preparation. 
Mixtures of the peroxidisable phospholipids were also tested in solution of 90% 
methanol, 10% water without PC 16:0/16:0. Solutions were assessed for particle 
formation (e.g. liposomes or micelles) using a Zetasizer APS (Malvern Instruments Ltd, 
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UK) but no discernible populations of particles were detected. The pH of methanol and 
aqueous solutions was kept at between pH 3–4 [213]. 
 
4.3.4 Peroxidation  
Peroxidation was initiated by the addition of ferrous iron in the form of ammonium 
ferrous sulfate. Peroxidation involved two components: that associated with ferrous iron 
and that independent of ferrous iron i.e. auto peroxidation, both occurring in the same 
incubations. To separate these contributions, liposomes were incubated both with and 
without ferrous iron. Auto peroxidation (without ferrous iron) was then taken away 
from total peroxidation (i.e. that with ferrous iron) in order to distinguish peroxidation 
initiated by the presence of ferrous iron only. 
Lipid hydroperoxide (LOOH) concentration was used as a measure of 
peroxidation using the xylenol orange (FOX-2) assay as previously described [203] and 
as reviewed by Bou et al. [113]. All results were reported as lipid hydroperoxides 
produced per 18:2n-6 (mmol LOOH per mol 18:2n-6). No LOOH was detected in the 
concentrated stock solutions (maintained under nitrogen). In order to determine 
conditions for maximum LOOH production, liposomes composed of BHCL and PC 
16:0/16:0 at a ratio of 1:3 BHCL:PC 16:0/16/0 (w/w) were tested against increasing 
concentrations of ferrous iron using an incubation time of ten min. A second series of 
incubations was conducted using incubation times of between 5–120 min and 100 M 
ferrous
 
iron to ensure the maximum level of product was formed. Based on these results 
subsequent experiments using liposomes were carried out over 10 min with 100 M 
ferrous iron used to initiate peroxidation. Data was analysed by one-way ANOVA with 
Tukey post hoc tests using GraphPad Prism 5.04 (GraphPad Software, San Diego, USA) 
and IBM SPSS Statistics 19 (IBM, New York, USA). 
 
4.4 Results 
4.4.1 LOOH formation in diffuse solution 
In diffuse solution (90% methanol, 10% water), the total lipid hydroperoxide formation 
(mmol LOOH per mol 18:2n-6) was higher for BHCL (305.3±13.6) and PA (356.6±9.2) 
than PC, PE, or PG phospholipids (all below 200) (Figure 4.1A). PC 18:2/18:2, PE 
16:0/18:2 and PE 18:2/18:2 produced significantly higher total LOOH than PC 
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16:0/18:2 and PG 16:0/18:2, and neither PC 16:0/18:2 nor PG 16:0/18:2 produced more 
total LOOH than PC 16:0/16:0, the negative control. While auto peroxidation (without 
added ferrous iron) was below 50 mmol LOOH per mol 18:2n-6 for most 
phospholipids, levels of 61.78±17.9 and 100.3±17.7 were reached for PC 18:2/18:2 and 
PE 18:2/18:2 respectively, with both values significantly higher than PC 16:0/16:0 
(Figure 4.1B). This auto peroxidation accounted for the major component of total 
peroxidation of these two phospholipids. Iron-mediated LOOH production (i.e. total 
peroxidation minus auto peroxidation) was highest in PA 16:0/18:2 (355.6±8.4), 







Figure 4.1. Lipid hydroperoxide production (mmol LOOH per mol 18:2n-6) of phospholipids 
matched for linoleic acid (18:2n-6) content in a solution of 1:9 water to methanol (v/v). 
Peroxidation was initiated by the addition of 100 µM ferrous iron in the form of ammonium 
ferrous sulfate for total peroxidation (A) or without iron to determine auto peroxidation (B). 
Peroxidation due to initiation with ferrous iron alone (C) was calculated as the difference 
between total peroxidation minus auto peroxidation. LOOH levels were tested after 60 min of 
reaction. Data are presented as mean ±SEM, n=6. Non-identical letters indicate significant 










































































































































4.4.2 Maximizing LOOH formation in liposomes 
Initial experiments found that BHCL alone did not readily peroxidise in aqueous 
solution, but LOOH production was greatly increased when BHCL was incorporated 
into liposomes with PC 16:0/16:0 (Figure 4.2). Auto peroxidation was maximal when 
only BHCL was present and reduced with increasing levels of PC 16:0/16:0. The 
maximal level of ferrous initiated BHCL peroxidation occurred at a ratio of 1:3 (w:w) 
BHCL to PC 16:0/16:0. This ratio produced LOOH levels significant greater 1:1 BHCL 
to PC 16:0/16:0. Based on these results, all subsequent comparisons between head 
groups and their ability to peroxidise were carried out at a ratio of 1:3 of peroxidisable 
phospholipids to PC 16:0/16:0. This ratio was also used to optimise concentration of 
ferrous iron and time of incubation necessary to produce maximal LOOH in liposomes 
(Figure 4.3). Results from BHCL in diffuse solution are shown for comparison. The 
concentration of ferrous iron found to maximise LOOH production of peroxidisable 
phospholipids was 100 µM (Figure 4.3A). The maximum rate of LOOH production was 
35.3±1.1 (mmol LOOH per mol 18:2n-6 per min), which occurred within the first 5 min 
of incubation. The rate then dropped to 3.2±1.2 (mmol LOOH per mol 18:2n-6 per min) 
between 5 to 10 min (Figure 4.3B). LOOH amounts were stable after ten min at a ratio 
of 1:3 (BCHL:PC 16:0/16:0).  
 
 
Figure 4.2 Production of lipid hydroperoxides (mmol LOOH per mol 18:2n-6) after sixty min of 
reaction of bovine heart cardiolipin (BHCL) in liposomal mixtures of BHCL and PC 16:0/16:0. 
Total peroxidation (A) was initiated by the addition of 100 µM ferrous iron in the form of 
ammonium ferrous sulfate while auto peroxidation (B) was not initiated by iron. Peroxidation 
due to initiation with ferrous iron alone (C) calculated as the difference between total 
peroxidation minus auto peroxidation. Data are presented as mean ±SEM, n=6. Non-identical 
letters indicate significant differences within each graph for P<0.05. 
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Figure 4.3. Production of lipid hydroperoxides (mmol LOOH per mol 18:2n-6) from bovine 
heart cardiolipin (BHCL) in liposomes containing PC 16:0/16:0 at a ratio of 1:3 (w/w) or BHCL 
diffuse in a solution of 1:9 water to methanol (v/v). All experiments contained 194 mM of 
18:2n-6. A) values varying concentrations of ammonium ferrous sulfate after 60 min of 
incubation and B) values with increased incubation time and with 100 µM ammonium ferrous 
sulfate. Values are means ±SEM, n=4. 
 
 
4.4.3 Comparison of LOOH production of phospholipid classes in liposomes 
All phospholipids incorporated into liposomes in aqueous media peroxidised readily 
and had significantly higher levels of total LOOH production than the negative control 
(Figure 4.4A). There was a more uniform level of auto peroxidation in the liposomes in 
comparison to diffuse solutions and PE 16:0/18:2, PE 18:2/18:2, and PG 16:0/18:2 had 
higher levels than the negative control, PC 16:0/16:0 (Figure 4.4B). Overall, iron-
initiated peroxidation was the dominant contribution to total peroxidation in all 
phospholipids tested (Figure 4.4C). Iron-initiated production of LOOH, the primary 
outcome of these experiments, was less homogenous in outcome than auto peroxidation. 
The phospholipid with the highest level of iron-initiated peroxidation (mmol LOOH per 
mol of 18:2n-6) was PC 18:2/18:2, followed by PE 16:0/18:2, PE 18:2/18:2 and PC 
16:0/18:2, BHCL, PG 16:0/18:2, and PA 16:/18:2. The amount of iron-initiated LOOH 
production ranged from 103.3 to 296.1 (mmol LOOH per mol of 18:2n-6). Although 
BHCL had a lower level of iron-initiated production of LOOH (202.5±5.3) than other 
phospholipids when normalised for 18:2n-6 content, it was only statistically lower than 
PC 18:2/18:2. 
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4.5.1 Differences in diffuse solution and liposomes 
This chapter compared the iron-initiated peroxidation of cardiolipin (CL) and species of 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG) 
and phosphatidic acid (PA) matched for linoleic acid (18:2n-6) content when diffuse in 
solution or in liposomes in aqueous medium. Interest in this comparison came from 
experiments conducted by Paul Else examining phospholipid peroxidation using the 
updated ferrous oxidation-xylenol orange (FOX-2) assay for lipid hydroperoxides 
(LOOH). In these experiments very high levels of peroxidation were observed for 
bovine heart CL (BHCL) but not for PC or PE phospholipids containing 18:2n-6. Initial 
work showed that this peroxidation was taking place in the FOX-2 solution rather than 
in prior assays, suggesting that the CL head group influences peroxidation in ways that 
PC and PE do not. When phospholipid classes were tested in diffuse solution, the 
ranking of iron-mediated lipid hydroperoxide production was PA> BHCL>> PE> PC, 
PG. The cause of the retarded peroxidation of PG, PC and PE and much higher 
peroxidation for the phospholipids PA and BHCL is not obvious, but may be related to 






Figure 4.4 Production of lipid hydroperoxides (mmol LOOH per mol 18:2n-6) by phospholipid 
classes matched for 18:2n-6 in liposomes containing PC 16:0/16:0. Peroxidation was initiated 
by the addition of 100 µM ferrous iron in the form of ammonium ferrous sulfate for total 
peroxidation (A) or without iron to determine auto peroxidation (B). Peroxidation due to 
initiation with ferrous iron alone (C) was calculated as the difference between total peroxidation 
minus auto peroxidation. LOOH levels were tested after ten min of reaction. Data are presented 
as mean±SEM, n=6. Non-identical letter indicate significant differences within each graph for 
P<0.05, as determined by Tukey post-hoc tests. 
 
 
negative charges [24]. Auto peroxidation in methanol did not follow the same trends as 
iron-mediated peroxidation, with PC 18:2/18:2 and PE 18:2/18:2 the only phospholipids 
to show significantly higher LOOH production.  
In contrast, all phospholipid classes showed similar levels of iron-mediated 
















































































































































hydroperoxide production in liposomes was PC> PE> CL> PG> PA. PC and PE are the 
largest head groups relative to phospholipid size and were uncharged under the 
experimental conditions used while the head groups of PG, CL and PA are relatively 
smaller and negatively charged. Previous studies have suggested that negatively charged 
phospholipid head groups can increase peroxidation by attracting ferrous iron [202], but 
this was not strongly supported by the present study. The differences between the 
results found in liposomes compared to those produced in methanol highlights the 
importance of the models used to test peroxidation. 
 
4.5.2 Cardiolipin and peroxidation 
The present results are in contrast to previous reports that CL peroxidises more readily 
than other head groups [30, 169, 207]. One reason for this difference is in the use of free 
iron rather than cytochrome c, as cytochrome c forms a tight complex with CL but not 
with other phospholipids [159, 169]. A second reason is the choice of stabilizing agents 
for liposome preparation. In order to maximise iron-initiated peroxidation and ensure 
the availability of CL, BHCL and the other phospholipids were incorporated into 
liposomes containing a non-peroxidisable ‘carrier’ phospholipid (PC 16:0/16:0). A 
recent study by Roginsky [207] reported CL peroxidises at twice the rate of the methyl 
ester of 18:2 per bis-allylic methylene group when used with Triton X-100 (a detergent) 
to form CL micelles. CL and 18:2 methyl esters were incubated at different 
concentrations (0.6–2 mM to 5–20 mM respectively) in the same concentration of 
Triton X-100. However, Triton X-100 contains endogenous peroxide (0.22%: see Sigma 
MSDS sheet) that can accelerate rates of peroxidation and potentially total product 
formation. This factor may have influenced the results. In addition, methyl esters are far 
more resistant peroxidation than those in phospholipids containing the same 
peroxidisable fatty acids (Else and Kraffe, in preparation). 
Another explanation as to why CL may appear to peroxidise more readily and 
produce more product is that peroxidation can be measured as oxidation per bis-allylic 
methylene group, as in the present study and [207], or per phospholipid. As a              
di-phospholipid rich in 18:2n-6, mammalian CL is far more likely to peroxidise on a per 
phospholipid basis than other classes that typically contain only up to one PUFA [79, 
214]. Wiswedel et al. [30] compared the peroxidation of CL, PC and PE from rat brain 
during oxidative stress and reported that CL content of the mitochondria dropped away 
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more rapidly than both PE and PC. Using values for the acyl composition of mouse 
brain mitochondria for CL, PE and PC [215], the peroxidative index of these 
phospholipids can be calculated to be 106, 170 and 76 respectively. This might indicate 
that the early peroxidation of CL is disproportionate to its peroxidative potential. 
However, peroxidation was measured by the ‘disappearance’ of phospholipids from a 
mass spectrum, a process that measures peroxidation per phospholipid rather than per 
bis-allylic methylene group. Due to its structure, CL is approximately twice as likely to 
‘disappear’ as PE or PC with comparable peroxidative indexes. This re-evaluated 
peroxidative potential of the molecule is in-line with the relative disappearance of the 
different phospholipids found by Wiswedel et al. [30]. Similarly, the relative early 
disappearance of CL from other studies on rat brain mitochondria during oxidative 
stress [216] and in lungs during acute hyperoxic lung injury [169] can be similarly 
explained without requiring CL to show exceptional peroxidative capacity. 
 
4.5.3 Limitations 
The limitation of the FOX-2 assay to measure in vitro peroxidation are due to its slow 
sampling speed which cannot accurately be used to measure the phases of peroxidation. 
The use of the FOX-2 assay is an accurate measure of the maximum product of 
peroxidation but does not record data faster enough to identify distinct lag and 
propagation phases of peroxidation (Figure 4.3, [202]). The maximum rate of 
peroxidation was measured for BHCL in diffuse solutions and liposomes, but the length 
of the lag phase and rate of peroxidation during this phase could not be measured. This 
limitation is shared by similar assays including the thiobarbituric acid reactive 
substances (TBARS) assay. These limitations are addressed in Chapter Five, which 
describes results obtained following the purchase of a six-channel oxygen meter 
(Strathkelvin Instruments) that provided a more sensitive and continuous measurement 
of peroxidation. A further limitation was the use of iron as an initiator of peroxidation. 
The 100 µM ferrous iron used in these experiments is likely to be far in excess of iron 
concentrations found in under physiological conditions, and iron is only one of many 
possible initiators that may be used to study peroxidation. Future work in this area could 
consider physiologically relevant concentrations of iron alongside other initiators such 





The experiments presented in this Chapter show that the CL and PA classes increased 
peroxidation products in diffuse solution when compared to other phospholipid classes 
independently of PUFA composition. In comparison, peroxidation in liposomes was 
similar between classes, with the small differences in peroxidation related to head group 
size. In contrast to past studies, CL did not have higher peroxidation (as measured by 
product formation) compared to other phospholipid classes in liposomes, suggesting 




5 Chapter Five            
An antioxidant-like action for non-peroxidisable phospholipids using 
ferrous iron as a peroxidation initiator 
 
5.1 Overview 
Phospholipids with saturated (e.g. PC 16:0/16:0) and monounsaturated fatty acids (e.g. 
PC 16:0/18:1) are some of the most common phospholipids found in membranes, and 
under normal conditions are generally non-peroxidisable. This chapter presents an in 
vitro investigation into an antioxidant-like effect of PC 16:0/16:0 and PC 16:0/18:1 
during iron-mediated peroxidation in liposomes. This study used more sophisticated 
techniques than Chapter Four to measure multiple aspects of peroxidation including the 
period of the lag phase and the associated rates of peroxidation. This chapter is closely 
based the article ‘An antioxidant-like action for non-peroxidisable phospholipids using 
ferrous iron as a peroxidation initiator’ by Cortie CH and Else PL, BBA Biomembranes, 
2015, 1846(6): p. 1303-1307. The structure of the chapter differs from the accepted 
article to avoid repetition with earlier chapters. CHC developed the method used in this 
study and collected all data except that presented in Figure 5.5. CHC analysed all data 
and drafted the work. PLE proposed the study, collected the data for Figure 5.5, and 
supervised all aspects of the work. 
 
5.2 Introduction 
Peroxidation is a constitutive process in living systems and is part of healthy functions 
but also pathology and aging [217, 218]. Peroxidation is a free radical reaction that 
typically progresses through three well-recognised phases; i) the lag phase, a duration of 
time (TLag) with a slow rate of reaction (RLag) and product formation, ii) the propagation 
phase, with a fast rate of reaction (RMax) and product formation and, iii) termination due 
to substrate exhausting or antioxidant quenching (Figure 2.9, [96]). From a biological 
perspective, the lag phase is important as it offers the opportunity to prevent 
peroxidation entering into the more damaging propagation phase. It is within the lag 
phase that membrane antioxidants and enzymes can stop the peroxidation reaction, and 




The chemistry of peroxidation is complex [5, 219], but the peroxidation of cellular 
membranes can be mainly attributed to the polyunsaturated fatty acids (PUFA) present 
in membrane phospholipids. As a result of the differences in the bond energies of 
hydrogen to the carbons of fatty acids, PUFA are far more likely to undergo 
peroxidation than saturated fatty acids (SFA) or monounsaturated fatty acids (MUFA) 
([73], Table 2.2). As a consequence, phospholipids that contain one or more PUFA are 
peroxidisable phospholipids (PPLs) while phospholipids containing only SFA and/or 
MUFA are non-peroxidisable phospholipids (non-PPLs). Despite the challenge PUFA 
present to living organisms in terms of peroxidation, PPLs are prevalent in membranes. 
In mammals, for example, membrane phospholipids typically possess between 30 to 
60% of their total fatty acids as PUFA [18, 220], making PPLs a major portion of 
membrane phospholipids. 
The current research examines if non-PPLs can protect PPLs from peroxidising. 
This work examines the separate peroxidation of two PPLs (a natural phospholipid, soy 
phosphatidylcholine, and a synthetic phospholipid phosphatidylcholine, PC 16:0/18:2) 
in the presence of one of two different non-PPLs (PC 16:0/16:0 and PC 16:0/18:1) to 
determine if any protection occurs. Peroxidation was induced by low levels of ferrous 
iron rather than the more common high concentrations of azo-initiator such as AAPH in 
order to produce a more natural peroxidative stimulus. Although the mechanism by 
which iron initiates lipid peroxidation is still under debate [100], poorly-ligated iron is a 
problem common to a number of pathologies [105]. The results of this study suggest 
that the presence of non-PPLs decreases the rates of peroxidation resulting in the 
extension of the duration of the lag phase producing an antioxidant-like action. 
 
5.3 Methods 
5.3.1 Materials  
The phosphatidylcholines PC 16:0/16:0, PC 16:0/18:1, PC 16:0/18:2 and Soy PC (fatty 
acid composition of 14.9% 16:0, 3.7% 18:0, 11.4% 18:1n-9, 63% 18:2-6, 5.7% 18:3n-3 
and 1.2% unknown) were purchased from Avanti Polar Lipids (Alabaster, USA) 
without added butylated hydroxytoluene (BHT) as antioxidant. Ammonium ferrous 
sulfate ((NH4)2Fe(SO4)2.6H2O), sodium sulfate and butylated hydroxytoluene (BHT) 
were purchased from Sigma-Aldrich (St Louis, USA). Methanol (HPLC grade) and 
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sulfuric acid (98%) were purchased from Crown Scientific (Rowville, Australia). All 
chemicals used were of analytical grade. 
 
5.3.2 Liposome preparation  
Stock solutions of phospholipids (125 mM) of both peroxidisable (PC 16:0/18:2 and 
Soy PC) and non-peroxidisable (PC 16:0/16:0 or PC 16:0/18:1) phosphatidylcholines 
were made-up in methanol and stored at –20 
o
C under nitrogen. Phospholipids from 
each stock solution were combined to produce the required phosphatidylcholine 
mixtures. Each phospholipid mixture was dried down under a stream of nitrogen for a 
minimum of 90 min (or until completely dry) at 42 
o
C, made-up to 10 mM using 
deionised water (42 
o
C, pH 3), stirred continuously for 45 min (42 
o
C) then passed nine 
times across a 0.1 μm pore polycarbonate membrane (Avanti Polar Lipids) using a 
Mini-Extruder (Avanti Polar Lipids) at (42 
o
C). Following extrusion, samples were 
diluted to 2.5 mM. Samples of liposomes were taken from each preparation, before and 
after peroxidation, in order to measure liposome size. BHT was added to prevent further 
peroxidation. In addition, the lipid hydroperoxide (LOOH) level of each liposomal 
preparation was measured prior to initiation of peroxidation and only those preparations 
with no measureable levels of LOOH were used. 
 
5.3.3 Measurement of lipid peroxidation and liposome size 
Peroxidation was measured using oxygen consumption as a measure of peroxyl 
formation. Oxygen consumption was measured using Clarke-type microelectrodes 
(Strathkelvin Instruments) with up to six electrodes used simultaneously. Oxygen 
consumption measurements were made over 2 hr periods at 37 
o
C using a RC-650 six-
electrode respirometer. Oxygen consumption data was acquired each second from each 
microelectrode using a Six-Channel Oxygen Meter (Strathkelvin Instruments). Oxygen 
electrodes were prepared fresh daily using high sensitivity, fast response membranes 
(YSI Life Sciences, Morningside, Australia). Care was taken to remove any trace of 
lipid hydroperoxides adhering to the respiration wells between experiments. Prior to any 
measurement, microelectrodes were allowed to stabilise and thermally equilibrate to 
37
o
C for a minimum period of 30 min. Incubations were stirred continuously during 
experimentation. Microelectrode calibration was performed as per manufacturer's 
instruction using air saturated, filtered deionised water with sodium sulfate used to 
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determine oxygen range. At 37 
o
C the oxygen concentration used was 6.73 mg or 210.3 
µmol of oxygen/L of water at prevailing atmospheric pressure. 
Peroxidation was initiated using 10 µM ferrous iron derived from ammonium 
ferrous sulfate (pH 3–4). Liposomes were made up to a final concentration of 2.5 mM, 
with PPLs present at between 2.5 and 0.5 mM and non-PPLs added from 0.5 to 2.0 mM 
(20–80%). Graphs show the decrease in PPL and increase in non-PPL from left to right. 
The inset in each figure show the same experiment carried for liposomes composed of 
the same amount of PPL only (2.5–0.5 mM). Except for the period of the lag phase 
(TLag), all measurements are normalised for the concentration of PPL. Measurements 
made during peroxidation included: rate of peroxidation during the lag phase (RLag), 
maximum rate of peroxidation during the propagation phase (RMax), duration of the lag 
phase (TLag) and total amount of oxygen consumed during the lag phase (ALag), as 
shown in Figure 2.9. RLag and RMax were determined using segmental linear regression 
analysis GraphPad Prism 5.04 (GraphPad Software, San Diego, USA) where the model 
divided the data into RLag and RMax segments for each replicate and using an iterative 
process proceeded to determine the best fit for each segment. The duration of the TLag 
was taken as the period between the point of ferrous iron addition to the point of 
intersection between the derived RLag and RMax segments [96].  
Liposome size was determined using a Malvern Zetasizer (Malvern, UK) at a 
refractive index of 1.46 at 37 
o
C. Measurements were taken before and after each 
experiment with liposomes found to vary in size between 140 and 155nm. No 
significant change in liposome size was detected as a result of time of incubation (120 
min), phospholipid composition or peroxidation. All results were analysed using 2-way 
ANOVAs with Bonferroni post-hoc tests using GraphPad Prism 5.04. 
 
5.4 Results 
5.4.1 Extension of the lag phase 
The duration of the lag phases (TLag) of liposomes composed of the peroxidisable 
phospholipids (PPLs) Soy PC (Figure 5.1A) and PC 16:0/18:2 (Figure 5.1B) were 
extended by the presence of the non-PPLs PC 16:0/16:0 or PC 16:0/18:1. The insets in 
each figure show TLag in the absence of non-PPLs at the same concentration of PPL as 
in the main graphs (2.5 mM down to 0.5 mM). In the absence of non-PPLs, 
concentrations of 2.5 to 0.5 mM of Soy PC and PC 16:0/18:2 showed no change in the 
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duration of their lag phases (Figure 5.1 insets). The presence of either non-PPL with 
Soy PC or PC 16:0/18:2 increased the TLag significantly when present at 60% and 80% 
of liposomal phospholipids. The presence of PC 16:0/16:0 increased the TLag of Soy PC 
by up to 4.7–fold and that of PC 16:0/18:2 by up to 2.6–fold. In comparison, the 
presence of PC 16:0/18:1 increased the TLag of Soy PC by up to 3.1–fold and that of PC 
16:0/18:2 by up to 5.3–fold. One major difference between the two PPLs was the 
duration of TLag in the absence of non-PPLs which was approximately 9–fold longer for 
Soy PC compared to PC 16:0/18:2 (3.9–7.0 min for Soy PC compared to 0.43–0.79 min 




Figure 5.1. The period of the lag phase (TLag) during iron-mediated peroxidation of the 
peroxidisable phospholipids (PPLs) Soy PC (A) and PC 16:0/18:2 (B) in the presence of the 
non-peroxidisable phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1. PPLs were 
measured at concentrations between 2.5 and 0.5 mM, with non-PPLs added to make all final 
concentrations of phospholipid 2.5 mM. The inset in each figure shows the response of each 
PPL in the absence of any non-PPL across the same concentration range (2.5–0.5 mM). 
Peroxidation was initiated with 10 µM ammonium ferrous sulphate. Values are averages ±SEM, 
n=6. Significant differences between PPLs in the presence (main graph) and absence (inset) of 
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5.4.2 Changes in rate 
The ability of non-PPLs to increase the duration of the lag phase of PPLs appears to be 
due to their capacity to reduce rates of peroxidation (Note: with the exception of TLag all 
other parameters were normalised to account for the differences in PPL concentration). 
This is shown in the rates of peroxidation during the lag (RLag, Figure 5.2A and B) and 
propagation (RMax; Figure 5.3A and B) phases of Soy PC and PC 16:0/18:2 respectively. 
The RLag and RMax values remain constant across an increasing percentage of both     
non-PPLs. The RLag and RMax were lower for Soy PC than PC 16:0/18:2, and both    
non-PPLs had similar effects on the rates. In the absence of non-PPLs, the RLag of Soy 
PC increased 2.1–fold (from 1.4 to 3.0 mmol of O2 per mole of Soy PC per minute, 
Figure 5.3A inset) and that of PC 16:0/18:2 increased 3.2–fold (from 3.6 to 11.7 mmol 
of O2 per mole of PC 16:0/18:2 per minute, Figure 5.3B inset). Similarly, in the absence 
of non-PPLs, the RMax of Soy PC increased 2.1–fold (Figure 5.3A inset) and that of PC 
16:0/18:2 by 1.3–fold (Figure 5.3B inset). 
 
 
Figure 5.2. Rates of iron-initiated peroxidation during the lag phase (RLag) of the peroxidisable 
phospholipids (PPLs) A) Soy PC and B) PC 16:0/18:2 in the presence of the non-peroxidisable 
phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1. PPLs were measured at 
concentrations between 2.5 and 0.5 mM, with non-PPLs added to make all final concentrations 
of phospholipid 2.5 mM. The inset in each figure shows the response of each PPL in the 
absence of any non-PPL across the same concentration range (2.5–0.5 mM). Rates were 
normalised for differences in the concentration of PPL. Peroxidation was initiated with 10 µM 
ammonium ferrous sulphate. Values are averages ±SEM, n=6. Significant differences between 
PPLs in the presence and absence of non-PPLs are indicated with * for P<0.05 and *** for 
P<0.001. In the insets, # indicates significant differences at P<0.05 for values in comparison to 
the original PPL concentration of 2.5 mM. 
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Figure 5.3. Rates of iron-initiated peroxidation during the propagation phase (RMax) of the 
peroxidisable phospholipids (PPLs) A) Soy PC and B) PC 16:0/18:2 in the presence of the non-
peroxidisable phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1. PPLs were measured 
at concentrations between 2.5 and 0.5 mM, with non-PPLs added to make all final 
concentrations of phospholipid 2.5 mM. The inset in each figure shows the response of each 
PPL in the absence of any non-PPL across the same concentration range (2.5–0.5 mM). Rates 
were normalised for differences in the concentration of PPL. Peroxidation was initiated with 10 
µM ammonium ferrous sulphate. Values are averages ±SEM, n=6. Significant differences 
between PPLs in the presence and absence of non-PPLs are indicated with * for P<0.05 and *** 
for P<0.001. In the insets, # indicates significant differences at P<0.05 for values in comparison 
to the original PPL concentration of 2.5 mM. 
 
 
The ability of non-PPLs to inhibit the RLag was supported by measurements of the 
total amount of oxygen consumed during the lag phase (ALag) by Soy PC and synthetic 
PC 16:0/18:2. The presence of non-PPLs increased the total amount of oxygen 
consumed during the lag phase of both Soy PC (Figure 5.4A) and PC 16:0/18:2 (Figure 
5.4B), being statistically significant when present at 80% of liposomal phospholipid. 
This inhibition is likely due to the ability of each PPL to reach a critical level of 
peroxidation product (presumably peroxyl radicals) needed to transition into the 
propagation phase. 



















































































































































































w ith PC 16:0/18:1
Peroxidisable phospholipid
w ith PC 16:0/16:0
Key
w ith PC 16:0/18:1
Peroxidisable phospholipid
w ith PC 16:0/16:0
Key
A) Soy PC B) PC 16:0/18:2




Figure 5.4. Amount of O2 consumed by the end of the lag phase (ALag) of iron-mediated 
peroxidation of the peroxidisable phospholipids (PPLs) A) Soy PC and B) PC 16:0/18:2 in the 
presence of the non-peroxidisable phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1. 
PPLs were measured at concentrations between 2.5 and 0.5 mM, with non-PPLs added to make 
all final concentrations of phospholipid 2.5 mM. The inset in each figure shows the response of 
each PPL in the absence of any non-PPL across the same concentration range (2.5–0.5 mM). All 
parameters measured were normalised for differences in the concentration of PPL. Values are 
averages ±SEM, n=6. Significant differences between PPLs in the presence and absence of non-
PPLs are indicated with * for P<0.05 and *** for P<0.001. In the insets, # indicates significant 
differences at P<0.05 for values in comparison to the original PPL concentration of 2.5 mM. 
 
 
5.4.3 The importance of the ratio of Fe2+ to PPL 
The increases in normalized rates of peroxidation of PPLs seen with decreasing PPL 
concentration can be explained by changes in the ratio of Fe
2+ 
to PPL. This presumably 
occurs because 10 µM ferrous iron did not produce a maximal peroxidation response, 





PPL increased from 1:250 to 1:50. To test the importance of relative 
concentrations of Fe
2+
 to PPLs, the RMax of Soy PC was measured at both variable 
(1:250 to 1:50) and constant (1:250) Fe
2+
:PPL ratios. The result shows that increases in 
the RMax were removed once the ratio of Fe
2+
 to PPL ratio was held constant (Figure 
5.5). 
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Figure 5.5. The relative maximal rates of peroxidation (Rmax) of Soy PC at either constant 
(1:250) or increasing (1:250 to 1:50) ratios of Fe
2+
 to Soy PC. Statistical differences show 
comparisons between measurements at the same Soy PC concentration but different Fe
2+
:Soy 




5.5.1 Non-peroxidisable phospholipids have an antioxidant-like action 
Antioxidant molecules and enzymes are considered key defences in controlling the 
radical-generating reactions of peroxidation. These defences act by extending the lag 
phase of peroxidation, thus preventing the transition to the more damaging propagation 
phase [96, 108], and so the duration of the lag phase is commonly considered to reflect 
the antioxidant status of membranes [108]. Many factors influence peroxidation 
including both physical and chemical aspects of the lipid and their packing within 
membranes, with the polyunsaturated fatty acid (PUFA) content being particularly 
important [15, 64]. The role of non-peroxidisable phospholipids (non-PPLs) containing 
saturated fatty acids (SFA) or monounsaturated fatty acids (MUFA) in influencing 
peroxidation has been only examined in a limited number of studies [16, 221]. The 
present work suggests that these non-PPLs can produce an antioxidant-like action that 
protects peroxidisable phospholipids (PPLs), therefore preventing the propagation of 
peroxidation in membranes. This action appears to be accomplished by decreasing the 
overall rate of peroxidation during the lag phase and impeding the build-up of 
peroxidation product necessary to enter into propagation phase. As a result, the presence 
of non-PPLs extends the duration of the lag phase which is likely to be the most 
important antioxidant-like action produced by these phospholipids in membranes. Non-






















membranes [18], and it is at this level that the significant antioxidant-like activity of 
non-PPLs extends the lag phase by 2.5–fold to 5.3–fold. 
The antioxidant-like action of non-PPLs was found to have a greater influence on 
the extracted Soy PC than the synthetic PC 16:0/18:2 even though these two 
phospholipids have a similar acyl composition. Soy lecithin, which is primarily soy PC, 
has a high level of antioxidants [222] and so the extended lag phase of Soy PC is likely 
due to the presence of antioxidants co-extracted during purification. If this is the case, 
the greater influence of non-PPLs on Soy PC than PC 16:0/18:2 suggests a synergistic 
action of the antioxidants present in Soy PC with the antioxidant-like action of the non-
PPLs. Such an action could reduce the levels of antioxidant needed in membranes to 
control peroxidation reactions by providing more time for antioxidants to be recycled or 
for damaged phospholipids to be removed. 
Indications of some antioxidant-like actions for non-peroxidisable phospholipids 
have been previously reported by Lee et al. (1998) [16] who examined liposomes 
containing phosphatidylcholines with a constant proportion of 18:2n-6 (37.5%) and 
varying amounts of 18:1n-9 and 16:0. This study found that “when 16:0 was replaced 
by 18:1 there was a marked increase in the lag time”. The study of Lee et al. did not 
vary the concentration of non-PPLs and emphasised the role of 18:1n-9. In the present 
work, the concentration of non-PPLs varied and both PC 16:0/16:0 and 16:0/18:1 were 
found to be capable of extending the lag phase of Soy PC and PC 16:0/18:2. An 
antioxidant-like action for PC 16:0/16:0 has also been shown in the study of            
Soto-Arriaza et al. (2008) [221] examining the peroxidation of liposomes made-up of 
egg PC and varying amounts of PC 16:0/16:0 (0–60 mol%). This study found that PC 
16:0/16:0 inhibited peroxidation “beyond that expected from the unsaturated lipid 
dilution”. The antioxidant action was interpreted as being due to a rigidification of the 
bilayer and ‘capture’ of initiating radicals. This explanation is slightly contrary to the 
result of the present study where PC 16:0/16:0 and PC 16:0/18:1 were both found to 
display antioxidant-like activity even though their transition temperatures are quite 
different, (41.5 
o
C for PC 16:0/16:0 and –2 
o
C for PC 16:0/18:1 [223]). It is therefore 
possible that the antioxidant-like action of these non-PPL works by steric hindrance 
without requiring rigidification. The peroxidation reaction requires lipid radicals to 
come in contact with each other in the plane of the monolayer in order to continue 
peroxidation and this requires diffusion as peroxidation appears not to cross monolayers 
within the bilayer [23]. The presence of non-PPL may ‘cage’ lipid radicals within the 
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monolayer and thus slow rates of peroxidation. The ability of different non-PPLs to 
perform this task is likely to depend upon their individual structure and acyl 
composition. This mechanism appears not to be a simple linear dilution effect as shown 
for PC 16:0/18:2 where a 20% increase in PC 16:0/18:1 (60–80%) increased lag 
duration 3–fold. 
 
5.5.2 Methodological considerations 
One reason the antioxidant-like action of non-PPL has only been recognised in a small 





, or radiation) to maximize the peroxidation response. The levels of 
ferrous iron needed to produce a maximal peroxidation response (100–1000 µM) would 
have overwhelmed any protective effect of the non-PPL. In the present study, the use of 
a submaximal ferrous iron concentration (10 µM) added extra complexity due to 
variable ratios of Fe
2+
 to PPLs, but did allow non-PPLs to exhibit their antioxidant 
capacity. As even a 10 µM ferrous iron peroxidation stimulus is likely to be extremely 
high in vivo, the strength of the antioxidant-like action of non-PPLs in the membrane of 
normal working cells is likely to be biological relevant. 
 
5.5.3 Limitations 
The use of oxygen consumption to measure peroxidation addresses the limitations of the 
methods used in Chapter Four. A general limitation of the in vitro studies presented in 
this thesis was the use of a single initiator, iron, in peroxidation assays. Iron-initiated 
peroxidation is biologically relevant but chemically complex. Radical clocks such as 
AAPH produce ROS at a known rate and could have been used to better determine the 
kinetics of the peroxidation reactions [5, 96], but these kinetics are still complex [224] 
and initiating peroxidation in this manner may not accurately model physiological 
conditions. Future studies of peroxidation would benefit from the use of multiple 
initiators including AAPH, iron, copper and haem to ensure that results are not limited 
to a single initiator. In addition, future work could also be extended to examine the 






Phospholipids composed of SFA and MUFA are present in cellular membranes at 
sufficient concentrations to extend the lag phase of peroxidation. This study shows these 
non-PPLs may play an important role in protecting membranes from peroxidation by 
extending the lag phase in a newly-described antioxidant-like action. It is suggested that 
this antioxidant-like action may assist cells at controlling peroxidation in membranes by 
working synergistically with other antioxidant defences. Future would in this area could 
test the homogeneity of these results with peroxidation caused by AAPH, and would 




6 Chapter Six                 
Of mice, pigs and humans: A lipidomics analysis of mitochondrial 
phospholipids from mammals with very different maximal lifespans 
 
6.1 Overview 
Maximal lifespan (MLS) has been found to be inversely related to the degree of 
membrane unsaturation, particularly of polyunsaturated fatty acids (PUFA). Previous 
comparative work in this area has examined membrane composition at the level of fatty 
acids, but little is known regarding the influence of phospholipid classes and individual 
phospholipid molecules. In addition, data for humans is extremely rare in this area. This 
chapter presents a shotgun lipidomics analysis of mitochondrial membranes and the 
peroxidation index of skeletal muscle, liver, and brain in three mammals that span the 
range of mammalian longevity. This work is closely based on ‘Of mice, pigs and 
humans: A lipidomics analysis of mitochondrial phospholipids from mammals with 
very different maximal lifespans’ by Cortie CH, Hulbert AJ, Norris SE, Mitchell TW, 
McAndrew D, and Else
 
PL, published in Experimental Gerontology, 2015, 70: 135-143. 
This chapter differs from the submitted work to avoid repetition with earlier chapters. 
CHC collected and analysed the samples, wrote the Excel algorithms used to identify 
molecular phospholipids and determine fatty acid composition, and drafted the article. 
SEN and TWM assisted in developing the mass spectrometry methods used. PLE and 
AJH designed the study, supervised the work, and assisted with drafting the article. 
 
6.2 Introduction 
Animal longevity has been inversely correlated with mitochondrial production of 
reactive oxygen species (ROS) and the degree of fatty acid unsaturation in membranes 
[12, 14]. These factors are closely related as ROS are both a cause and a product of the 
peroxidation of polyunsaturated fatty acids (PUFA) [5]. Propagation of peroxidation can 
adversely affect cell function by forming adducts with DNA and proteins, disrupting the 
structure of cell membranes, and propagating damage to lipids [4, 65]. The peroxidation 
of mitochondrial membranes is particularly important as mitochondria are the major 
source of ROS within cells [14] and mitochondrial failure is an indicator of aging [118]. 
Peroxidation primarily occurs at bis-allylic methylene groups as the reduction potential 
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of these groups is lower than that of other methylene groups [73]. Bis-allylic methylene 
groups are present in PUFA, but saturated fatty acids (SFA) and monounsaturated fatty 
acids (MUFA) do not contain these groups and are resistant to peroxidation. The 
number of bis-allylic methylene groups present in PUFA, and therefore the relative 
susceptibility of membranes to peroxidation, increases with the degree of 
polyunsaturation [21, 22]. Common mammalian PUFA include linoleic acid (18:2n-6) 
with one bis-allylic methylene group, arachidonic acid (20:4n-6) with three groups, and 
docosahexaenoic acid (22:6n-3) with five groups. 
The relative susceptibility of cellular membranes to peroxidation, termed a 
peroxidation index, can be determined from membrane composition and experimentally 
derived rates of peroxidation [12, 35]. A strong inverse correlation has been established 
between the peroxidation index and maximal lifespan (MLS) of skeletal muscle and 
liver mitochondria for a range of mammals [34, 35]. This relationship is best 
characterised for mammals, but similar relationships have also been found for birds 
[12], molluscs [37], bees [38], and strains of Caenorhabditis elegans [39]. Despite the 
breadth of prior work in this area it is not known 1) whether results for muscle 
mitochondrial membranes correspond to whole muscle, 2) if brain mitochondria exhibit 
a similar relationship between the peroxidation index and MLS as found in skeletal 
muscle and liver and 3) how different phospholipid classes and phospholipid molecules 
contribute to the peroxidation index. 
To address these questions, an in-depth lipidomics analysis was conducted using 
the common mouse (Mus musculus, MLS of 4 years), the domestic pig (Sus scofa, MLS 
of 27 years), and humans (Homo sapiens, MLS of 122 years). Mice and humans were 
chosen as examples of the extremes of mammal longevity (AnAge Database), and as 
data for human mitochondria is extremely rare. Pigs were chosen as they have a similar 
body mass to humans but a much shorter maximal lifespan. Shotgun lipidomics was 
used to determine phospholipid composition of mitochondrial-enriched fractions of 
skeletal muscle, liver and brain of each animal, and calculated the fatty acid 







Methanol and chloroform (HPLC grade or higher) were supplied by VWR International 
(Queensland, Australia). Analytical grade ammonium acetate was obtained from Crown 
Scientific (New South Wales, Australia). Sucrose, Tris, and ethylenediaminetetraacetic 
acid (EDTA) were supplied by Astral Scientific (New South Wales, Australia). Pierce 
BCA Protein Assay Kits were obtained from Thermo Fisher Scientific (Victoria, 
Australia). Butylated hydroxytoluene (BHT) was supplied by Sigma-Aldrich, (New 
South Wales, Australia). Phospholipid internal standards were purchased from Avanti 
Polar Lipids through Auspep (Victoria, Australia) and consisted of 20 µM of PC 
19:0_19:0, PE 17:0_17:0, and PS 17:0_17:0 and 10 µM of lyso-PC 17:0 and lyso-PE 
14:0. Internal standards were stored in 2:1 chloroform to methanol at –20 °C. 
 
6.3.2 Animals and tissues 
Skeletal muscle, liver and brain tissue samples were harvested from six mice (Mus 
musculus C57BL6; female) 12 months of age, six domestic pigs (Sus scrofa domesticus; 
mixed gender) approximately 6 months of age and six humans (Homo sapiens; mixed 
gender) ranging in age from 64 to 104 years. Mouse tissue was harvested immediately 
following euthanasia by CO2 inhalation. Pig tissue was harvested immediately following 
the death of each animal at the Wollondilly Abattoir (Picton, New South Wales, 
Australia). Human tissue was provided by the University of Wollongong body donation 
program (ethics number HE12/373). The post-mortem interval for human tissue was 
between three to seven days with the bodies maintained at 2–4 
o
C. Skeletal muscle was 
harvested from the intercostal muscle of all three mammals. Human liver was harvest by 
percutaneous liver biopsy. Similar regions of mouse and pig liver were taken following 
removal of the whole liver. Brain was harvested from humans through a burr hole 
approximately 20 mm superior to the external acoustic meatus by means of a surgical 
drill and a cutting biopsy needle. A similar region of the brain was harvested from mice 




6.3.3 Subcellular fractionation and lipid extraction 
Approximately 100 mg of tissue was extracted in 10% homogenising solution 
containing 20 mM Tris buffer, 250 mM sucrose and 2 mM EDTA, pH 7.4. The tissue 
was homogenated in glass-glass homogenizers and the homogenate was centrifuged (10 
min, 1,000 x g) to give a pellet containing nuclei and large cellular debris. Supernatant 
was collected and centrifuged (35 min, 10,000 x g) to produce a mitochondria-enriched 
pellet. All centrifugation steps were performed at 4°C. Characterization of the 
mitochondrial fraction was performed in preliminary work using lamb brain using 
cytochrome c as a mitochondrial marker and Na
+
/K ATPase as a marker for microsomal 
membrane. This assessment found a high level of cytochrome c but low levels of Na
+
/K 
ATPase in the mitochondrial fraction but low levels of cytochrome c in the microsomal 
fraction. Mitochondrial pellets were resuspended in milliQ H2O and total protein 
content was determined. Protein concentrations were determined using a BCA assay. 
Aliquots containing 75 µg of total protein and 50 µL of an internal standard mixture 
were added to 2 mL chloroform: methanol (2:1 v/v with 0.01% BHT). Phospholipid 
internal standards consisted of 20 µM each of PC 19:0/19:0, PE 17:0/17:0, and PS 
17:0/17:0: and 10 µM lyso-PC 17:0 and lyso-PE 14:0 in chloroform: methanol were 
purchased from Avanti Polar Lipids through Auspep (VIC, Australia). Lipids were 
extracted using a modified Folch method as previously described in Deeley et al (2008) 
[225]. Lipid extracts were reconstituted in 1 mL chloroform:methanol (1:2 v/v) and 
stored at -20°C until analysed. 
 
6.3.4 Mass spectrometry and bioinformatics analysis 
Nano-electrospray ionization mass spectrometry of lipid extracts was performed using a 
hybrid triple quadrupole linear ion trap mass spectrometer (QTRAP® 5500 AB Sciex, 
MA, USA) equipped with an automated chip-based nano-electrospray source (TriVersa 
Nanomate™, Advion Biosciences, NY, USA). Samples were diluted to approximately 
10 µM for total phospholipid, and 50 µl of diluted sample was spiked with 50 µl of 
ammonium acetate in chloroform and methanol (1:2 v/v) for a final concentration of     
5 mM of ammonium acetate. Samples were loaded onto 96–well plates. Plates were 
centrifuged (10 min, 2200 x g) prior to direct infusion. Spray parameters were set at a 
gas pressure of 0.4 psi and a voltage of 1.2 kV and 1.1 kV for positive and negative ion 
mode respectively for all acquisitions. 
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Phospholipid data was acquired by targeted ion scans using multi-channel 
acquisition. All scans used are listed in Appendix A. As a result of the ammonium 
acetate, phospholipids of all classes were protonated (M+H)
+
 in the positive ion mode, 
phospholipids of the PC class formed acetate ions (M+OAc)
-
 in the negative ion mode, 
and phospholipids of PE, PS, PG and PA formed anions (M-H)
-
 in the negative ion 
mode. Target lists for these charged phospholipids were made using the 
Glycerophospholipid MS/MS Prediction tool (www.lipidmaps.org) and converted to 
targeted ion lists for use in Lipidview™. Phospholipids of the PC, PE and PS classes 
were quantified from internal standards using positive ion scans for head groups while 
phospholipids in the PG and PA classes were quantified from internal standards using 
negative precursor ion scans for fatty acids. Phospholipid molecular species were 
determined from positive and negative scans was using custom-written spreadsheets in 
Microsoft Excel 2010 (Microsoft Corporation, Redmond, USA). Phospholipids were 
first quantified at the sum composition level, e.g. PC 34:1 from head group scans before 
the molecular level composition was determined, e.g. PC 16:0_18:1. Negative precursor 
ion scans were also used to quantify phospholipid isobaric species within classes. 
Isobaric phospholipid species containing either alkyl ethers or vinyl ethers 
(plasmalogens) could not be differentiated using this method and therefore the sum of 
alkyl ethers and plasmalogens were reported. Processing settings in LipidView™ 
software were set at a mass tolerance of 0.5 Da, with a minimum intensity of 0.1% and 
a minimum signal-to-noise ratio of 10. Phospholipid species that comprised less than 
0.5% of each phospholipid class across the tissue were present in less than 66% of the 
tissue samples were removed from analysis. Values are normalized relative to total 
concentration of phospholipid in each phospholipid class. Phospholipid structure was 
reported using the nomenclature proposed by Liebisch et al. [74]. 
 
6.3.5 Fatty acid composition 
Membrane fatty acid composition was calculated from quantified molecular 
phospholipid species using custom Excel calculators. The fatty acid composition of the 
combined phospholipid classes (PC, PE, PS, PG, and PA) were calculated, and the fatty 
acid composition of PC, PE and PS were calculated for each class. The sum of saturated 
fatty acids (SFA) included ether-linked species. As double bond position with fatty 
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acids could not be determined using the method of analysis, all fatty acids are reported 
without omega-designations. 
 
6.3.6 The peroxidation index 
The peroxidation index was calculated from membrane composition as (% MUFA x 
0.025) + (% PUFA with 1 bis-allylic methylene group x 1) + (% PUFA with 2 bis-
allylic methylene groups x 2) + (% PUFA with 3 bis-allylic methylene groups x 4) + (% 
PUFA with 4 bis-allylic methylene groups x 6) + (% PUFA with 5 bis-allylic methylene 
groups x 8) based on experimental values from [21]. This gives a peroxidation index per 
100 fatty acids. The relative contribution of each phospholipid class to the peroxidation 
index was calculated as the peroxidation index of each class multiplied by the relative 
abundance of each class. This calculation gave the relative contribution of each class as 
a percentage of the total peroxidation index. Similarly, the contributions of molecular 
phospholipids to the peroxidation index were calculated from he peroxidation index and 
relative abundance of molecular phospholipids 
 
6.3.7 Statistical analysis 
Two-way ANOVAs (animal x measure) with Bonferroni post-hoc tests were used for all 
comparisons. All statistical analyses were completed using GraphPad Prism 5.04 
(GraphPad Software, San Diego, USA). 
 
6.4 Results 
6.4.1 Phospholipid composition of skeletal muscle mitochondria 
Greater than 85% of phospholipids found in the mitochondria of skeletal muscle were 
phosphatidylcholines (PC) and phosphatidylethanolamines (PE), 10% were 
phosphatidylserines (PS) and less than 5% were phosphatidylglycerols (PG) and 
phosphatidic acids (PA) (Figure 6.1A). Phosphatidylinositol (PI) was not examined due 
to a PI standard not being available for use. Mice and pigs possessed a lower percentage 
of PC and a higher percentage of PE than humans. No significant difference was found 
in the relative distribution of PS between species. PA was present in mouse muscle 
mitochondria but was absent in human and pig muscle. The muscle mitochondria of 
mice possessed a much higher percentage of phospholipids containing multiple bis-
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allylic methylene groups than humans or pigs (Figure 6.2A). This occurred throughout 
the phospholipid classes and included PC 16:0_20:4 with three bis-allylic methylene 
groups, and PC 16:0_22:6, PE 18:0_22:6 and PS 18:0_22:6 which each have five bis-
allylic methylene groups. In contrast, human and pig mitochondria had much lower 
levels of these highly peroxidative phospholipids but had a higher abundance of 
phospholipids containing 18:2, the PUFA containing only one bis-allylic methylene 
group. These phospholipids included PC 16:0_18:2 and PE 18:0_18:2. Mouse and pig 
muscle shared similar levels of phospholipid resistant to peroxidation such as PC 
16:0_18:1 with humans having more of these peroxidation resistant phospholipids, 
including PC 16:0_18:1 as well as PC 18:1_18:1. 
 
6.4.2 Phospholipid composition of liver mitochondria 
The relative distribution of phospholipid classes in liver mitochondria was similar to 
that found for muscle mitochondria, with PC, PE and PS accounting for the majority 
(>90%) of phospholipids (Figure 6.1B). The percentages of PC, PE and PS did not 
differ between mice and humans whereas pigs possessed a lower percentages of PC and 
a higher percentage of PE than mice or humans. PS was also significantly higher in 
mice than in the pigs. Mice and humans shared a similar high percentage of PE 
18:0_20:4, whereas mice and pigs shared a high level of PS 18:0_20:4. Mice tended to 
possess phospholipids with more bis-allylic methylene groups than humans (Figure 
6.2B). Mice and humans shared similarly high levels of peroxidation-resistant PC 
16:0_18:1 compared to pigs. Overall, differences between species were smaller in the 






Figure 6.1. Distribution of phospholipid classes in A) skeletal muscle mitochondria, B) liver 
mitochondria and C) brain mitochondria of mice (M. musculus), pigs (S. scrofa) and humans (H. 
sapiens). Values are presented as mean mol% of total phospholipids ±SEM, n=6. Significant 
differences are indicated with *** for P<0.001. PC, phosphatidylcholine; PE, 




6.4.3 Phospholipid composition of brain mitochondria 
The distribution of PC and PE phospholipids in brain mitochondria was very similar in 
mice and pigs, whereas humans had significantly more PC and less PE (Figure 6.1C). 
The only other major difference was that PS was statistically lower in the mitochondria 
of mice than pigs. The phospholipids with the most bis-allylic methylene groups in 
brain mitochondria were species of PE and PS (Figure 6.2C). Of these, mice brain 
contained a higher percentage of PE 16:0_22:6 but similar levels of PE 18:0_22:6 to 
humans. Pigs had less PE 16:0_22:6 than mice and less PE 18:0_22:6 than mice and 
humans. Interestingly, humans had more PS 18:0_22:6 than the other two species. Two 
of the most common phospholipids in brain mitochondria were the peroxidation 
resistant PC 16:0_16:0 and PC 16:0_18:1, with mice having more PC 16:0_16:0 and 
humans more PC 16:0_18:1. 
 

























Figure 6.2. Common phospholipid compositions for A) phosphatidylcholine (PC), B) 
phosphatidylethanolamine (PE), and C) phosphatidylserine (PS) of mitochondria isolated from 
the tissues of mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). Values are 
presented as mean mol% of total phospholipids in each class ±SEM, n=6. Significant 
differences are indicated with * for P<0.05, ** for P<0.01 and *** for P<0.001. 
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6.4.4 Fatty acid composition by class 
The fatty acid composition of total phospholipids (PC, PE, PS, PG, and PA) for muscle, 
liver and brain mitochondria of mice, pigs, and humans are shown in Table 6.1. The 
most common types of fatty acids in the combined phospholipid fraction were saturated 
fatty acids (SFA) including alkenyl ethers and vinyl ethaers (plasmalogens), which 
comprised 39–46% of fatty acids in muscle mitochondria, 44–45% in liver 
mitochondria, and 50–54% in brain mitochondria. The mitochondria of mice and pigs 
contained around 13–20% monounsaturated fatty acids (MUFA), but the mitochondria 
of humans had a higher percentage of MUFA. Mouse and pig mitochondria contained 
higher percentages of polyunsaturated fatty acids (PUFA) in muscle, liver, and brain 
compared to humans. Mouse mitochondria invariably contain higher percentages of 
22:6, the fatty acid with the most bis-allylic methylene groups, than either pigs or 
humans. For all tissues, mouse mitochondria contained a higher percentage of 22:6. Pig 
mitochondria contained more 18:2 in muscle, 22:5 in liver and brain, and 22:4 in brain. 
All species possessed high levels of 20:4 in all tissues.  
Table 6.2 shows the PUFA composition of the major phospholipid classes (PC, 
PE, and PS) in each tissue for each species. In most cases, PE contained the highest 
percentage of PUFA and the highest levels of 22:6, with the only exception being PS in 
liver. Muscle mitochondria in mice were unique as it was the only tissue in which 22:6 
was present at high percentages in PC, PE and PS. Human mitochondria contained a 
lower percentage of PUFA than mice or pigs in PC, PE, and PS. Of the tissues 
examined, liver mitochondria showed the smallest difference in total PUFA and 22:6 
content between the three animals. In most tissues, values for pig mitochondria were 
intermediate between values for mouse and human mitochondria. Interestingly, PUFA 
was lower in the PC (3.4%) and higher in the PE (54%) of human brain mitochondria 
than in any other tissue mitochondria examined.  
As alkyl ethers and plasmalogens could not be differentiated and were reported 
together. These ethers were most commonly found in the PE phospholipids of 
mitochondria, and were lower in the mitochondria of muscle and brain of mice than in 
humans and pigs (Table 6.3).). Alkyl ethers and plasmalogens were largely absent in the 














Table 6.1. Acyl composition (mol%) of the combined phospholipids of mitochondria from mouse, pig, and human tissues 
 Skeletal Muscle  Liver  Brain 
 Mouse Pig Human  Mouse Pig Human  Mouse Pig Human 


































 24.7±0.6 22.5 ±1.4
M
 






  18.0±0.9 15.0±0.7
H






   24.5±1.0
M,P
 






  12.7±1.8 13.2±0.5 12.3±1.6  0.3±0.1 0.6±0.2     0.3±0.1 
20:4 8.3±0.8 7.2±0.6   6.5±1.3  16.9±2.5 16.9±0.8 13.2±1.9  8.2±0.1
H
 7.0±0.7    4.3±0.2
M
 




  5.1±0.5 




  2.5±0.4 
22:6   19.6±1.4
P,H
   0.6±0.1
M
   1.4±0.2
M




    9.9±0.9
M
 
            

















  18.5±1.0   16.5±0.8
H















  35.6±1.8   36.7±0.7
H










Values are mean mol% of the combined phospholipid fraction ±SEM, n=6. Superscript indicates significant differences of mean within the 
corresponding tissue at P<0.05:
 M
, mouse (M. musculus); 
P
, pig (S. scrofa) and; 
H
, human (H. sapiens). Combined acyl composition was calculated from 
quantified molecular species of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, and phosphatidic acid of 
mitochondria. Acyls less than 3 mol% of all tissues are not listed but have been included in all calculations. ∑SFA, total saturated fatty acids including 











Table 6.2. Polyunsaturated fatty acid composition (mol% of total fatty acids) in mitochondrial phosphatidylcholine, 
phosphatidylethanolamine, and phosphatidylserine. 
 Skeletal muscle  Liver  Brain 
 Mouse   Pig  Human  Mouse  Pig Human  Mouse Pig Human 
Phosphatidylcholine         
18:2     10.9±1.0
P,H
      32.1±1.0
 M,H
     21.8±1.2
M,P
   18.7±2.2 16.3±0.4 16.9±2.7    0.6±0.1   0.5±0.2    0.5±0.1 
20:4     10.8±0.9
P,H
      4.1±0.2
 M
     4.1±0.9
M
     8.2±1.0     9.8±0.6
H
    4.5±1.3
P
      5.4±0.2
H
   2.8±0.8      2.8±0.2
M
 
22:4   0.5±0.2    0.5±0.2   0.4±0.2     0.0±0.0   0.2±0.0   0.0±0.0     0.0±0.0
P
        1.6±0.6
M,H
     0.0±0.0
P
 
22:5   0.9±0.2    0.4±0.1   0.9±0.3     0.0±0.0   1.9±0.2   0.8±0.2    0.0±0.0   0.0±0.0    0.0±0.0 
22:6     11.2±1.1
P,H
      0.2±0.1
 M
     0.1±0.0
M
     2.0±0.5   1.6±0.2   1.0±0.3        4.1±0.2
P,H
        2.3±0.3
M,H
        0.0±0.0
M,P
 
ΣSFA     49.5±0.5
P,H
    42.5±0.4
 M
   39.8±1.5
M
   45.2±2.8 46.0±0.3 46.7±2.0      64.6±0.4
P,H
     61.5±0.7
M,H
      57.4±1.3
M,P
 
ΣMUFA   15.9±0.5
H
    18.0±0.9
H
     31.4±1.2
M,P
   24.0±2.9 21.0±0.9 29.6±2.9      24.1±0.4
P,H
      30.8±0.7
M,H
      38.4±1.0
M,P
 




   28.9±2.1 29.7±0.7 23.1±2.7    10.0±0.0
H
     7.1±0.5
H
        3.4±0.3
M,P
 
            
Phosphatidylethanolamine         
18:2    6.7±2.1
P
    28.3±1.5
 M
 19.3±3.0     0.0±0.0 10.1±0.5   0.0±0.0    0.0±0.0   1.0±0.5    0.0±0.0 
20:4   9.6±4.7  13.6±1.4 16.5±1.7   38.2±3.7 25.8±0.6 38.6±3.1  12.4±0.3 12.8±1.3    7.6±0.9 
22:4   1.7±0.7    3.5±0.5   3.3±0.8     2.6±0.8   2.0±0.2   1.4±0.6    3.4±0.3 10.2±0.7  14.8±1.6 
22:5   7.6±1.7    3.3±0.6   4.0±1.2     0.0±0.0   3.6±0.2   4.3±1.2    3.8±0.7   9.7±0.9    6.8±1.1 
22:6      23.4±5
P,H
      0.4±0.1
 M
     1.1±0.4
M
     9.3±2.9   4.4±0.5   5.2±1.4  26.8±0.5 15.6±1.0  24.8±1.3 
ΣSFA     43.0±1.6
P,H
    33.3±1.6
 M
   36.4±1.2
M
     41.7±1.8
H
 43.6±0.4   47.0±0.8
M
  43.6±0.5    39.8±1.5
H
   43.8±0.7
P
 
ΣMUFA     7.6±1.7
H
  10.0±0.7   15.5±2.5
M
       8.4±1.8
H
    7.7±0.5
H
       2.5±0.8
P,H
      9.6±0.6
H
      7.8±1.5
H
        2.1±0.6
M,P
 
ΣPUFA 49.0±0.6  49.2±0.8 44.2±2.2      50.0±0.0
P
   45.9±0.2
M
 49.5±0.2    46.2±0.9
H
    49.3±0.9
H
      53.9±1.0
M,P
 
            
Phosphatidylserine          
18:2   0.0±0.0    0.0±0.0    0.0±0.0     0.0±0.0   0.0±0.0   0.0±0.0    0.0±0.0   0.0±0.0    0.0±0.0 
20:4   2.7±0.9  20.0±0.7    3.4±0.8     27.1±1.1
H
   27.2±1.6
H
      15.5±3.4
P,M
    5.2±0.2   2.6±0.5    2.9±0.2 
22:4   2.7±0.5    4.8±1.1    5.3±0.6     1.8±0.5   2.6±0.5    3.8±0.4     5.3±0.4
P
      10.3±1.3
M,P
     5.1±0.4
P
 
22:5   5.5±0.6    4.2±1.3    7.9±1.6     1.5±0.5   6.3±0.5    6.6±1.2     0.0±0
P,H
        9.3±1.7
M,H
        3.3±0.2
M,P
 
22:6     30.3±2.6
P,H
      3.3±0.8
 M
      7.7±1.1
M
     16.6±0.7
P
   10.1±1.6
M
 14.1±1.7        8.9±0.7
P,H
       4.5±0.5
M,H
      21.8±1.3
M,P
 
ΣSFA     45.3±1.1
P,H
    17.0±2.6
 M




 49.3±0.1   43.6±1.5
M
  39.8±0.8    4.9±0.5
H
   39.4±0.4
P
 
ΣMUFA     13.4±2.5
P,H
      68.9±5.1
 M,H
      48.1±6.1
M,P
       3.0±0.4
H
     4.6±0.4
H
      16.4±3.7
M,P
      40.9±0.7
P,H
   28.4±2.6
M
    27.6±1.2
M
 
ΣPUFA     41.2±1.5
P,H
    14.2±2.5
 M
    24.2±3.1
M
   47.0±0.4 46.1±0.3   40.0±2.2
P
      19.3±0.9
P,H
      26.6±2.4
M,H
      33.1±0.9
M,P
 
Values are mean mol% of the phospholipid classes, ±SEM, n=6. Superscript indicates significant differences of mean within the corresponding tissue at 
P<0.05:
 M
, mouse (M. musculus); 
P
, pig (S. scrofa), and; 
H
, human (H. sapiens). ∑SFA, total saturated fatty acids including acyl ethers; ∑MUFA, total 












Table 6.3. Alkenyl ether and vinyl ether composition (mol% of total acyls, alkenyl ethers, and vinyl ehters) present in the combined 
phospholipids, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine fractions of mitochondria. 





 Mouse Pig Human  Mouse Pig Human  Mouse Pig Human 
            
Combined PL     0.4±0.1
P,H
      7.8±0.6
M,H
    2.1±0.3
M,P
    0.5±0.2 0.8±0.1 1.1±0.3      0.4±0.2
P,H
   3.2±0.4
M
   3.2±0.6
M
 
Phosphatidylcholine     0.0±0.0
P,H
    10.0±0.7
M,H
     2.2±0.3
M,P
     0.0±.0.0 0.4±0.0 0.9±0.3    0.0±0.0
H
   0.0±0.0
H
     2.6±0.7
M,P
 
Phosphatidylethanolamine     1.0±0.3
P,H
   3.6±0.4
M
   2.8±0.5
M
    2.6±0.8 1.3±0.1 2.3±0.7      0.9±0.4
P,H
   6.9±0.7
M
   5.3±1.0
M
 
Phosphatidylserine 0.7±0.3 0.0±0.0 0.0±0.0    0.0±0.0 1.5±0.2 0.0±0.0  0.0±0.0 1.4±0.4 0.0±0.0 
            
 
Values are mean mol% of acyls of the phospholipid fraction, ±SEM, n=6. Superscript indicates significant differences of mean within the corresponding 
tissue at P<0.05:
 M
, mouse (M. musculus); 
P
, pig (S. scrofa), and; 
H
, human (H. sapiens). Acyl ethers represents the sum of acyls identified as 
plasmalogens and alkyl ethers, but may also include odd-chain fatty acids. Combined phospholipid composition (combined PL) was calculated from 
quantified molecular species of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, and phosphatidic acid 





6.4.5 The contributions of phospholipid class to peroxidation index 
The peroxidation index of muscle, liver and brain mitochondria was higher in mice than 
in humans, with this difference greater in muscle than liver and brain (Figure 6.3A). The 
muscle mitochondria of mice had a peroxidation index 3 times that of humans, and the 
peroxidation index of liver and brain mitochondria was higher in mice than humans. 
The peroxidation index for pigs were more similar to those of humans for muscle, but 
more similar to mice for liver and brain. Tissue-dependent differences in the 
peroxidation index were not consistent between mice, humans and pigs. The 
peroxidation index of mouse muscle mitochondria was nearly two times that of mouse 
liver and brain mitochondria. In contrast, the peroxidation index of humans muscle was 
lower than liver or brain. Overall, the peroxidation index of pigs was more similar to 
humans than mice.  
The relative contributions of PC, PE and PS to the peroxidation index were more 
similar between animals than between tissues (Figure 6.3B). The relative contributions 
of PC and PE phospholipids to the total peroxidation index were comparable in muscle 
mitochondria, but PE was a larger contributor in liver mitochondria and the dominant 
contributor in brain mitochondria where it accounts for over 80% of the total 
peroxidation index. Interestingly, the relative contribution of PC to the total 
peroxidation index of brain mitochondria decreased with MLS while the relative 





Figure 6.3. The peroxidation index of A) the total phospholipid fractions and B) the contribution 
of phospholipid class as a percentage of the peroxidation index in muscle, liver and brain 
mitochondria of mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). The 
contributions of each phospholipid class to peroxidation index was calculated as the 
peroxidation index of each class multiplied by the percentage of each class (Figure 6.1). Values 
are means ±SEM, n=6. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, 
phosphatidylserine. Significant differences are indicated with * for P<0.05, ** for P<0.01 and 




6.5.1 Peroxidation, membrane composition, and maximum life span 
An inverse relationship has been found between maximal lifespan (MLS) and 
membrane peroxidation index for mammals and other animal classes [12, 37-39]. In this 
study, shotgun lipidomics was used to examine this relationship at the level of 
molecular phospholipids and fatty acid composition in the mitochondria of muscle, 
liver, and brain. This chapter is one of the most in-depth studies of the phospholipid 
composition of mammalian mitochondrial membranes published to date. The 
peroxidation index of muscle mitochondria of mice and humans was found to fit the 
trends for whole skeletal muscle [29], and the peroxidation indexes for liver 
mitochondria were similar to published trends [45]. The peroxidation index of brain 
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mitochondria from mice and humans has not been previously described, but would seem 
to fit with the differences found in other tissues of mice and humans with high values 
for mice and lower values for humans. The peroxidation values of pig mitochondria 
were similar to mice for liver and brain mitochondria but more similar to humans for 
skeletal muscle mitochondria. Overall, the peroxidation index of pigs was lower than 
expected for muscle and liver [29, 34], but the membrane composition of pig 
mitochondria is consistent with past studies of membrane composition in pig muscle 
that used gas chromatography to determine membrane composition [226]. 
The higher peroxidation values of mice mitochondria were due to both a higher 
percentage of PUFA and a higher number of bis-allylic methylene groups per PUFA 
than for humans. Muscle mitochondria of mice contained a high percentage of 22:6, the 
PUFA with the most bis-allylic methylene groups and therefore the PUFA most 
vulnerable to peroxidation. In comparison, human muscle mitochondria contained a 
high percentage of 18:2, the PUFA with the least number of bis-allylic methylene 
groups and therefore less susceptible to peroxidation. A similar difference was found in 
brain mitochondria, but not in liver. No difference in PUFA profile was seen between 
liver mitochondria of mice and humans, and differences in the peroxidation index were 
due to the higher percentage of total PUFA in mice than humans. In contrast, pig 
mitochondria had a higher percentage of total PUFA but a similar PUFA profile to 
human mitochondria. These results support past findings that the percentage of 22:6 is 
lower in the muscle and liver of longer-lived mammals [40, 220]. 
Differences in the peroxidation indexes of each tissue varied by species. Mice had 
a higher peroxidation index in the muscle mitochondria than liver or brain mitochondria 
while humans and pigs had a lower peroxidation index in muscle and liver mitochondria 
than brain mitochondria. The primary PUFA in muscle mitochondria was 22:6 in mice 
but 18:2 in humans and pigs, which partly explained the large differences seen in the 
peroxidation indexes of muscle mitochondria. The primary PUFA in liver was 20:4, but 
22:6 was also found at low levels in all animals. This contrasts to the only previous 
investigation of human liver mitochondria which reported no 22:6 [138], but supports 
the finding that membrane composition varies less between species in liver than muscle 
[220]. This may be explained by the ability of liver to regenerate liver, and it is possible 
that the peroxidation of membrane lipids has less long-term ramifications to cell health 
in liver compared to post-mitotic tissues such as skeletal muscle and brain.  
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The primary PUFA in brain mitochondria was 22:6, which has previously been 
found to be at similar levels in a range of mammalian species [220] suggesting that 
peroxidation index of brain is high and comparable in mammals. In this study, however, 
the peroxidation index of mitochondria in the mouse brain was greater than that of 
humans. As peroxidation is associated with numerous pathologies, including neuronal 
diseases [227], the high 22:6 content found in brain has the potential to be detrimental 
to long-term survival. An alternative view proposed by Yavin et al. (2002) suggests that 
22:6 may not be as susceptible to peroxidation might be expect from its structure [228]. 
It is also possible that 22:6 may protect the brain from inflammation by serving as a 
precursor for resolvins [229]. In the current study, a negative association was found 
between the 22:6 content of brain mitochondria and lifespan for the combined 
phospholipid, PC, and PE. Brain PS was found to contain more 22:6 in humans than 
mice or pigs, suggesting a possible positive correlation in PS, but overall these results 
support the view that the 22:6 content of brain is inversely correlated with MLS. The 
enzymatic peroxidation of PUFA, however, is involved in a broad range of cell 
signalling pathways and is required for healthy brain function [8]. For example, the loss 
of 22:6 in brain is associated with severe brain anomalies including Zellweger 
syndrome [230] and Alzheimer’s disease [231]. As a speculative hypothesis for the 
difference in the peroxidation indexes of muscle and brain mitochondria, I propose that 
that muscle membranes are exposed to more ROS than brain membranes, and that 
oxidative damage to muscle is more detrimental to organism survival than oxidative 
damage to the central nervous system. 
 
6.5.2 Contributions of phospholipids to the peroxidation index 
For all three mammals, PC and PE had relatively equal contributions to the peroxidation 
index of muscle mitochondria, but the relative contribution of PE was the dominant 
contributor in liver and brain mitochondria. PUFA are generally less common in the PC 
classes than the PE or PS classes [20], and the high ratio of PC to PE present in the 
mitochondria of human muscle and brain may represent an adaptation to limiting 
membrane peroxidation independently of fatty acid composition. The significance of the 
distribution of PUFA across phospholipid to peroxidation remains to be established as 
data in this area is uncommon and often contradictory due to differences in methods 
used [15, 202]. 
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The peroxidation index was largely determined by a surprisingly low number of 
molecular phospholipids (Figure 6.4). The greatest difference between animal species 
was the contributions of PC 16:0_22:6 and PE 18:0_22:6 in mice muscle mitochondria 
and the contributions of PC 16:0_18:2 and PC 18:0_18:2 in pig and humans 
mitochondria. The higher percentages of PC 16:0_22:6 and PE 18:0_22:6 found in the 
muscle of mice in comparison to pigs or humans supports is similar to comparisons 
between mice and naked mole rats (Heterocephalus glaber, MLS of 28 years) [40, 44]. 
As PC 16:0_22:6 is synthesized de novo by mammals but PE 18:0_22:6 is not [86], 
mammals with longer lifespans may have adapted to decrease the peroxidation index of 
muscle membranes by decreasing the de novo synthesis of PC 16:0_22:6, increase 
remodelling of PC 16:0_22:6 to other molecular species of PC, and limiting the 
synthesis of PE 18:0_22:6 during remodelling. 
This replacement of PUFA susceptible to peroxidation with the less susceptible 
18:2 seen in muscle was not found in liver mitochondria where the phospholipids with 
the largest contribution to the peroxidation index was PE 18:0_20:4 in all species, or in 
brain mitochondria where the greatest contributor was PE 18:0_22:6 for all three 
species. The high contribution of PE to the peroxidation index in brain has been 
previously identified as being due to high levels of 22:6, but had not previously been 
identified as being due to the presence of a single molecular species [80]. Despite 
having a potentially high risk of undergoing peroxidation, the percentage of PE 
18:0_22:6 in the mitochondria of healthy adult human brain remains relatively constant 
during normal adult aging [232] and 22:6 has been even been identified as having a 





Figure 6.4. Molecular phospholipids with the largest contribution to the peroxidation index of 
mitochondria from mouse (M. musculus), pig (S. scrofa) and human (H. sapiens) tissues. The 
percentage of peroxidation index is determined from the peroxidation index and relative 
abundance of molecular phospholipids. 
 
 
6.5.3 Importance of non-peroxidising phospholipids 
The most abundant peroxidation-resistant phospholipid found in mitochondria was     
PC 16:0_18:1 in all tissues, suggesting that this phospholipid may be important to 
membrane function. As PC 16:0_18:1 is one of the few molecular phospholipids that 
mammalian cells can assemble de novo, high levels may indicate that comparatively 
limited phospholipid remodelling of this phospholipid is taking place [86]. The 
advantages of PC 16:0_18:1 include a lower melting point than phospholipids 
containing SFA [24] and an increased resistance to peroxidation in comparison to 
phospholipids containing PUFA [21, 73]. These benefits are similar to those of         
non-methylene interrupted PUFA associated with long-lived molluscs [37]. Another 
interesting feature of PC 16:0_18:1 is its apparent capacity to delay the onset of 
peroxidation by extending the lag phase of peroxidation as described in Chapter Five. It 
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is likely that PC 16:0_18:1 serves as a substitute for phospholipids containing PUFA 
and therefore may be a useful biomarker of membrane resistance to oxidative damage. 
Phospholipids with vinyl-ethers at the sn-1 position (commonly termed 
plasmalogens) may also increase membrane resistance by acting as a sacrificial target 
for ROS [233, 234]. Plasmalogens have been positively associated with longevity in 
mammals [40] but not in consistently in molluscs [37], suggesting that the link between 
longevity and the presence of plasmalogens in membranes remains unclear. In the 
current study, isobaric alkyl ethers and plasmalogens could not be differentiated as the 
method used cannot identify the position of bonds and therefore the vinyl ether of 
plasmalogens cannot be differentiated from an alkyl ether that contains a double bond 
elsewhere along it’s chain. This is an important distinction as only the vinyl ether 
inhibits the loss of the phosphoethanolamine head group, and therefore the method 
underestimated PE-plasmalogens when using a neutral loss of 141 to identify PE 
phospholipids [235]. The present study used the conservative approach of reporting the 
sum of alkyl ethers and plasmalogens together without using a correction factor for 
plasmalogens [40, 236]. The sum of alkyl ethers and plasmalogens comprised <3% of 
the PE fraction of mitochondria and were largely absent from the PC and PS fractions. 
An exception to this finding was the high percentage of alkyl ethers in the PC fraction 
of pig muscle mitochondria. This is possibly a case of incorrect identification because 
odd-chain fatty acids cannot be distinguished from alkyl ethers or plasmalogens with 
the present mass spectrometry method with complete certainty. However, odd-chain 
fatty acids were not reported in a review of studies of pig tissues [226]. Overall, the 
mitochondria of muscle and brain contained a lower percentage of alkyl ethers and 
plasmalogens in mice than in pigs or humans, suggesting that alkyl ethers and 
plasmalogens may be positively associated with MLS in mammals. 
 
6.5.4 Limitations 
Although the use of human tissues is very valuable, working with human tissues 
presents several difficulties including the precious nature of the samples and the 
inevitable post-mortem interval prior to lipid extraction. The average post-mortem 
interval of the present study was four days. Lipid composition has been reported to 
show only minor changes with post-mortem intervals of three days [237] and five days 
[238]. We are not aware of any studies examining lipid degradation over longer-post-
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mortem intervals, although such a study would be useful. The relative stability of 
membrane lipids during the post-mortem interval suggests that the post-mortem interval 
of the human tissue used in this study was unlikely to greatly affect the overall 
conclusions. The inclusion of human tissue in this study also limited the amount of 
sample available to approximately 100 mg per sample, resulting in mitochondrial yield 
that was sufficient for the analysis but did not allow for extensive purification steps. 
A further limitation of the present study is that cardiolipin (CL), a phospholipid 
class that comprises 10-15% of mitochondrial phospholipids [17], was not able to be 
measured with the methods used. CL is a di-phospholipid with a highly conserved fatty 
acid composition of CL 18:2/18:2/18:2/18:2 in mammalian tissues [79] that is 
considered to be important in lipid-proteins interactions with proteins of the eletron 
transport (ETC) chain and early apoptotic evens [165, 166, 169, 239]. CL as been 
reporeted to have a similar contribution to the peroxidation index across a range of 
mammal species [80, 138], and although the composition of CL can be influenced by 
dietary fatty acids and may therefore differ between species (Chapter Three) this is not 
expected to be the case for mice or pigs and is unlikely in humans. The absence of CL 
from the analysis underestimates the peroxidation index of each animal, and the values 
presented may be lower than reported values generated with alternative methods for 
mammalian muscle and liver [12, 29]. This underestimation is unlikely to greatly affect 
the large differences in peroxidation index between species. 
An additional consideration of this study (and many aging studies) is the 
comparison of animals at very different stages of their MLS. The mice examined in the 
present study had reached 25% of the MLS, the pigs examined had reached only around 
2% of their MLS, and humans varied from 50-80% of their MLS. The phospholipid 
composition of mammalian membranes does appear to change gradually over the adult 
lifespan. In human brain, small increases in phospholipids containing 22:6 and small 
decreases in phospholipids containing 20:4 were found with increasing age, but the 
percentage of mitochondrial PE 18:0_22:6 was found to be consistent across a wide 
range of ages [232]. An increase in the 22:6 content and peroxidation index with age has 
also been reported for mouse muscle membranes [145], but overall differences in the 
membrane PUFA composition and peroxidation index across a species lifespan seem 





This work has shown that the mitochondria of muscle, liver and brain of mice are highly 
susceptible to peroxidation while the tissues of pigs and humans are less susceptible to 
peroxidation. Human membranes differed from mouse and pig membranes by 
containing a lower percentage of PUFA, suggesting that this may be a protective form 
of lipid remodelling. Somewhat surprisingly, a relatively small number of molecular 
phospholipids that contributed the majority of the peroxidation index in each tissue. The 
differences in these molecular species varied across tissues and suggests that differences 
in lipid remodelling in muscle may be particularly important for lifespan. Overall, this 
study shows that the link between membrane susceptibility and peroxidation is more 
complex than PUFA content and the peroxidation index. Other elements of membrane 
composition found to be associated with lifespan were the percentages of alkenyl ethers 
and plasmalogens, the ratio of PC to PE, and the percentage of peroxidation resistant-
phospholipids such as PC 16:0_18:1. These findings supported the ‘membrane-
pacemaker’ theory of aging and the importance of peroxidation as a mechanism of 
aging. Future work in this area would benefit from examining these measures across a 
wider range of mammals and other animal classes. 
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The damage to mitochondria caused by peroxidation is associated with aging, and it 
has been suggested that humans have the unusual ability to exclude highly 
peroxidisable phospholipids from their mitochondrial membranes. Past comparisons of 
the peroxidation index of mitochondrial and microsomal membranes of human tissues 
has shown high variability, and no single study has examined both fractions using the 
same methods. This chapter presents a shotgun lipidomics analysis of mitochondrial 
and microsomal membranes from skeletal muscle, liver, and brain from humans. Mice 
and pig tissues were also examined to determine if differences in mitochondrial and 
microsomal fractions were unique to humans. 
 
7.2 Introduction 
The maximal lifespan (MLS) of humans (Homo sapiens) is 122 years, which is 3–4 fold 
longer than other mammal species with similar body masses (AnAge database, Figure 
2.10). No single explanation for human longevity has yet been universally accepted, but 
one possible explanation is that human membranes are resistant to the damage of 
cellular components caused by peroxidation [4, 65]. Peroxidation is initiated by reactive 
oxygen species (ROS) and primarily affects the bis-allylic methylene groups found in 
polyunsaturated fatty acids (PUFA) present in membranes [14, 36, 240]. The relative 
vulnerability of membranes to peroxidation, termed a peroxidation index, can be 
calculated from the percentage of membrane PUFA, the number of bis-allylic methylene 
groups present in this PUFA, and experimentally derived rates of peroxidation [35]. 
Chapter Six of this thesis found that the mitochondrial membranes of skeletal muscle, 
liver and brain contained a lower percentage of PUFA in humans than in mice (Mus 
musculus, MLS of 4 years) or pigs (Sus scrofa, MLS of 27 years). As a result, the 
mitochondria of these organs had a lower peroxidation index in humans than in mice or 
pigs, suggesting that human mitochondria are less susceptible to peroxidation than 
mouse or pig mitochondria. An inverse relationship between MLS and the peroxidation 
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index has also been reported in a variety of other mammals [29], birds [12], molluscs 
[37], bees [38], and strains of Caenorhabditis elegans [39] suggesting a strong link 
between longevity and membrane composition. 
The composition of mitochondrial phospholipid is of particular importance to  
age-related peroxidation as mitochondria are a major source of ROS within cells [14, 
36] and mitochondrial failure is an indicator of aging [118]. Based on differences in the 
membrane fatty acid composition reported for whole liver [241-243] and liver 
mitochondria [138], Hulbert (2010) suggested that humans exclude highly peroxidisable 
fatty acids from their mitochondrial membranes to prevent peroxidation damage and 
extend longevity [45, 240]. Unfortunately, human data in this area is rare and highly 
variable due to the differences in methods used by different laboratory groups. In the 
few studies available, the peroxidation indexes calculated for whole cell membranes 
were 110 [241], 170 [242] and 280 [243], while the peroxidation index calculated for 
mitochondria was 50 [138]. If these findings are correct, mitochondria are far less 
susceptible to peroxidation than other cellular membranes in humans, but not in other 
exceptionally long-lived mammals or in mammals with MLS close to those predicted 
for their mass, [45, 134, 244, 245]. On this basis, it was hypothesized that 1) 
mitochondrial membranes have a lower peroxidation index than other cellular 
membranes in human tissues and 2) there is no difference in the peroxidation index 
between mitochondrial membranes and other cellular membranes in other mammals. 
To test these hypotheses, this chapter used shotgun-lipidomics to compare the 
membrane composition and peroxidation index of mitochondrial and microsomal 
fractions from humans, mice (Mus musculus, MLS of 4 years) and pigs (Sus scrofa, 
MLS of 27 years). Microsomal fractions, which contain the phospholipids from the 
plasma membrane, endoplasmic reticulum (ER), Golgi apparatus, secretory vesicles and 
endosomes [246], represent an average cell membrane in the absence of mitochondria. 
Mice and pigs were chosen as examples of mammals that have lifespans similar to other 
mammals of their mass (AnAge Database) and therefore serve as control species for 
exceptionally long-lived humans. 
 
7.3 Methods 
The samples and methods used in this chapter are described in Chapter Six (6.3. 
Methods). In addition to these methods, a microsomal pellet and supernatant were 
7.3. Method 
97 
isolated from the supernatant by centrifuging at 100,000 x g for 40 min at 4 
o
C [246]. In 
the present study, two-way ANOVAs (tissue x fraction) with Bonferroni post-hoc tests 
were used to compare mitochondrial and microsomal fractions within each species for 
each tissue GraphPad Prism 5.04 (GraphPad Software, San Diego, USA). 
 
7.4 Results 
7.4.1 Phospholipid composition 
The distribution of phospholipid classes in the mitochondrial and microsomal 
membranes of skeletal muscle, liver and brain are shown for mice, pigs and humans in 
Table 7.1. In skeletal muscle, the percentage of phosphatidylcholine (PC) was higher in 
the mitochondrial fraction than the microsomal fraction for humans and mice but lower 
in the mitochondrial fractions than the microsomal fraction for pigs. The percentage of 
phosphatidylethanolamine (PE) did not differ significantly between the mitochondrial 
and microsomal fractions for humans and mice, but was higher in the mitochondrial 
fraction than the microsomal fraction for pigs. No significant differences were found 
between the mitochondrial and microsomal fractions for phosphatidylserine (PS), 
phosphatidylglycerol (PG) or phosphatidic acid (PA). Phospholipid composition did not 
differ greatly between the mitochondrial and microsomal fractions of mouse or pig 
skeletal muscle, but some differences were seen for human muscle (Table 7.2). The 
percentage of PC 16:0_16:0 was higher in the mitochondrial fraction than the 
microsomal fraction in mice and the percentage of PE 18:0_18:2 was higher in the 
mitochondrial fraction than the microsomal fraction of pigs, but no other significant 
differences were observed. In humans, the percentages of PC 16:0_18:1, PC 18:0_18:2 
and PE 18:0_18:2 were lower in the mitochondrial fraction than the microsomal 
fraction. The full list of phospholipids identified in the mitochondrial and microsomal 
fraction of skeletal muscle is presented in Appendix Table B1. 
In liver, the only difference in the percentages of phospholipid classes was a 
statistically higher level of PE in pig mitochondrial membranes (Table 7.1). Within 
classes, however, liver contained more differences in the relative amounts of molecular 
phospholipids between fractions than seen for muscle (Table 7.2). For mice, higher 
percentages of PC 16:0_16:0, PC 16:0_18:1, PE 18:0_20:4 and PS 18:1_18:1 were seen 
in mitochondria compared to microsomes, but a far lower percentage of PE 16:0_22:6 
was seen in mitochondria. Similarly, pigs were found to have a higher percentage of PE 
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16:0_20:4 but a lower percentage of PE 18:0_18:2 in their mitochondria than their 
microsomes, and human mitochondria contained a higher percentage of PE 18:0_20:4 
than human microsomes. The full list of phospholipids identified in the mitochondrial 
and microsomal fraction of liver is presented in Appendix Table B12.  
For the brain mitochondrial and microsomal fractions, PE was higher in the 
mitochondrial fraction of both mice and pigs, PC was higher in the mitochondrial 
fraction of humans, and PA was lower in the mitochondrial fraction for all three animals 
(Table 7.1). No significant differences were seen for the other phospholipid classes. 
Multiple differences were seen in the relative abundance of molecular phospholipids of 
brain (Table 7.2). A higher percentage of PC 16:0_16:0 was found in the mitochondrial 
fraction than the microsomal fraction of mouse brain while the percentages of both PE 
18:0_22:5 and PE 18:0_22:6 were higher in the mitochondrial fraction than the 
microsomal fraction of human brain. The percentage of PS 18:0_18:1 was higher in the 
mitochondrial fraction than the microsomal fraction of mice and pigs, and the 
percentage of PS 18:1_18:1 was higher in the mitochondrial fraction than the 
microsomal fraction of pigs and humans. Differences in the distribution of peroxidisable 
species of PS were mixed, with the percentage of PS 18:0_20:4 higher in the 
mitochondrial fraction of mouse, the percentage of PS 18:0_22:5 higher in the 
mitochondrial fraction of pigs but the percentage of PS 18:0_22:6 lower in the 
mitochondrial fraction of pigs. The full list of phospholipids identified in the 


















  Mitochondrial Microsomal Mitochondrial Microsomal Mitochondrial Microsomal 
 
         Muscle PC 62.1±0.4   53.6±2.7* 61.5±0.7   68.6±2.8** 73.8±3.0    65.4±2.7** 
 PE 27.7±0.5 31.3±5.2  32.6±0.6     18.6±2.1***  16.3±3.1 21.0±2.1 
 PS   6.1±0.5   8.0±1.8    5.8±0.6 7.4±2.4    8.7±0.2 12.5±0.7 
 PG   1.2±0.2   2.9±0.5    0.2±0.0 0.4±0.1    1.2±0.2   0.8±0.3 
 PA   3.0±0.2   4.3±0.8    0.0±0.0 5.1±2.1    0.0±0.0   0.3±0.2 
          
Liver PC 64.6±5.0 65.3±1.7  57.1±2.2 60.4±2.0  67.5±3.8 66.5±2.4 
 PE 24.2±3.6 27.8±1.9  35.8±1.6 30.3±1.4*  22.7±3.4 23.9±1.2 
 PS   9.1±1.6   4.1±0.3   2.1±0.6 2.9±0.2    5.9±0.4   5.3±0.7 
 PG   2.2±0.2   0.9±0.1   2.7±0.7 4.5±1.3    3.6±0.6   4.0±0.8 
 PA   0.0±0.0   2.0±0.2   1.7±0.4 2.0±0.2    0.4±0.1   0.3±0.1 
          
Brain PC 43.0±1.6 43.9±2.6  41.0±1.8 39.1±1.0  58.0±2.3       37.4±2.8*** 
 PE 45.6±0.9       34.0±1.4***  45.4±2.3       29.3±2.1***  32.7±2.2 36.2±1.5 
 PS   6.7±0.3   4.8±0.5  11.4±1.2 15.3±1.0    9.3±0.7 14.8±1.5 
 PG   1.5±0.4   5.6±0.9    0.8±0.3   4.4±0.8    0.0±0.0   0.0±0.0 
 PA   3.2±0.6       11.7±2.7***    1.5±0.7         1.9±3.4***    0.0±0.0          1.6±1.3*** 
Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). Values are presented as mean mol% of total phospholipids 
±SEM, n=6. Significant differences between mitochondrial and microsomal fractions are indicated with * for P<0.05, ** for P<0.01, and *** for 









Table 7.2. Significant differences in the acyl composition of phosphatidylcholine (PC), 
phosphatidylethanolamine (PE) and phosphatidylserine (PS) between the mitochondrial 
and microsomal membranes of mouse, pig, and human tissue. 
    
 
Mol%  
Tissue Animal Class Phospholipid 
 
Mitochondrial Microsomal P 
 
Muscle Mouse PC PC 16:0_16:0 
 
6.4±0. 3 0.0±0.0 P< 0.0001 
 
 PE None  – – – 
 
 PS None  – – – 
 
Pig PC None  – – – 
  
PE PE 18:0_18:2  28.0±2.1 16.2±3.5 P< 0.05 
  
PS None  – – – 
 
Human PC PC 16:0_18:1  22.4±1.8 29.4±1.9 P< 0.05 
   
PC 18:0_18:2  20.7±2.7 26.9±2.7 P< 0.05 
  
PE PE 18:0_18:2  0.0±0.0 7.1±0.6 P< 0.05 
  
PS None  – – – 
      
        
Liver Mouse PC PC 16:0_16:0  9.5±2.3 0.0±0.0 P< 0.05 
   
PC 16:0_18:1  32.0±6.7 14.1±0.8 P< 0.0001 
  
PE PE 16:0_22:6  0.0±0.0 31.5±1.3 P< 0.0001 
   
PE 18:0_20:4  64.4±8.3 20.8±0.6 P< 0.0001 
  
PS PS 18:0_18:1  6.0±0.8 0.1±0.1 – 
 
Pig PC None  – – – 
  
PE PE 16:0_20:4  4.7±0.2 0.0±0.0 P< 0.001 
   
PE 18:0_18:2  15.6±0.6 19.5±1.9 P< 0.01 
  
PS None  – – – 
Human PC None  – – – 
  PE PE 18:0_20:4  69.5±7.8 50.6±5.7 P< 0.05 
  PS None  – – – 
        
 
Brain Mouse PC PC 16:0_16:0 
 
15±2.8 4.9±2.1 P< 0.0001 
 
 PE None  – – – 
 
 PS PS 18:0_18:1  41.0±3.1 30.8±3.0 P< 0.01 
 
  PS 18:0_20:4  10.4±0.4 0.0±0.0 P< 0.01 
  PS 18:1_18:1  20.4±1.6 12.1±3.0 P< 0.05 
 Pig PC None  – – – 
  PE None  – – – 
  
PS PS 18:0_18:1  33.7±4.2 4.7±0.6 P< 0.0001 
   
PS 18:0_22:6  8.9±1.1 47.1±3.9 P< 0.0001 
   
PS 18:0_22:5  18.5±3.4 9.1±0.9 P< 0.05 
 
Human PC None  – – 
  PE PE 18:0_20:4  13.9±1.8 6.9±0.9 P< 0.05 
   
PE 18:0_22:6  38.5±2.8 25.3±1.3 P< 0.001 
  
PS PS 18:1_18:1  12.7±1.3 8.4±1.1 P< 0.05 
      
Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). Values 
are presented as mean mol% of total phospholipids in each class ±SEM, n=6. Significant 





7.4.2 Fatty acid composition 
Although phospholipid composition varied between tissues and between species, the 
fatty acid compositions of the mitochondrial and microsomal fractions within tissues 
were generally similar (Table 7.3). In skeletal muscle, small but significant differences 
were seen in the 18:0 content of mice and the 16:0 content of pigs, but no differences 
were seen for humans. In liver, the mitochondrial fraction of mice contained a higher 
percentage of 18:1, a lower percentage of 22:6, but a higher percentage of PUFA 
overall. Similar patterns were not seen in the mitochondrial fraction of pigs or humans, 
although pig mitochondria had a slightly higher percentage of 20:4. In brain, 16:0 was 
higher in the mitochondrial fraction of all three animals, 18:0 was higher in the 
mitochondrial fraction of pigs, and 18:1 was higher in the mitochondrial fraction of 
mice. Overall, MUFA was lower in the mitochondrial fraction of pig brain, but higher in 
the mitochondrial fraction of human brain. Acyl ethers were also not found to differ 





















Muscle 16:0 26.0±0.7 27.7±0.5 
 
19.2±0.4   23.0±2.1* 
 
25.9±2.5 26.3±1.2 




10.5±1.2   9.7±0.6 










 20:4   8.3±0.8   9.1±0.4 
 
  7.2±0.6   6.4±0.3 
 
  6.5±1.3   5.4±0.6 
 22:6 19.6±1.4 18.5±0.8 
 
  0.6±0.1   0.9±0.4 
 
  1.4±0.2   1.5±0.2 
 Acyl ethers    1.0±.0.2 0.4±.1    7.3±0.7   7.8±0.6    0.5±0.1   2.1±0.3 



































 20:4 16.9±2.5 13.9±0.6 
 
16.9±0.8   14.2±1.0* 
 
13.2±1.9 14.8±2.2 
 22:5   0.1±0.0   1.1±0.2 
 
  2.7±0.2   2.5±0.2 
 
  1.8±0.4   1.5±0.4 
 22:6   5.3±0.5     12.4±0.6** 
 
  3.0±0.3   4.7±0.5 
 
  2.9±0.4   3.4±0.8 
 Acyl ethers   0.8±0.1   0.5±0.2   0.8±0.1   0.7±0.1   0.0±0.0   1.1±0.3 
 ∑SFA 44.5±1.7 43.5±0.8 
 
44.0±0.4  44.2±0.6 
 
45.6±1.3 45.1±1.2 










Brain 16:0 23.9±1.6    18.1±1.4** 
 
19.6±1.2   15.2±1.7* 
 
23.9±1.8    15.0±1.3** 
 18:0 26.3±1.0   29.9±0.8* 
 
24.7±0.6   25.1±0.9* 
 
22.5±1.4 25.7±1.3 





 20:4   8.2±0.1   7.8±1.4 
 
  7.0±0.7   7.8±0.3 
 
  4.3±0.2   4.0±0.3 
 22:5   1.6±0.3   3.6±0.7 
 
  6.2±0.6   5.5±1.3 
 
  2.5±0.4   6.0±1.7 
 22:6 14.3±0.3 14.3±0.9 
 
  8.2±0.4   9.9±1.2 
 
  9.9±0.9   7.9±0.9 
 Acyl ethers   1.5±0.4   0.4±.02 
 
  1.5±0.3   3.2±0.4 
 
  4.5±0.8   3.2±0.6 
 ∑SFA 54.4±0.4 55.1±2.0 50.1±0.9 43.7±1.5 51.3±0.8 48.9±0.6 
 ∑MUFA 18.6±0.4 14.7±1.2 
 
20.0±0.9   26.7±1.5* 
 
26.0±1.2     23.0±1.1** 





Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). s double bond positon could not be ascertained with the method used, fatty acids 
are reported as carbon: double bonds without omega position Values are mean mol% of the combined phospholipid fraction ±SEM, n=6. Significant differences 
between fractions are indicated with * for P<0.05, ** for P<0.01 and *** for P<0.001. Combined acyl composition was calculated from quantified molecular species 
of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, and phosphatidic acid of mitochondria. Acyls less than 3 mol% of all 
tissues are not listed but have been included in all calculations. ∑SFA, total saturated fatty acids including acyl ethers; ∑MUFA, total monounsaturated fatty acids; 








7.4.3 Susceptibility to peroxidation 
The peroxidation index of combined phospholipids did not differ greatly between 
mitochondrial and microsomal fractions of skeletal muscle, liver and brain for humans 
mice, or pigs (Figure 7.1). The only exception was mouse liver in which the 
peroxidation index was significantly lower in the mitochondrial fraction than the 
microsomal fraction. The contributions of phospholipid classes to the peroxidation 
index of the mitochondrial and microsomal fractions showed numerous but inconsistent 
differences (Figure 7.2). A higher contribution of PE was found in pig mitochondria for 
muscle, liver and brain, but this was the only difference that was consistent across 
tissues. For muscle, human had a higher contribution for PC but a lower contribution for 
PS in the mitochondrial the microsomal fraction and no differences were seen for mice 
(Figure 7.2A). In liver, no difference was seen for humans but a lower contribution of 
PC and a higher contribution of PS was seen in the mitochondrial that the microsomal 
fraction of mice (Figure 7.2B). Differences between the contributions to the 
peroxidation index of mitochondrial and microsomal fractions were most common in 
brain (Figure 7.2C). The relative contribution of PC to the peroxidation index was 
higher in the mitochondrial fraction than the microsomal fraction of brain for humans 
and pigs, but lower in the mitochondrial fraction of mice. The relative contribution of 
PE was higher in the mitochondrial fraction than the microsomal fraction of pig brain, 
and the contribution of PS was higher in the microsomal fraction of pig and human 
brain. 
 
Figure 7.1. The peroxidation index of the in microsomal fraction and mitochondrial-enriched 
fraction of the A) skeletal muscle, B) liver, and C) brain of mouse (M. musculus), pigs (S. 
scrofa), and humans (H. sapiens). The peroxidation index is calculated using values from 
Holman [21]. Values are means ±SEM, n=6. Significant differences of P<0.001 are indicated 
with ***. 
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Figure 7.2. Relative contributions of the major phospholipid classes to the peroxidation index of 
the microsomal fraction and mitochondrial fraction of A) skeletal muscle, B) liver, and C) brain 
of mouse (M. Musculus), pigs (S. scrofa), and humans (H. sapiens). Values are means ±SEM, 
n=6. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine. 
Significant differences are indicated with * for P<0.05, ** for P<0.01 and *** for P<0.001. 
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7.5.1 Composition of mitochondrial and microsomal membranes 
Humans (Homo sapiens) have a maximal lifespans (MLS) of 122 years, which is far 
higher than the MLS of mammals with similar body masses (AnAge Database). The 
peroxidation of mitochondrial membranes is considered a major cause of aging [4, 65, 
118], and one possible explanation for human longevity is that human mitochondria are 
less susceptible to peroxidation damage than expected for a mammal of their mass 
(Chapter Six). It has also been suggested that human mitochondria are less susceptible 
to peroxidation-related aging than other cellular membranes in humans [45, 240] and 
that this may be an evolutionary mechanism to extend longevity that is unique to 
humans [45, 134, 244, 245]. Unfortunately human data is rare in this area and only a 
limited number of studies from different laboratory groups have reported the fatty acid 
composition of whole liver [241-243] and liver mitochondria [138]. Unlike comparisons 
of this past work that found differences between the fatty acid composition and 
peroxidation index of liver mitochondria to whole liver cells [45, 240], the present study 
found few differences between the mitochondrial and microsomal fractions of muscle, 
liver and brain in humans. The peroxidation indexes of the mitochondrial and 
microsomal fractions did not differ significantly, with the peroxidation index of human 
liver mitochondria lower than previously reported [138] but the peroxidation index of 
human liver microsomes higher than previous reports for whole liver [241-243] (Figure 
7.3.). Unlike humans, mice (Mus musculus, MLS of 4 years) and pigs (Sus scrofa, MLS 
of 27 years) are examples of mammals with MLS similar to those of other mammals of 
their body mass. Comparisons of the mitochondrial and microsomal membranes of, 
found similar peroxidation indexes between mitochondrial and microsomal fractions of 
skeletal muscle, liver, and brain for each animal. Overall, mammalian mitochondria and 
microsomal membranes were found to be similar in their susceptibility to peroxidation 






Figure 7.3. Comparison of the peroxidation index of human (H. sapiens) liver from this chapter 
with published values for humans. 
 
 
A notable exception was mouse liver, where a higher peroxidation index was 
found for the microsomal fraction than the mitochondrial fraction. This difference was 
primarily due to the higher percentage of 22:6, a highly peroxidisable PUFA, in the 
microsomal fraction and may be related to 22:6n-3 synthesis. Standard mouse diets are 
generally low in long chain omega-3 fatty acids including 22:6n-3, and the primary 
source of 22:6 present in mouse tissues is 22:6n-3 synthesized in liver [247] by the fatty 
acid elongase ‘elongation of very long-chain fatty acids type 2’ (ELOVL–2) [248]. 
ELOVL–2 is highly expressed in mouse liver [248] where it is located in the 
endoplasmic reticulum (ER) [83], [88]. The ER is a major component of the microsomal 
fraction, and so high levels of 22:6n-3 synthesis in liver are likely to be reflected in a 
higher percentage of 22:6 and a higher peroxidation index found in the microsomal 
fraction than the mitochondrial fraction. A high level of 22:6n-3 synthesis in the 
microsomal fraction may also account for the higher percentage of PE 16:0_22:6 in 
mouse liver mitochondria as PE 16:0_22:6 is one of only four fatty acid compositions of 
PE that are synthesized de novo in mammals [86]. In comparison to mice, no difference 
was seen in the peroxidation index or percentage of 22:6 in liver mitochondrial and 
microsomal fractions for pigs or humans, suggesting that 22:6 synthesis is more 
common in mice liver than pig or human liver. This difference in 22:6 synthesis is 
likely to be related to the requirements of higher percentages of 22:6 in the tissues of 
mice than in the tissues of pigs or humans (Chapter Six). 
The relative abundance of phospholipid classes did not differ significantly 


























mitochondrial and microsomal PC and PS may reflect the common origin of these 
classes in the ER [82, 83]. The PC and PS produced in the ER are transported to 
mitochondrial and other cellular membranes either through vesicular pathways 
involving endosomal compartments and the Golgi apparatus or non-vesicular pathways 
using lipid transporter proteins [68]. Differences in the levels of PC found in muscle 
suggest some variation in how PC is imported into cellular membranes. Unlike PC and 
PS that must be imported into mitochondria, PE may be either imported from the ER or 
synthesised in mitochondria by the decarboxylation of PS [83]. The ability of 
mitochondria to synthesise PE independently of the ER may explain the high PE found 
in the mitochondrial fraction of all pig tissues and in mouse brain. This increase could 
also be associated with a higher importation of PE into mitochondria as no significant 
decrease in mitochondrial PS was observed. No difference in the levels of mitochondrial 
and microsomal PE was observed in other mouse or human tissues, suggesting pigs 
might be unusual in their regulation of PE levels. Mitochondria also synthesise 
phosphatidic acid (PA) and phosphatidylglycerol (PG) [83], but the only consistent 
finding in all three animals was a lower percentage of PA in the mitochondrial fraction 
of brain, which contrasts with a past report that phospholipid class was similar in the 
mitochondrial and microsomal fractions of rat brain [249]. The low amount of PA in 
mitochondria may be due a high degree of export to the microsomal membranes, or may 
be related to the role of PA as a substrate in the mitochondrial synthesis of PG and 
cardiolipin (CL) [83]. 
The mitochondrial and microsomal membranes of muscle, liver and brain 
generally contained similar molecular species of phospholipid. This is perhaps 
surprising considering that mitochondria possess different isoforms of enzymes for both 
fatty acid synthesis and phospholipid remodelling than the cytosol [17, 84]. The 
similarities between the phospholipid composition of the mitochondria suggest that 
fraction-specific enzyme isoforms do not greatly differ in their selectivity or function. 
Interestingly, in the few instances where molecular species of PC did differ between 
fractions, there was a trend for PC 16:0_16:0 and PC 16:0_18:1 to be higher in the 
mitochondrial fraction. As these phospholipids are synthesized de novo, this finding 
suggests that slightly less remodelling of PC is occurring in the mitochondria than in the 
microsomes [86]. No significant differences in percentages of PS as a class were found 
for any tissue, but the percentage of molecular species of PS did differ significantly in 
the mitochondrial and microsomal fractions of brain. The result of this asymmetrical 
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distribution was an increase in the percentage of two non-peroxidisable phospholipids, 
PS 18:0_18:1 in mice and pigs and PS 18:1_18:1 in humans. The increase in the 
percentages of PS 18:0_20:4 in mice and humans and PS 18:0_22:5 in pigs may be 
related to the role of PS oxidation in plasma membranes during pro-apoptotic signalling 
[250]. 
 
7.5.2 Phospholipid contributions to the peroxidation index 
With the exception of mouse liver, the peroxidation indexes of mitochondrial and 
microsomal membranes did not differ greatly in mice, pig or human tissues. Greater 
differences between fractions were seen in the relative contribution of phospholipid 
classes to the peroxidation index, but these differences were not generally consistent 
within species or tissues. The relative contribution of phospholipid classes to the 
peroxidation index was determined by both the relative abundance of phospholipid class 
and distribution of molecular phospholipids within that class (Table 7.4). The largest 
differences in phospholipid distribution were higher levels of non-peroxidisable 
phospholipids such as PC 16:0_16:0 , PC 16:0_18:1, PS 18:0_18:1 and PS 18:1_18:1 in 
mitochondrial membranes compared to microsomal membranes. In addition to replacing 
phospholipids containing PUFA, two non-peroxidisable phospholipids, PC 16:0_16:0 
and PC 6:0_18:1, have been found to exhibit an antioxidant-like activity (Chapter Five). 
It has yet to be determined if a similar antioxidant-like effect is caused by                  




Table 7.4. Contributions of phospholipid classes and molecular phospholipids to the 
peroxidation index in the mitochondrial fraction relative to the microsomal fraction of 
mouse, pig, and human tissues. 
 
Tissue  Animal  Class  Contribution relative  Reason 
   to microsomal 
fraction 
Class Phospholipid species 
Muscle Mouse PC –   
   PE –   
   PS –   
  Pig PC –   
   PE Increased Higher PE Higher PE 18:0_18:2 
   PS –   
  Human PC Increased Higher PC None 
   PE Decreased Lower PE* None 
    PS Decreased Lower PS* None 
      
Liver Mouse PC Decreased  Higher PC 16:0_16:0, 
Higher PC 16:0_18:1 
   PE –   
   PS Increased Higher PS* None 
  Pig PC –   
   PE Increased Higher PE Higher PE 16:0_20:4 
   PS Decreased   
  Human PC –   
   PE –   
   PS –   
            
Brain Mouse PC –     
   PE Increased Higher PE None 
   PS –   
  Pig PC Increased Lower PE,PS*  
   PE Decreased Lower PE,  None 
   PS Decreased Lower PS* Higher PS 18:0_18:1 
  Human PC Increased Higher PC  None 
   PE –   
    PS Decreased Lower PS* Higher PS 18:1_18:1 
      
Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens).  





A difference in the percentages of phospholipid with alkenyl ethers and vinyl 
ethers (plasmalogens)between membranes may also indicate an adaptation to decrease 
peroxidation. Plasmalogens are phospholipids with vinyl-ether bonds at the sn-1 
position, and this vinyl bond has been suggested to have an antioxidant-like action by 
acting as a sacrificial target for ROS [233]. Unlike other phospholipids, plasmalogens 
are synthesised in peroxisomes [83], and PE plasmalogens are transported into cellular 
membranes via a non-vesicular, ATP dependent pathway. The majority of alkenyl 
ethers and plasmalogens are present in the PE class. Plasmalogens in this class inhibit 
the loss of the phosphoethanolamine head group, and therefore the method used 
underestimated PE-plasmalogens when using a neutral loss of 141 to identify PE 
phospholipids [235]. A correction factor of 3.45 can be used to correct for this, but only 
if the plasmalogens can be differentiated from alkenyl ethers. This differentiation is not  
possible in the present study due to the methodology used, and so the present study took 
the conservative approach of reporting the sum of alkyl ethers and plasmalogens 
together without using a correction factor for plasmalogens [40, 236]. If a correction 
factor was used, the percentages of plasmalogens in human brain would be comparable 
to past findings [251]. In the present study, the percentage of alkenyl ethers and 
plasmalogens did not differ between mitochondrial and microsomal fractions of any 
tissue, and the high levels reported in the membranes of pig muscle mitochondria 
(Chapter Six) were also found in the membranes of pig muscle microsomes. These 
results suggest that acyl ethers do not confer additional protection to mammal 
mitochondria. This work contrasts to a previous finding of higher percentages of 




This chapter shares the limitations addressed in Chapter Six (Section 6.5.4) with regards 
to the post-mortem interval of the human tissue used, the absence of cardiolipin (CL) 
from the present analysis, and the comparison of species from different stages of their 
MLS. As a result of CL not being included in the analysis, the peroxidation indexes of 
mitochondrial membranes presented in this study are an underestimation. This 
underestimation does not, however, affect the conclusion of this study as the data did 
not support the hypothesis that the peroxidation index of mitochondrial membranes is 
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lower than that of microsomal membranes in humans. In addition, the analysis shows 
the high degree of similarity in mitochondrial and microsomal membranes (with the 
exception of CL) and suggests that the inclusion of CL into mitochondria does not 
influence the composition of molecular phospholipids present in other classes within the 
membrane. This work is also limited to a small number of species, which prevents the 
use of linear slopes to compare trends in cellular fractions. Future work could address 
this limitation by extending the number of species examined. A number of caveats 
should also be applied to the isolation techniques used to separate the mitochondrial and 
microsomal fractions of tissues. The techniques used were not tissue specific, and it is 
possible that synapsosomes may have co-sedimented out with brain mitochondria. 
These membranes would not have been as abundant as mitochondrial membranes and 
are unlikely to have greatly affected mitochondrial purity but should still be considered 
in future studies.  
7.6 Conclusion 
The present study used shotgun lipidomics to compare the membrane composition and 
peroxidation index of mitochondrial and microsomal membranes of skeletal muscle, 
liver and brain from humans, mice and pigs. The membrane composition of both 
fractions were similar for all three species, which does not support the hypothesis that 
humans prevent mitochondrial damage by excluding highly peroxidisable phospholipids 
form mitochondria. This one of the first lipidomics studies of the membrane 
composition and peroxidation index of cellular fractions, and suggests that membrane 
composition differs more between tissues that cellular fractions in mammals. Future 
work in this area could examine other cellular fractions within mammal tissues or in 





8 Chapter Eight               
Conclusion and outlook 
 
8.1 Membrane composition, peroxidation and longevity 
“It remains for us to discuss youth and age, life and death. To come to a definite 
understanding of these things would complete our study on animals.” 
Aristotle [1], ‘On Longevity and Shortness of Life’, Part 6. 
 
Aristotle may have been optimistic in his belief that a “definite understanding” of life 
could ever be reached, and continuing work in this area has shown biological systems to 
be some of the most complex systems yet encountered. This thesis has focussed on one 
fundamental element of cellular structure, membrane glycerophospholipids, in an 
attempt to better understand the importance of peroxidation of membrane phospholipids 
to oxidative stress, cellular damage, and aging. This thesis contains three studies that 
used different methodologies. The first study examined the relationship between dietary 
fats and mitochondrial membrane composition in Chapter Three, the second study 
investigated the importance of phospholipid composition to peroxidation in Chapter 
Four and Chapter Five, and third study examined the relationship between the 
susceptibility of membrane phospholipids to peroxidation and species longevity in 
Chapter Six and Chapter Seven. This chapter summarises the outcomes and significance 
of these findings and suggests future directions for this work. 
 
8.1.1 Cardiolipin composition is influenced by dietary fats 
Cardiolipin (CL) is widely considered to be primarily composed of linoleic acid   
(18:2n-6). This is probably due the persistent citation of early reports that found a high 
content of 18:2n-6 in CL (reviewed in [20, 51]), and a high percentage of                     
CL 18:2/18:2/18:2/18:2 in mammalian muscle [79]. Numerous published studies have 
reported that docosahexaenoic acid (22:6n-3) is selectively incorporated into CL, but 
these studies are frequently overlooked. The analysis of dietary data presented in 
Chapter Three reviews all available studies that have examined the influence of dietary 
fatty acids on CL composition in mice and rats. Interestingly, this review showed that 
when both 18:2n-6 and 22:6n-3 were present in the same diet, 22:6n-3 was incorporated 
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into heart CL at the expense of 18:2n-6. This occurred in heart when 22:6n-3 was up to 
~20% of dietary fatty acids and in liver when 22:6n-3 is up to 10% of total dietary fatty 
acids, suggesting that the regulation of CL composition may differ between tissues. This 
finding contrasts to the general view that CL has a highly regulated 18:2n-6 content that 
is not influenced by diet, and suggests that molecular species of CL containing 22:6n-3 
may be more common than previously considered. The incorporation of 22:6n-3 into 
CL and mitochondrial phosphatidylcholine (PC) and phosphatidylethanolamine (PE) 
reported in this analysis would greatly increase the peroxidation index of mitochondrial 
membranes, and may make mitochondria more susceptible to apoptosis induced by 
peroxidation [199]. 
 
8.1.2 The importance of phospholipid composition to peroxidation 
Most in vivo studies of peroxidation have focused on the role of the PUFA content of 
phospholipids, but other elements of phospholipid composition may also influence 
peroxidation. Chapter Four presents a comparison of the amount of peroxidation 
product produced by phospholipids of the CL, PC, PE, phosphatidic acid (PA) and 
phosphatidylglycerol (PG) classes that were matched for PUFA content. This 
comparison arose from observations made in the Else laboratory that bovine heart CL 
readily undergoes peroxidation in methanol, but that phospholipid of PC and PE do not 
despite have a similar peroxidation index. Upon further investigation, the ranking of 
iron-mediated lipid hydroperoxide production was found to be greater in CL and PA 
when tested in diffuse solutions (1:9 water to methanol v/v), but this was not found for 
CL and PA tested in liposomes in aqueous solutions. The order of lipid hydroperoxide 
production from highest to lowest for the phospholipid classes tested was PA> CL>> 
PE> PC, PG in methanol but PC> PE> CL> PG> PA in liposomes. These differences in 
class suggest that head group charge may influence peroxidation in methanol, but 
relative head group size appears to have a greater influence on peroxidation in 
liposomal bilayers. It was concluded that whatever properties make phospholipids of the 
CL and PA classes readily susceptible to peroxidation in methanol did not influence 
peroxidation in liposomes, and therefore may not be physiologically relevant. Past 
comparisons of phospholipid classes have had similar difficulties in establishing a 
relationship between phospholipid class and peroxidation, with some studies reporting 
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an influence of class due to charge, others due to phospholipid shape, and a few due to 
protein interactions [15].  
A more sophisticated study of peroxidation was carried out in Chapter Five using 
oxygen consumption as a measure of peroxidation. This chapter examined the ability of 
non-peroxidisable phospholipids (non-PPL) to extend the lag phase through an 
antioxidant-like action. While most in vitro studies of peroxidation focus on either the 
maximal rate of peroxidation or the products of peroxidation, Chapter Five contained 
multiple measures of peroxidation as proposed by Pinchuk and Lichtenberg (2014) [96] 
including rates of peroxidation during the lag phase, the length of the lag phase, and 
rates of peroxidation during the propagation phase. The length of the lag phase is a 
particularly important measure of peroxidation as the lag phase is a period of limited 
oxidative stress where cells can nullify oxidative damage in order to maintain a healthy 
physiological state [108]. It is possible that healthy cells exist in this phase indefinitely 
by limiting reactive oxygen species (ROS) production with lipid-soluble antioxidants 
such as α–tocopherol. The antioxidant-like ability of non-PPLs to delay peroxidation 
through steric hindrance or ‘caging’ of ROS may be particularly efficient in maintaining 
the lag phase as non-PPLs are unlikely to be damaged or consumed in the same manner 
as other antioxidants. This effect may also be widespread as non-PPLs are major 
component of most cells. In addition, the antioxidant-like action of non-PPL is 
predicted to work synergistically with other antioxidant systems to greatly enhance their 
effectiveness as shown in Figure 8.1. 
 
 
Figure 8.1. Oxygen consumption as a measure of the iron-mediated peroxidation of 
peroxidisable phospholipids (PPL) alone, with non-PPLs, with antioxidants, and with both   
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8.1.3 Membrane composition and lifespan 
Chapter Six and Chapter Seven of this thesis investigated the relationship between 
membrane susceptibility to peroxidation and the maximal lifespan (MLS) of three 
mammals. Skeletal muscle, liver and brain from mice (Mus musculus, MLS of 4 years), 
pigs (Sus scrofa, MLS of 27 years) and humans (Homo sapiens, MLS of 122 years) 
were examined using shotgun lipidomics. In Chapter Six, an interspecies comparison 
found a link between mitochondrial membrane composition and longevity, with mouse 
mitochondria containing high percentages of highly unsaturated PUFA in all 
phospholipid classes, human mitochondria containing low percentages of PUFA content 
with a low degree of unsaturation, and pig mitochondria sharing characteristics of both 
mice and human. The results for the peroxidation indexes calculated for skeletal muscle 
mitochondria are compared with published values for mammal species in Figure 8.2. As 
can be seen from the figure, the values of Chapter Six, particularly for pigs, are slightly 
lower than the published trend for mammals. This low value may be a result of using 
shotgun lipidomics as this method has been found to report a lower percentage of 
membrane PUFA than the gas chromatography (GC) methods used in the majority of 
work in this area [18]. This difference may be due to the lipidomics analysis not 
including phosphatidylinositol and CL, which are both classes of phospholipid with 
high PUFA content [20]. Despite these small differences to past work, however, the 
comparison of membrane composition between mice, pigs and humans supports the link 
between membrane composition and longevity proposed in the “Membrane Pacemaker 
Theory Of Aging” and similar theories. 
This thesis also presents one of the first investigations into how phospholipid 
classes and individual species of molecular phospholipids contribute to the peroxidation 
index. Somewhat surprisingly, the peroxidation index of membranes was primarily 
determined by a limited number of molecular phospholipids species (Figure 6.4). 
Molecular species of both PC and PE were large contributors to the peroxidation index 
in skeletal muscle, PE 18:0_20:4 was the major contributor in liver, and PE 18:0_22:6 
was the major contributor in brain. Another molecular phospholipid species of 
particular interest was PC 16:0_18:1, a non-PPL found to increase the lag phase of 
peroxidation in Chapter Five that was far more common in the tissues of human than of 
mice or pigs. This finding suggests that human membranes are more likely to be 
protected by the antioxidant-like action of this phospholipid in comparison to the 
membranes of mice or pigs. 
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Figure 8.2. Comparison of the peroxidation index of mitochondria from mice, pig and human 
skeletal muscle values from Chapter Six, (red crosses) to published values for mammal muscle 
from [29] (grey circles). 
 
 
Chapter Seven used the same methods and samples as Chapter Six to investigate 
whether humans are capable of excluding highly peroxidisable fatty acids from their 
mitochondrial membranes. If this were the case, it would represent an ability to decrease 
the rate of aging caused by mitochondrial damage and may explain why humans have 
exceptionally long lifespans in comparison to others mammals. This ability was thought 
to be unique to humans, and was not be expected to be present in mammals such as 
mice or pigs that have lifespans close to those predicted for their body mass. An intra-
species comparison of the mitochondrial and microsomal membranes in humans, mice, 
and pigs found a high degree of similarity between organelle membrane composition 
within the tissues of each species, although some small differences were seen for 
individual phospholipid classes. Mouse liver had a higher peroxidation index in the 
microsomal fraction, possibly due to to 22:6n-3 synthesis. With the exception of this 
tissue, however, no differences were found in the peroxidation indexes of mitochondrial 
and microsomal fractions of tissues of human, mice or pigs. This finding suggests that 
the exceptionally longevity of humans is not due to a unique ability to decrease the 
susceptibility of their mitochondria membranes to peroxidation, and that humans are 
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A significant outcome of this thesis was the lipidomics profiling of human tissues 
to a level of detail not previously described. To the best of my knowledge, the work 
presented in this thesis is one of the most comprehensive examinations of the membrane 
composition and peroxidation index of humans and other mammals to date. Working 
with human tissues has many challenges, but results for human tissues are of particular 
relevance both to the understanding of human physiology and studies of mammalian 
longevity and aging. Overall, the finding that the membranes of human tissues 
contained a low percentage of PUFA and a high percentage of non-PPLs suggests that 
human longevity may be due to an ability to prevent the propagation of peroxidation in 
all cellular membranes, and thereby limit oxidative stress and damage. 
 
8.2 Outlook and future directions 
The work presented in this thesis supports the association between membrane 
susceptibility to peroxidation and lifespan, but emphasise the need for caveats on the 
traditional measures of the peroxidation index. Traditional calculations of the 
peroxidation index are based on GC measures of fatty acid composition and do not take 
into account the potential other elements of phospholipid composition such as class, 
non-PPLs, and plasmalogens to influence peroxidation. This thesis has shown the 
importance of measuring the contribution of such elements to peroxidation using in 
vitro peroxidation studies in addition to the distribution of these elements in animal 
tissues using a lipidomics analysis. It would also be valuable to identify how 
components of membranes such sterols, proteins, and lipophilic antioxidants may 
influence peroxidation. Future work in this area could incorporate the importance of 
these elements into the traditional measure of the peroxidation index to reach a better 
understanding of the interaction between membrane composition and oxidative stress in 
natural systems. My suggestions for such future work include:  
1) Examining how the incorporation of dietary 22:6n-3 into CL affects membrane 
susceptibility to peroxidation and animal longevity. 
2) Investigations of whether CL and other phospholipid classes influence the rates 
and lag phases of peroxidation in liposomal systems. 
3) Replicating the antioxidant-like effect of non-PPLs using different combinations 
of phospholipid classes, fatty acid compositions, and initiators of peroxidation to 
clarify the underlying mechanism. 
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4) Proving experimentally that the antioxidant-like effect of non-PPLs affect works 
synergistically with lipophilic antioxidants present in cellular membranes. 
5) Comparative studies of tissues from humans and mammals of similar sizes but 
shorter lifespans to determine membrane composition using shotgun lipidomics 
and membrane susceptibility to peroxidation using in vitro assays to test the lag 
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Appendix A – Scans used in shotgun lipidomics analysis. 
Appendix Table A. Targeted ion scans used to acquired phospholipid data 
 Ion Mode Scan DP EP CE CXP Mass Range Da/ second 
 
Fatty acid chain scans 
PC Positive PI 184.1 100 10 47 8 640–1000 200 
Lyso–PC Positive PI 184.1 100 10 47 8 450–600 200 
PE Positive NL 141 100 10 30 8 685–950 200 
Lyso–PE Positive NL 141 100 10 30 8 400–600 200 
PS Positive NL 185 100 10 30 8 755–965 200 
 
Fatty acid chain scans 
    
14:0 Negative PI 227.2 -100 -10 -55 -11 580–900 1000 
16:1 Negative PI 253.2 -100 -10 -55 -11 600–900 1000 
16:0 Negative PI 255.2 -100 -10 -55 -11 600–900 1000 
17:0 Negative PI 269.3 -100 -10 -55 -11 560–900 1000 
18:3 Negative PI 277.2 -100 -10 -40 -11 600–900 1000 
18:2 Negative PI 279.2 -100 -10 -40 -11 600–900 1000 
18:1 Negative PI 281.3 -100 -10 -55 -11 600–900 1000 
18:0 Negative PI 283.3 -100 -10 -55 -11 600–900 1000 
19:0 Negative PI 297.3 -100 -10 -55 -11 600–900 1000 
20:5 Negative PI 301.2 -100 -10 -40 -11 500–1000 1000 
20:4 Negative PI 303.2 -100 -10 -40 -11 600–1000 1000 
20:3 Negative PI 305.2 -100 -10 -40 -11 600–1000 1000 
20:2 Negative PI 307.2 -100 -10 -40 -11 600–1000 1000 
20:1 Negative PI 309.2 -100 -10 -55 -11 600–1000 1000 
20:0 Negative PI 311.2 -100 -10 -55 -11 600–1000 1000 
22:6 Negative PI 327.2 -100 -10 -40 -11 700–1000 1000 
22:5 Negative PI 329.2 -100 -10 -40 -11 700–1000 1000 
22:4 Negative PI 331.2 -100 -10 -40 -11 700–1000 1000 
22:3 Negative PI 333.3 -100 -10 -40 -11 600–1000 1000 
22:2 Negative PI 335.2 -100 -10 -40 -11 700–1000 1000 
22:1 Negative PI 337.3 -100 -10 -55 -11 700–1000 1000 
22:0 Negative PI 339.3 -100 -10 -55 -11 600–1000 1000 
24:1 Negative PI 365.3 -100 -10 -55 -11 700–1000 1000 
Mass shifting was prevented in negative ion mode by increasing number of summed scans. PI precursor 
ion, NL neutral loss, DP declustering potential, EP entrance potential, CE collision energy, CXP collision 
cell exit potential, PC phosphatidylcholine; PE phosphatidylethanolamine; PS phosphatidylserine. 
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Appendix B – Distribution of phospholipids in mitochondrial 
and microsomal fractions of mouse, pig and human tissues. 
Appendix Table B1. Distribution of phospholipid classes in the mitochondrial and 
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Appendix Table B2. Distribution of phospholipid classes in the mitochondrial and 
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Appendix Table B3. Distribution of phospholipid classes in the mitochondrial and 
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         Values are means ±SEM, n=6. 
 
 
 
